"","Patient_Id","Sample_Id","Overall_Survival_Months","Overall_Survival_Status","Tp_53_Mutation","Dnmt_3_A_Mutation","Risk.Classification","Npm_1_Consensus_Call","treatment_1","treatment_2","treatment_3","treatment_4","treatment_5","treatment_6","treatment_7","treatment_8","treatment_9","treatment_10","treatment_11","treatment_12","treatment_13"
"1","aml_ohsu_2018_1011","aml_ohsu_2018_13-00098",NA,NA,NA,NA,"Good","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","MEC (Cytarabine, Etoposide, Mitoxantrone)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"2","aml_ohsu_2018_1027","aml_ohsu_2018_13-00123",0.3,"1:DECEASED",NA,NA,"Good","Positive",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"3","aml_ohsu_2018_1045","aml_ohsu_2018_13-00145",6.38,"1:DECEASED",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","Azacitidine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"4","aml_ohsu_2018_1046","aml_ohsu_2018_13-00146",5.2,"1:DECEASED","Negative","Negative","Good","Negative","COG-AAML1031 (IT/IV Cytarabine, Daunorubicin, Etoposide, Mitoxantrone +/- Bortezomib or Sorafenib)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"5","aml_ohsu_2018_1049","aml_ohsu_2018_13-00149",8.78,"1:DECEASED","Negative","Negative","Intermediate","Negative","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"6","aml_ohsu_2018_1051","aml_ohsu_2018_13-00150",13.29,"1:DECEASED",NA,NA,"Poor","Negative","7+3 (Cytarabine, Idarubicin)","Sunitinib","HAM (Cytarabine, Mitoxantrone)","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","Decitabine","Busulfan, Cyclophosphamide",NA,NA,NA,NA,NA,NA,NA
"7","aml_ohsu_2018_1054","aml_ohsu_2018_13-00157",45.36,"0:LIVING","Negative","p.Q696fs*9; MAF 40%","Good","Positive","7+3 (Cytarabine, Idarubicin)","MiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"8","aml_ohsu_2018_1058","aml_ohsu_2018_13-00163",13.16,"0:LIVING","Negative","Negative","Good","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","Cytarabine, Methotrexate","Busulfan, Cyclophosphamide",NA,NA,NA,NA,NA,NA,NA,NA,NA
"9","aml_ohsu_2018_1060","aml_ohsu_2018_13-00165",14.44,"1:DECEASED",NA,NA,"Intermediate","Positive","Busulfan, Fludarabine","7+3 (Cytarabine, Idarubicin)","HiDAC","HAM (Cytarabine, Mitoxantrone)",NA,NA,NA,NA,NA,NA,NA,NA,NA
"10","aml_ohsu_2018_1061","aml_ohsu_2018_13-00166",33.55,"1:DECEASED",NA,NA,"Intermediate","Negative","GCLAM (G-CSF, Cladribine, Cytarabine, and Mitoxantrone) ","7+3 (Cytarabine, Idarubicin)","HiDAC","HAM (Cytarabine, Mitoxantrone)","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","Azacitidine","MEC (Cytarabine, Etoposide, Mitoxantrone)","Cladribine",NA,NA,NA,NA,NA
"11","aml_ohsu_2018_1072","aml_ohsu_2018_13-00186",4.14,"1:DECEASED","Negative","Negative","Poor","Negative",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"12","aml_ohsu_2018_1078","aml_ohsu_2018_13-00195",31.97,"0:LIVING","Negative","p.R882H; MAF 50%","Good","Positive","7+3 (Cytarabine, Idarubicin)","MiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"13","aml_ohsu_2018_1082","aml_ohsu_2018_13-00201",8.13,"1:DECEASED","Negative","p.N879D; MAF 50%","Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","Busulfan, Cyclophosphamide",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"14","aml_ohsu_2018_1086","aml_ohsu_2018_13-00202",24.74,"1:DECEASED",NA,NA,"Good","Positive",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"15","aml_ohsu_2018_1088","aml_ohsu_2018_13-00204",0.23,"1:DECEASED","Negative","Negative","Good","Negative","ATRA (Tretinoin)","3+7 (Cytarabine, Daunorubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"16","aml_ohsu_2018_1093","aml_ohsu_2018_13-00242",8.36,"1:DECEASED","Positive",NA,"Poor","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","MEC (Cytarabine, Etoposide, Mitoxantrone)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"17","aml_ohsu_2018_1094","aml_ohsu_2018_13-00218",45.95,"0:LIVING","Negative","Negative","Good","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","MEC (Cytarabine, Etoposide, Mitoxantrone)","Busulfan, Cyclophosphamide",NA,NA,NA,NA,NA,NA,NA,NA,NA
"18","aml_ohsu_2018_1098","aml_ohsu_2018_13-00294",87.53,"1:DECEASED",NA,NA,"Intermediate","Negative","Fludarabine, Melphalan","Dasatinib","7+3 (Cytarabine, Idarubicin)","HiDAC","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","Azacitidine","MEC (Cytarabine, Etoposide, Mitoxantrone)","Rituximab","Busulfan, Cyclophosphamide",NA,NA,NA,NA
"19","aml_ohsu_2018_1098","aml_ohsu_2018_13-00294",87.53,"1:DECEASED",NA,NA,"Intermediate","Negative","Fludarabine, Melphalan","Dasatinib","7+3 (Cytarabine, Idarubicin)","HiDAC","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","Azacitidine","MEC (Cytarabine, Etoposide, Mitoxantrone)","Rituximab","Busulfan, Cyclophosphamide",NA,NA,NA,NA
"20","aml_ohsu_2018_1098","aml_ohsu_2018_14-00780",87.53,"1:DECEASED",NA,NA,"Intermediate","Negative","Fludarabine, Melphalan","Dasatinib","7+3 (Cytarabine, Idarubicin)","HiDAC","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","Azacitidine","MEC (Cytarabine, Etoposide, Mitoxantrone)","Rituximab","Busulfan, Cyclophosphamide",NA,NA,NA,NA
"21","aml_ohsu_2018_1098","aml_ohsu_2018_14-00780",87.53,"1:DECEASED",NA,NA,"Intermediate","Negative","Fludarabine, Melphalan","Dasatinib","7+3 (Cytarabine, Idarubicin)","HiDAC","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","Azacitidine","MEC (Cytarabine, Etoposide, Mitoxantrone)","Rituximab","Busulfan, Cyclophosphamide",NA,NA,NA,NA
"22","aml_ohsu_2018_1101","aml_ohsu_2018_13-00232",32.93,"0:LIVING","Negative","Negative","Intermediate","Negative","Busulfan, Fludarabine","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"23","aml_ohsu_2018_1103","aml_ohsu_2018_13-00236",65.56,"0:LIVING",NA,NA,"Poor","Negative","Cyclophosphamide, Fludarabine, TBI","FLAG (Fludarabine, High-dose Cytarabine, G-CSF)","COG-AAML0531 (Cytarabine, Daunorubicin, Etoposide, L-Asparaginase, Mitoxantrone +/- Gemtuzumab)","Treo/Flu/TBI (Treosulfan, Fludarabine, Total Body Irradiation)","COG-AAML07P1",NA,NA,NA,NA,NA,NA,NA,NA
"24","aml_ohsu_2018_1104","aml_ohsu_2018_13-00237",5.79,"1:DECEASED","Negative","Negative","Poor","Negative","3+7 (Cytarabine, Daunorubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"25","aml_ohsu_2018_1104","aml_ohsu_2018_13-00237",5.79,"1:DECEASED","Negative","Negative","Poor","Negative","3+7 (Cytarabine, Daunorubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"26","aml_ohsu_2018_1104","aml_ohsu_2018_13-00255",5.79,"1:DECEASED","Negative","Negative","Poor","Negative","3+7 (Cytarabine, Daunorubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"27","aml_ohsu_2018_1104","aml_ohsu_2018_13-00255",5.79,"1:DECEASED","Negative","Negative","Poor","Negative","3+7 (Cytarabine, Daunorubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"28","aml_ohsu_2018_1105","aml_ohsu_2018_13-00247",6.55,"0:LIVING","Negative","Negative","Good","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"29","aml_ohsu_2018_1108","aml_ohsu_2018_13-00245",28.19,"0:LIVING",NA,NA,"Good","Negative","COG-AAML1031 (IT/IV Cytarabine, Daunorubicin, Etoposide, Mitoxantrone +/- Bortezomib or Sorafenib)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"30","aml_ohsu_2018_1111","aml_ohsu_2018_13-00250",11.71,"1:DECEASED",NA,NA,"Intermediate","Negative","Azacitidine","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"31","aml_ohsu_2018_1113","aml_ohsu_2018_13-00253",8.98,"1:DECEASED","Negative","Negative","Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","MEC (Cytarabine, Etoposide, Mitoxantrone)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"32","aml_ohsu_2018_1117","aml_ohsu_2018_13-00260",33.26,"0:LIVING","p.S366A; MAF 50%","Negative","Good","Negative","COG-AAML0531 (Cytarabine, Daunorubicin, Etoposide, L-Asparaginase, Mitoxantrone +/- Gemtuzumab)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"33","aml_ohsu_2018_1118","aml_ohsu_2018_13-00262",14.97,"1:DECEASED",NA,NA,"Poor","Positive","Crenolanib","MEC, plexifor, GCSF","Sorafenib","7+3 (Cytarabine, Idarubicin) plus LBH","Clofarabine, Cytarabine",NA,NA,NA,NA,NA,NA,NA,NA
"34","aml_ohsu_2018_1119","aml_ohsu_2018_13-00266",4.24,"1:DECEASED","Negative","Negative","Poor","Negative","7+3 (Cytarabine, Idarubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"35","aml_ohsu_2018_1121","aml_ohsu_2018_13-00268",3.72,"1:DECEASED",NA,NA,"Intermediate","Negative","GCLAM (G-CSF, Cladribine, Cytarabine, and Mitoxantrone) ","3+7 (Cytarabine, Daunorubicin)","MEC (Cytarabine, Etoposide, Mitoxantrone)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"36","aml_ohsu_2018_1123","aml_ohsu_2018_13-00270",4.97,"0:LIVING","Negative",NA,"Good","Negative","COG-AAML1031 (IT/IV Cytarabine, Daunorubicin, Etoposide, Mitoxantrone +/- Bortezomib or Sorafenib)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"37","aml_ohsu_2018_1126","aml_ohsu_2018_13-00273",7.27,"1:DECEASED",NA,"p.R882H; MAF 50%","Intermediate","Positive","Fludarabine, Melphalan","7+3 (Cytarabine, Idarubicin)","HiDAC","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA
"38","aml_ohsu_2018_1131","aml_ohsu_2018_13-00281",6.22,"1:DECEASED","Negative","Negative","Intermediate","Negative","Azacitidine, Lenalidomide",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"39","aml_ohsu_2018_1137","aml_ohsu_2018_13-00286",37.83,"0:LIVING","Negative","Negative","Intermediate","Positive","HiDAC","7+3 (Cytarabine, Idarubicin)","Busulfan, Cyclophosphamide",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"40","aml_ohsu_2018_1153","aml_ohsu_2018_13-00331",25.03,"1:DECEASED","Negative","Negative","Good","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","MEC (Cytarabine, Etoposide, Mitoxantrone)","Cyclophosphamide, Etoposide, TBI",NA,NA,NA,NA,NA,NA,NA,NA
"41","aml_ohsu_2018_1153","aml_ohsu_2018_13-00331",25.03,"1:DECEASED","Negative","Negative","Good","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","MEC (Cytarabine, Etoposide, Mitoxantrone)","Cyclophosphamide, Etoposide, TBI",NA,NA,NA,NA,NA,NA,NA,NA
"42","aml_ohsu_2018_1153","aml_ohsu_2018_14-00044",25.03,"1:DECEASED",NA,NA,"Good","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","MEC (Cytarabine, Etoposide, Mitoxantrone)","Cyclophosphamide, Etoposide, TBI",NA,NA,NA,NA,NA,NA,NA,NA
"43","aml_ohsu_2018_1153","aml_ohsu_2018_14-00044",25.03,"1:DECEASED",NA,NA,"Good","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","MEC (Cytarabine, Etoposide, Mitoxantrone)","Cyclophosphamide, Etoposide, TBI",NA,NA,NA,NA,NA,NA,NA,NA
"44","aml_ohsu_2018_1157","aml_ohsu_2018_13-00338",82.96,"0:LIVING","Negative","Negative","Good","Negative","7+3 (Cytarabine, Idarubicin)","3+7 (Cytarabine, Daunorubicin)","Azacitidine, Gemtuzumab","MEC (Cytarabine, Etoposide, Mitoxantrone)","Etoposide, Cytarabine",NA,NA,NA,NA,NA,NA,NA,NA
"45","aml_ohsu_2018_1159","aml_ohsu_2018_13-00342",29.67,"0:LIVING","Negative","Negative","Good","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","Donor Lymphocyte Infusion","GCLAC (GCSF, Clofarabine & Cytarabine)","MEC (Cytarabine, Etoposide, Mitoxantrone)","Decitabine","Fludarabine, Cyclophosphamide, TBI",NA,NA,NA,NA,NA,NA
"46","aml_ohsu_2018_1161","aml_ohsu_2018_13-00353",8.88,"1:DECEASED","Negative","Negative","Intermediate","Negative","GCLAM (G-CSF, Cladribine, Cytarabine, and Mitoxantrone) ","7+3 (Cytarabine, Idarubicin)","HiDAC","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA
"47","aml_ohsu_2018_1161","aml_ohsu_2018_13-00353",8.88,"1:DECEASED","Negative","Negative","Intermediate","Negative","GCLAM (G-CSF, Cladribine, Cytarabine, and Mitoxantrone) ","7+3 (Cytarabine, Idarubicin)","HiDAC","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA
"48","aml_ohsu_2018_1161","aml_ohsu_2018_14-00015",8.88,"1:DECEASED",NA,NA,"Intermediate","Negative","GCLAM (G-CSF, Cladribine, Cytarabine, and Mitoxantrone) ","7+3 (Cytarabine, Idarubicin)","HiDAC","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA
"49","aml_ohsu_2018_1161","aml_ohsu_2018_14-00015",8.88,"1:DECEASED",NA,NA,"Intermediate","Negative","GCLAM (G-CSF, Cladribine, Cytarabine, and Mitoxantrone) ","7+3 (Cytarabine, Idarubicin)","HiDAC","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA
"50","aml_ohsu_2018_1162","aml_ohsu_2018_13-00346",15.76,"1:DECEASED",NA,NA,"Poor","Negative","Azacitidine, Sorafenib","7+3 (Cytarabine, Idarubicin)","HiDAC","Crenolanib","PLX3397","Fludarabine, Cyclophosphamide, Thiotepa, TBI","AC220 (Ambit)",NA,NA,NA,NA,NA,NA
"51","aml_ohsu_2018_1163","aml_ohsu_2018_13-00354",10.86,"1:DECEASED","Negative","Negative","Intermediate","Negative","5+2 (Cytarabine, Idarubicin)","7+3 (Cytarabine, Idarubicin)","Decitabine","Stanford Protocol 9153 (TLI, ATG)",NA,NA,NA,NA,NA,NA,NA,NA,NA
"52","aml_ohsu_2018_1171","aml_ohsu_2018_13-00365",13.82,"1:DECEASED","Positive","Negative","Poor","Positive","Azacitidine, Lenalidomide","Temozolomide, Vorinostat",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"53","aml_ohsu_2018_1181","aml_ohsu_2018_13-00383",23.65,"1:DECEASED","Negative","Negative","Intermediate","Negative","Cytarabine","Azacitidine","Stanford Protocol 9153 (TLI, ATG)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"54","aml_ohsu_2018_1181","aml_ohsu_2018_13-00383",23.65,"1:DECEASED","Negative","Negative","Intermediate","Negative","Cytarabine","Azacitidine","Stanford Protocol 9153 (TLI, ATG)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"55","aml_ohsu_2018_1181","aml_ohsu_2018_13-00384",23.65,"1:DECEASED","Negative","Negative","Intermediate","Negative","Cytarabine","Azacitidine","Stanford Protocol 9153 (TLI, ATG)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"56","aml_ohsu_2018_1181","aml_ohsu_2018_13-00384",23.65,"1:DECEASED","Negative","Negative","Intermediate","Negative","Cytarabine","Azacitidine","Stanford Protocol 9153 (TLI, ATG)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"57","aml_ohsu_2018_1184","aml_ohsu_2018_13-00393",40.69,"1:DECEASED",NA,NA,"Poor","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","AG-221","HAM (Mitoxantrone, Cytarabine) plus Crenolanib","Fludarabine, Melphalan, ATG",NA,NA,NA,NA,NA,NA,NA,NA
"58","aml_ohsu_2018_1184","aml_ohsu_2018_13-00393",40.69,"1:DECEASED",NA,NA,"Poor","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","AG-221","HAM (Mitoxantrone, Cytarabine) plus Crenolanib","Fludarabine, Melphalan, ATG",NA,NA,NA,NA,NA,NA,NA,NA
"59","aml_ohsu_2018_1184","aml_ohsu_2018_15-00053",40.69,"1:DECEASED",NA,NA,"Poor","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","AG-221","HAM (Mitoxantrone, Cytarabine) plus Crenolanib","Fludarabine, Melphalan, ATG",NA,NA,NA,NA,NA,NA,NA,NA
"60","aml_ohsu_2018_1184","aml_ohsu_2018_15-00053",40.69,"1:DECEASED",NA,NA,"Poor","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","AG-221","HAM (Mitoxantrone, Cytarabine) plus Crenolanib","Fludarabine, Melphalan, ATG",NA,NA,NA,NA,NA,NA,NA,NA
"61","aml_ohsu_2018_1187","aml_ohsu_2018_13-00396",7.5,"1:DECEASED","p.R273S; MAF 40%",NA,"Poor","Negative","7+3 (Cytarabine, Idarubicin)","Decitabine","Bu/Flu/TBI (Busulfan, Fludarabine, Total Body Irradiation)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"62","aml_ohsu_2018_1190","aml_ohsu_2018_13-00406",0.07,"1:DECEASED","Negative","p. R882C; MAF 50%","Poor","Negative",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"63","aml_ohsu_2018_1190","aml_ohsu_2018_13-00406",0.07,"1:DECEASED","Negative","p. R882C; MAF 50%","Poor","Negative",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"64","aml_ohsu_2018_1190","aml_ohsu_2018_13-00409",0.07,"1:DECEASED","Negative","p.R882C; MAF 50%","Intermediate","Negative",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"65","aml_ohsu_2018_1190","aml_ohsu_2018_13-00409",0.07,"1:DECEASED","Negative","p.R882C; MAF 50%","Intermediate","Negative",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"66","aml_ohsu_2018_1193","aml_ohsu_2018_13-00417",4.18,"1:DECEASED","Negative",NA,"Intermediate","Positive","Decitabine, Midostaurin",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"67","aml_ohsu_2018_1194","aml_ohsu_2018_13-00420",12.6,"1:DECEASED",NA,NA,"Poor","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","Azacitidine","MEC (Cytarabine, Etoposide, Mitoxantrone)","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA
"68","aml_ohsu_2018_1196","aml_ohsu_2018_13-00424",0.76,"1:DECEASED","Positive","Negative","Poor","Negative","Azacitidine, Lenalidomide",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"69","aml_ohsu_2018_1197","aml_ohsu_2018_13-00425",15.99,"0:LIVING",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","Busulfan, Cyclophosphamide",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"70","aml_ohsu_2018_1224","aml_ohsu_2018_13-00450",4.08,"1:DECEASED",NA,NA,"Good","Positive","7+3 (Cytarabine, Idarubicin)","Crenolanib",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"71","aml_ohsu_2018_1226","aml_ohsu_2018_13-00454",NA,NA,NA,NA,"Good","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"72","aml_ohsu_2018_1233","aml_ohsu_2018_13-00468",12.17,"1:DECEASED","Negative","Negative","Poor","Negative","5+2 (Cytarabine, Idarubicin)","7+3 (Cytarabine, Idarubicin)","MEC (Cytarabine, Etoposide, Mitoxantrone)","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA
"73","aml_ohsu_2018_1233","aml_ohsu_2018_13-00468",12.17,"1:DECEASED","Negative","Negative","Poor","Negative","5+2 (Cytarabine, Idarubicin)","7+3 (Cytarabine, Idarubicin)","MEC (Cytarabine, Etoposide, Mitoxantrone)","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA
"74","aml_ohsu_2018_1233","aml_ohsu_2018_13-00557",12.17,"1:DECEASED",NA,NA,"Poor","Negative","5+2 (Cytarabine, Idarubicin)","7+3 (Cytarabine, Idarubicin)","MEC (Cytarabine, Etoposide, Mitoxantrone)","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA
"75","aml_ohsu_2018_1233","aml_ohsu_2018_13-00557",12.17,"1:DECEASED",NA,NA,"Poor","Negative","5+2 (Cytarabine, Idarubicin)","7+3 (Cytarabine, Idarubicin)","MEC (Cytarabine, Etoposide, Mitoxantrone)","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA
"76","aml_ohsu_2018_1241","aml_ohsu_2018_16-00267",31.35,"0:LIVING",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","Azacitidine",NA,NA,NA,NA,NA,NA,NA,NA,NA
"77","aml_ohsu_2018_1243","aml_ohsu_2018_13-00487",11.78,"0:LIVING","Negative",NA,"Good","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"78","aml_ohsu_2018_1246","aml_ohsu_2018_13-00493",18.68,"1:DECEASED",NA,"Foundation, R882H; MAF 9%","Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","Crenolanib","Clofarabine, Cytarabine","Busulfan, Cyclophosphamide",NA,NA,NA,NA,NA,NA,NA
"79","aml_ohsu_2018_1246","aml_ohsu_2018_13-00493",18.68,"1:DECEASED",NA,"Foundation, R882H; MAF 9%","Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","Crenolanib","Clofarabine, Cytarabine","Busulfan, Cyclophosphamide",NA,NA,NA,NA,NA,NA,NA
"80","aml_ohsu_2018_1246","aml_ohsu_2018_14-00495",18.68,"1:DECEASED",NA,"R882H; MAF unlisted","Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","Crenolanib","Clofarabine, Cytarabine","Busulfan, Cyclophosphamide",NA,NA,NA,NA,NA,NA,NA
"81","aml_ohsu_2018_1246","aml_ohsu_2018_14-00495",18.68,"1:DECEASED",NA,"R882H; MAF unlisted","Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","Crenolanib","Clofarabine, Cytarabine","Busulfan, Cyclophosphamide",NA,NA,NA,NA,NA,NA,NA
"82","aml_ohsu_2018_1247","aml_ohsu_2018_13-00496",48.68,"0:LIVING",NA,NA,"Good","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"83","aml_ohsu_2018_1247","aml_ohsu_2018_13-00496",48.68,"0:LIVING",NA,NA,"Good","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"84","aml_ohsu_2018_1247","aml_ohsu_2018_13-00497",48.68,"0:LIVING",NA,NA,"Good","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"85","aml_ohsu_2018_1247","aml_ohsu_2018_13-00497",48.68,"0:LIVING",NA,NA,"Good","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"86","aml_ohsu_2018_1248","aml_ohsu_2018_13-00500",5.13,"1:DECEASED",NA,NA,"Intermediate","Negative","Azacitidine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"87","aml_ohsu_2018_1255","aml_ohsu_2018_13-00513",8.09,"1:DECEASED",NA,NA,"Poor","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","MEC (Cytarabine, Etoposide, Mitoxantrone)","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA
"88","aml_ohsu_2018_1257","aml_ohsu_2018_13-00515",21.64,"1:DECEASED",NA,NA,"Poor","Negative","Cytarabine, Fludarabine, Sorafenib","Crenolanib","Azacitidine","Sorafenib","Decitabine, Sorafenib ","Clofarabine, Cytarabine","Sapacitabine (CYC682-06)",NA,NA,NA,NA,NA,NA
"89","aml_ohsu_2018_1257","aml_ohsu_2018_13-00515",21.64,"1:DECEASED",NA,NA,"Poor","Negative","Cytarabine, Fludarabine, Sorafenib","Crenolanib","Azacitidine","Sorafenib","Decitabine, Sorafenib ","Clofarabine, Cytarabine","Sapacitabine (CYC682-06)",NA,NA,NA,NA,NA,NA
"90","aml_ohsu_2018_1257","aml_ohsu_2018_13-00593",21.64,"1:DECEASED",NA,NA,"Poor","Negative","Cytarabine, Fludarabine, Sorafenib","Crenolanib","Azacitidine","Sorafenib","Decitabine, Sorafenib ","Clofarabine, Cytarabine","Sapacitabine (CYC682-06)",NA,NA,NA,NA,NA,NA
"91","aml_ohsu_2018_1257","aml_ohsu_2018_13-00593",21.64,"1:DECEASED",NA,NA,"Poor","Negative","Cytarabine, Fludarabine, Sorafenib","Crenolanib","Azacitidine","Sorafenib","Decitabine, Sorafenib ","Clofarabine, Cytarabine","Sapacitabine (CYC682-06)",NA,NA,NA,NA,NA,NA
"92","aml_ohsu_2018_1261","aml_ohsu_2018_13-00522",11.15,"1:DECEASED",NA,NA,"Poor","Negative","Cyclophosphamide, Fludarabine, TBI","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","Azacitidine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"93","aml_ohsu_2018_127","aml_ohsu_2018_10-00819",41.58,"1:DECEASED",NA,NA,"Poor","Negative","Decitabine","Quizartinib","Mitoxantrone",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"94","aml_ohsu_2018_127","aml_ohsu_2018_10-00819",41.58,"1:DECEASED",NA,NA,"Poor","Negative","Decitabine","Quizartinib","Mitoxantrone",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"95","aml_ohsu_2018_127","aml_ohsu_2018_11-00261",41.58,"1:DECEASED",NA,NA,"Intermediate","Negative","Decitabine","Quizartinib","Mitoxantrone",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"96","aml_ohsu_2018_127","aml_ohsu_2018_11-00261",41.58,"1:DECEASED",NA,NA,"Intermediate","Negative","Decitabine","Quizartinib","Mitoxantrone",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"97","aml_ohsu_2018_1281","aml_ohsu_2018_13-00532",17.66,"1:DECEASED",NA,NA,"Intermediate","Negative","HiDAC","Crenolanib","Etoposide","Topotecan","Decitabine","Clofarabine","Thioguanine","7+3 (Cytarabine, Idarubicin)","Cyclophosphamide","Thiotepa","Sorafenib","Mitoxantrone","Vinorelbine"
"98","aml_ohsu_2018_1283","aml_ohsu_2018_13-00540",NA,NA,NA,NA,"Good","Negative","ATRA, Arsenic Trioxide",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"99","aml_ohsu_2018_1285","aml_ohsu_2018_13-00544",0.95,"1:DECEASED",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"100","aml_ohsu_2018_1286","aml_ohsu_2018_13-00545",18.26,"1:DECEASED","Negative","Negative","Poor","Negative","Dasatinib","7+3 (Cytarabine, Idarubicin)","Azacitidine","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA
"101","aml_ohsu_2018_1286","aml_ohsu_2018_13-00545",18.26,"1:DECEASED","Negative","Negative","Poor","Negative","Dasatinib","7+3 (Cytarabine, Idarubicin)","Azacitidine","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA
"102","aml_ohsu_2018_1286","aml_ohsu_2018_13-00546",18.26,"1:DECEASED","Negative","Negative","Poor","Negative","Dasatinib","7+3 (Cytarabine, Idarubicin)","Azacitidine","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA
"103","aml_ohsu_2018_1286","aml_ohsu_2018_13-00546",18.26,"1:DECEASED","Negative","Negative","Poor","Negative","Dasatinib","7+3 (Cytarabine, Idarubicin)","Azacitidine","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA
"104","aml_ohsu_2018_1314","aml_ohsu_2018_13-00551",48.91,"0:LIVING",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","MEC (Cytarabine, Etoposide, Mitoxantrone)","Busulfan, Cyclophosphamide",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"105","aml_ohsu_2018_1315","aml_ohsu_2018_13-00552",13.65,"1:DECEASED",NA,NA,"Poor","Negative","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","Azacitidine","Etoposide, Mitoxantrone",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"106","aml_ohsu_2018_1339","aml_ohsu_2018_13-00554",19.21,"1:DECEASED","C238R; MAF 5% (not confirmed by Sanger seq)","Negative","Poor","Negative",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"107","aml_ohsu_2018_1341","aml_ohsu_2018_13-00558",7.01,"1:DECEASED",NA,NA,"Poor","Negative","5+2 (Cytarabine, Idarubicin)","7+3 (Cytarabine, Idarubicin)","HAM (Cytarabine, Mitoxantrone)","Hydroxyurea","Busulfan, Cyclophosphamide",NA,NA,NA,NA,NA,NA,NA,NA
"108","aml_ohsu_2018_1343","aml_ohsu_2018_13-00563",33.59,"0:LIVING","Negative","Negative","Poor","Negative","Fludarabine, BCNU, Melphalan","Decitabine, Midostaurin",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"109","aml_ohsu_2018_1348","aml_ohsu_2018_13-00572",5.56,"1:DECEASED",NA,NA,"Poor","Negative","Nelarabine","POMP (Prednisone, Methotrexate, 6-MP, Vincristine)","3+7 (Cytarabine, Daunorubicin)","HyperCVAD","Azacitidine","GCLAC (GCSF, Clofarabine & Cytarabine)","CLAG-M (Cladribine, Cytarabine, Mitoxantrone, Filgrastim)",NA,NA,NA,NA,NA,NA
"110","aml_ohsu_2018_1349","aml_ohsu_2018_13-00573",10.95,"1:DECEASED",NA,NA,"Intermediate","Negative","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"111","aml_ohsu_2018_1353","aml_ohsu_2018_13-00578",18.68,"1:DECEASED",NA,NA,"Poor","Negative","7+3 (Cytarabine, Idarubicin)","Crenolanib","Azacitidine","MEC (Cytarabine, Etoposide, Mitoxantrone)","Decitabine, Sorafenib ","Quizartinib",NA,NA,NA,NA,NA,NA,NA
"112","aml_ohsu_2018_1353","aml_ohsu_2018_13-00578",18.68,"1:DECEASED",NA,NA,"Poor","Negative","7+3 (Cytarabine, Idarubicin)","Crenolanib","Azacitidine","MEC (Cytarabine, Etoposide, Mitoxantrone)","Decitabine, Sorafenib ","Quizartinib",NA,NA,NA,NA,NA,NA,NA
"113","aml_ohsu_2018_1353","aml_ohsu_2018_13-00581",18.68,"1:DECEASED",NA,NA,"Poor",NA,"7+3 (Cytarabine, Idarubicin)","Crenolanib","Azacitidine","MEC (Cytarabine, Etoposide, Mitoxantrone)","Decitabine, Sorafenib ","Quizartinib",NA,NA,NA,NA,NA,NA,NA
"114","aml_ohsu_2018_1353","aml_ohsu_2018_13-00581",18.68,"1:DECEASED",NA,NA,"Poor",NA,"7+3 (Cytarabine, Idarubicin)","Crenolanib","Azacitidine","MEC (Cytarabine, Etoposide, Mitoxantrone)","Decitabine, Sorafenib ","Quizartinib",NA,NA,NA,NA,NA,NA,NA
"115","aml_ohsu_2018_1355","aml_ohsu_2018_13-00535",8.52,"1:DECEASED",NA,NA,"Good","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","MEC (Cytarabine, Etoposide, Mitoxantrone)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"116","aml_ohsu_2018_1368","aml_ohsu_2018_13-00600",7.96,"0:LIVING","Negative",NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","MEC (Cytarabine, Etoposide, Mitoxantrone)","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA
"117","aml_ohsu_2018_1369","aml_ohsu_2018_13-00601",3.82,"1:DECEASED",NA,NA,"Intermediate","Negative","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"118","aml_ohsu_2018_1370","aml_ohsu_2018_13-00602",47.14,"0:LIVING",NA,NA,"Poor","Negative","Fludarabine, Melphalan","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"119","aml_ohsu_2018_1373","aml_ohsu_2018_13-00619",30.72,"1:DECEASED",NA,NA,"Good","Positive","Crenolanib","MEC (Cytarabine, Etoposide, Mitoxantrone)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"120","aml_ohsu_2018_1374","aml_ohsu_2018_13-00614",24.77,"1:DECEASED",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","Azacitidine","MiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"121","aml_ohsu_2018_1375","aml_ohsu_2018_13-00615",7.86,"0:LIVING","Negative","Negative","Good","Negative","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"122","aml_ohsu_2018_1377","aml_ohsu_2018_13-00622",4.05,"1:DECEASED",NA,NA,"Poor","Negative","S0919 Trial (Pravastatin, Idarubicin, Cytarabine)","7+3 (Cytarabine, Idarubicin)","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","Lenalidomide","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA
"123","aml_ohsu_2018_1378","aml_ohsu_2018_13-00625",19.9,"0:LIVING","Negative","Negative","Poor","Negative","SWOG S1203 (7+3 +/- Vorinostat)","Fludarabine, Cyclophosphamide, TBI",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"124","aml_ohsu_2018_1394","aml_ohsu_2018_13-00654",32.2,"1:DECEASED",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","Fludarabine, TBI","MiDAC","FATE Trial RIC (Fludarabine, Melphalan, Rabbit ATG) ","ODSH (2 O, 3-O Desulfated Heparin)",NA,NA,NA,NA,NA,NA,NA,NA
"125","aml_ohsu_2018_1394","aml_ohsu_2018_13-00654",32.2,"1:DECEASED",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","Fludarabine, TBI","MiDAC","FATE Trial RIC (Fludarabine, Melphalan, Rabbit ATG) ","ODSH (2 O, 3-O Desulfated Heparin)",NA,NA,NA,NA,NA,NA,NA,NA
"126","aml_ohsu_2018_1394","aml_ohsu_2018_13-00655",32.2,"1:DECEASED",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","Fludarabine, TBI","MiDAC","FATE Trial RIC (Fludarabine, Melphalan, Rabbit ATG) ","ODSH (2 O, 3-O Desulfated Heparin)",NA,NA,NA,NA,NA,NA,NA,NA
"127","aml_ohsu_2018_1394","aml_ohsu_2018_13-00655",32.2,"1:DECEASED",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","Fludarabine, TBI","MiDAC","FATE Trial RIC (Fludarabine, Melphalan, Rabbit ATG) ","ODSH (2 O, 3-O Desulfated Heparin)",NA,NA,NA,NA,NA,NA,NA,NA
"128","aml_ohsu_2018_1396","aml_ohsu_2018_13-00658",6.61,"0:LIVING","Negative","Negative","Good","Positive","7+3 (Cytarabine, Idarubicin)","MiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"129","aml_ohsu_2018_1397","aml_ohsu_2018_13-00659",12.7,"1:DECEASED","Negative","Negative","Intermediate","Negative","5+2 (Cytarabine, Idarubicin)","7+3 (Cytarabine, Idarubicin)","HiDAC","Busulfan, Cyclophosphamide",NA,NA,NA,NA,NA,NA,NA,NA,NA
"130","aml_ohsu_2018_1398","aml_ohsu_2018_13-00660",1.97,"0:LIVING","Negative","Negative","Poor","Negative","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"131","aml_ohsu_2018_1400","aml_ohsu_2018_14-00001",7.14,"0:LIVING","Negative","Negative","Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"132","aml_ohsu_2018_1400","aml_ohsu_2018_14-00001",7.14,"0:LIVING","Negative","Negative","Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"133","aml_ohsu_2018_1400","aml_ohsu_2018_14-00004",7.14,"0:LIVING","Negative","Negative","Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"134","aml_ohsu_2018_1400","aml_ohsu_2018_14-00004",7.14,"0:LIVING","Negative","Negative","Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"135","aml_ohsu_2018_1406","aml_ohsu_2018_14-00012",1.09,"1:DECEASED","Negative","Negative","Good","Positive","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"136","aml_ohsu_2018_1408","aml_ohsu_2018_14-00021",11.74,"1:DECEASED",NA,NA,"Intermediate","Negative","Hydroxyurea","Decitabine","Temozolomide, Vorinostat","Azacitidine, MLN4924",NA,NA,NA,NA,NA,NA,NA,NA,NA
"137","aml_ohsu_2018_1409","aml_ohsu_2018_14-00023",0.92,"0:LIVING",NA,NA,"Good","Positive","3+7 (Cytarabine, Daunorubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"138","aml_ohsu_2018_1410","aml_ohsu_2018_14-00026",NA,NA,NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","Azacitidine","MEC (Cytarabine, Etoposide, Mitoxantrone)",NA,NA,NA,NA,NA,NA,NA,NA,NA
"139","aml_ohsu_2018_1410","aml_ohsu_2018_14-00026",NA,NA,NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","Azacitidine","MEC (Cytarabine, Etoposide, Mitoxantrone)",NA,NA,NA,NA,NA,NA,NA,NA,NA
"140","aml_ohsu_2018_1410","aml_ohsu_2018_14-00244",NA,NA,NA,NA,"Poor","Negative","7+3 (Cytarabine, Idarubicin)","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","Azacitidine","MEC (Cytarabine, Etoposide, Mitoxantrone)",NA,NA,NA,NA,NA,NA,NA,NA,NA
"141","aml_ohsu_2018_1410","aml_ohsu_2018_14-00244",NA,NA,NA,NA,"Poor","Negative","7+3 (Cytarabine, Idarubicin)","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","Azacitidine","MEC (Cytarabine, Etoposide, Mitoxantrone)",NA,NA,NA,NA,NA,NA,NA,NA,NA
"142","aml_ohsu_2018_1431","aml_ohsu_2018_14-00034",29.8,"0:LIVING",NA,NA,"Good","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","Azacitidine","Busulfan, Cyclophosphamide",NA,NA,NA,NA,NA,NA,NA,NA,NA
"143","aml_ohsu_2018_1434","aml_ohsu_2018_14-00041",31.32,"0:LIVING","Negative","Negative","Poor","Negative","AG-221",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"144","aml_ohsu_2018_1435","aml_ohsu_2018_14-00045",19.14,"1:DECEASED",NA,NA,"Poor","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","MEC (Cytarabine, Etoposide, Mitoxantrone)","Busulfan, Cyclophosphamide",NA,NA,NA,NA,NA,NA,NA,NA,NA
"145","aml_ohsu_2018_1438","aml_ohsu_2018_14-00052",8.62,"1:DECEASED","Negative","Negative","Poor","Negative","CPX-351 (Liposomal Cytarabine + Daunorubicin)","Lenalidomide","MEC (Cytarabine, Etoposide, Mitoxantrone)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"146","aml_ohsu_2018_1438","aml_ohsu_2018_14-00052",8.62,"1:DECEASED","Negative","Negative","Poor","Negative","CPX-351 (Liposomal Cytarabine + Daunorubicin)","Lenalidomide","MEC (Cytarabine, Etoposide, Mitoxantrone)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"147","aml_ohsu_2018_1438","aml_ohsu_2018_14-00053",8.62,"1:DECEASED","Negative","Negative","Poor","Negative","CPX-351 (Liposomal Cytarabine + Daunorubicin)","Lenalidomide","MEC (Cytarabine, Etoposide, Mitoxantrone)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"148","aml_ohsu_2018_1438","aml_ohsu_2018_14-00053",8.62,"1:DECEASED","Negative","Negative","Poor","Negative","CPX-351 (Liposomal Cytarabine + Daunorubicin)","Lenalidomide","MEC (Cytarabine, Etoposide, Mitoxantrone)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"149","aml_ohsu_2018_1441","aml_ohsu_2018_14-00060",9.84,"1:DECEASED",NA,NA,"Poor","Negative","Azacitidine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"150","aml_ohsu_2018_1443","aml_ohsu_2018_14-00063",0.33,"1:DECEASED",NA,NA,"Poor","Negative","Bevacizumab",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"151","aml_ohsu_2018_1444","aml_ohsu_2018_14-00064",11.74,"1:DECEASED",NA,NA,"Intermediate","Negative","E7070, Idarubicin, Cytarabine","5+2 (Cytarabine, Idarubicin)","7+3 (Cytarabine, Idarubicin)","HiDAC","GCLAC (GCSF, Clofarabine & Cytarabine)","MEC (Cytarabine, Etoposide, Mitoxantrone)","BL-8040","IGN523",NA,NA,NA,NA,NA
"152","aml_ohsu_2018_1446","aml_ohsu_2018_14-00066",18.65,"0:LIVING","Negative",NA,"Intermediate","Negative","Fludarabine, Melphalan","Azacitidine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"153","aml_ohsu_2018_1448","aml_ohsu_2018_14-00067",22.66,"1:DECEASED",NA,NA,"Poor","Negative","Fludarabine, Melphalan","Lenalidomide","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"154","aml_ohsu_2018_1450","aml_ohsu_2018_14-00078",23.45,"1:DECEASED","Negative","Negative","Intermediate","Negative","COG-AAML1031 (IT/IV Cytarabine, Daunorubicin, Etoposide, Mitoxantrone +/- Bortezomib or Sorafenib)","Clofarabine, Cyclophosphamide, Etoposide","HAM (Cytarabine, Mitoxantrone)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"155","aml_ohsu_2018_1451","aml_ohsu_2018_14-00126",NA,"0:LIVING",NA,NA,"Intermediate","Negative",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"156","aml_ohsu_2018_1453","aml_ohsu_2018_14-00081",NA,NA,"V173M; MAF 80%","Negative","Poor","Negative","7+3 (Cytarabine, Idarubicin)","Azacitidine, Lenalidomide","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"157","aml_ohsu_2018_1461","aml_ohsu_2018_14-00092",18.62,"0:LIVING","Negative","p.T138I; MAF 50%","Good","Positive","Fludarabine, Melphalan","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"158","aml_ohsu_2018_1464","aml_ohsu_2018_14-00096",6.51,"1:DECEASED","Negative","Negative","Poor","Negative","7+3 (Cytarabine, Idarubicin)","GCLAC (GCSF, Clofarabine & Cytarabine)","Busulfan, Cyclophosphamide",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"159","aml_ohsu_2018_1466","aml_ohsu_2018_14-00113",64.74,"0:LIVING",NA,NA,"Good","Negative","Busulfan, Fludarabine","Etoposide, TBI","PETHEMA Trial LPA05 (ATRA (Tretinoin), Idarubicin, Mitoxantrone, Cytarabine)","Idarubicin, Mitoxantrone","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","ATRA, Arsenic Trioxide","ATRA, 6-MP, Methotrexate",NA,NA,NA,NA,NA,NA
"160","aml_ohsu_2018_1477","aml_ohsu_2018_14-00125",4.67,"0:LIVING",NA,NA,"Good","Negative","COG-AAML1031 (IT/IV Cytarabine, Daunorubicin, Etoposide, Mitoxantrone +/- Bortezomib or Sorafenib)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"161","aml_ohsu_2018_1481","aml_ohsu_2018_14-00127",6.81,"1:DECEASED","p.R273H, MAF 96%","Negative","Poor","Negative","7+3 (Cytarabine, Idarubicin)","Azacitidine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"162","aml_ohsu_2018_1484","aml_ohsu_2018_14-00134",5.53,"1:DECEASED","Negative","p.R882H; MAF 30%","Intermediate","Positive","Fludarabine, Melphalan","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","MEC (Cytarabine, Etoposide, Mitoxantrone)","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA
"163","aml_ohsu_2018_1485","aml_ohsu_2018_14-00135",8.29,"1:DECEASED","p.H193R; MAF 92%","Negative","Poor","Negative","Azacitidine","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"164","aml_ohsu_2018_1488","aml_ohsu_2018_14-00141",11.74,"1:DECEASED","Negative","Negative","Intermediate","Negative","Decitabine, Midostaurin",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"165","aml_ohsu_2018_1494","aml_ohsu_2018_14-00150",2.34,"1:DECEASED","Negative","Negative","Intermediate","Negative","CPX-351 (Liposomal Cytarabine + Daunorubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"166","aml_ohsu_2018_1495","aml_ohsu_2018_14-00152",11.02,"1:DECEASED",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","CLAG (Cladribine, Cytarabine, Filgrastim)","MiDAC","ODSH (2 O, 3-O Desulfated Heparin) ","SGN-CD33A",NA,NA,NA,NA,NA,NA,NA,NA
"167","aml_ohsu_2018_1495","aml_ohsu_2018_14-00152",11.02,"1:DECEASED",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","CLAG (Cladribine, Cytarabine, Filgrastim)","MiDAC","ODSH (2 O, 3-O Desulfated Heparin) ","SGN-CD33A",NA,NA,NA,NA,NA,NA,NA,NA
"168","aml_ohsu_2018_1495","aml_ohsu_2018_14-00152",11.02,"1:DECEASED",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","CLAG (Cladribine, Cytarabine, Filgrastim)","MiDAC","ODSH (2 O, 3-O Desulfated Heparin) ","SGN-CD33A",NA,NA,NA,NA,NA,NA,NA,NA
"169","aml_ohsu_2018_1495","aml_ohsu_2018_14-00173",11.02,"1:DECEASED",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","CLAG (Cladribine, Cytarabine, Filgrastim)","MiDAC","ODSH (2 O, 3-O Desulfated Heparin) ","SGN-CD33A",NA,NA,NA,NA,NA,NA,NA,NA
"170","aml_ohsu_2018_1495","aml_ohsu_2018_14-00173",11.02,"1:DECEASED",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","CLAG (Cladribine, Cytarabine, Filgrastim)","MiDAC","ODSH (2 O, 3-O Desulfated Heparin) ","SGN-CD33A",NA,NA,NA,NA,NA,NA,NA,NA
"171","aml_ohsu_2018_1495","aml_ohsu_2018_14-00173",11.02,"1:DECEASED",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","CLAG (Cladribine, Cytarabine, Filgrastim)","MiDAC","ODSH (2 O, 3-O Desulfated Heparin) ","SGN-CD33A",NA,NA,NA,NA,NA,NA,NA,NA
"172","aml_ohsu_2018_1495","aml_ohsu_2018_14-00757",11.02,"1:DECEASED",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","CLAG (Cladribine, Cytarabine, Filgrastim)","MiDAC","ODSH (2 O, 3-O Desulfated Heparin) ","SGN-CD33A",NA,NA,NA,NA,NA,NA,NA,NA
"173","aml_ohsu_2018_1495","aml_ohsu_2018_14-00757",11.02,"1:DECEASED",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","CLAG (Cladribine, Cytarabine, Filgrastim)","MiDAC","ODSH (2 O, 3-O Desulfated Heparin) ","SGN-CD33A",NA,NA,NA,NA,NA,NA,NA,NA
"174","aml_ohsu_2018_1495","aml_ohsu_2018_14-00757",11.02,"1:DECEASED",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","CLAG (Cladribine, Cytarabine, Filgrastim)","MiDAC","ODSH (2 O, 3-O Desulfated Heparin) ","SGN-CD33A",NA,NA,NA,NA,NA,NA,NA,NA
"175","aml_ohsu_2018_1505","aml_ohsu_2018_14-00171",14.18,"0:LIVING","Negative","Negative","Poor","Negative","CPX-351 (Liposomal Cytarabine + Daunorubicin)","Azacitidine","Methotrexate","Busulfan, Cyclophosphamide",NA,NA,NA,NA,NA,NA,NA,NA,NA
"176","aml_ohsu_2018_1508","aml_ohsu_2018_14-00175",33.06,"1:DECEASED",NA,NA,"Intermediate","Negative","Busulfan, Fludarabine","7+3 (Cytarabine, Idarubicin)","HiDAC","Donor Lymphocyte Infusion","Azacitidine","CLAG-M (Cladribine, Cytarabine, Mitoxantrone, Filgrastim)","Clofarabine","ODSH (2 O, 3-O Desulfated Heparin)",NA,NA,NA,NA,NA
"177","aml_ohsu_2018_1513","aml_ohsu_2018_14-00184",22.7,"0:LIVING",NA,NA,"Intermediate","Negative","ADE (Cytarabine, Daunorubicin & Etoposide)","Cyclophosphamide, TBI","Bu/Flu/TBI (Busulfan, Fludarabine, Total Body Irradiation)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"178","aml_ohsu_2018_1519","aml_ohsu_2018_14-00193",13.85,"1:DECEASED",NA,NA,"Good","Negative","7+3 (Cytarabine, Idarubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"179","aml_ohsu_2018_1527","aml_ohsu_2018_14-00212",NA,"0:LIVING",NA,NA,"Intermediate","Negative",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"180","aml_ohsu_2018_1528","aml_ohsu_2018_14-00245",23.72,"0:LIVING",NA,"p.R309G; MAF 31%","Intermediate","Negative","5+2 (Cytarabine, Idarubicin)","3+7 (Cytarabine, Daunorubicin)","Busulfan, Cyclophosphamide",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"181","aml_ohsu_2018_1532","aml_ohsu_2018_14-00228",25.92,"0:LIVING","Negative","p.R882C; MAF 46%","Good","Positive","7+3 (Cytarabine, Idarubicin)","Azacitidine","MEC (Cytarabine, Etoposide, Mitoxantrone)","MiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA
"182","aml_ohsu_2018_1532","aml_ohsu_2018_14-00228",25.92,"0:LIVING","Negative","p.R882C; MAF 46%","Good","Positive","7+3 (Cytarabine, Idarubicin)","Azacitidine","MEC (Cytarabine, Etoposide, Mitoxantrone)","MiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA
"183","aml_ohsu_2018_1532","aml_ohsu_2018_15-00482",25.92,"0:LIVING","Negative","p.R882C; MAF 39%","Good","Positive","7+3 (Cytarabine, Idarubicin)","Azacitidine","MEC (Cytarabine, Etoposide, Mitoxantrone)","MiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA
"184","aml_ohsu_2018_1532","aml_ohsu_2018_15-00482",25.92,"0:LIVING","Negative","p.R882C; MAF 39%","Good","Positive","7+3 (Cytarabine, Idarubicin)","Azacitidine","MEC (Cytarabine, Etoposide, Mitoxantrone)","MiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA
"185","aml_ohsu_2018_1533","aml_ohsu_2018_14-00231",4.54,"1:DECEASED",NA,NA,"Poor","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","Cytarabine","Decitabine, Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA,NA
"186","aml_ohsu_2018_1533","aml_ohsu_2018_14-00231",4.54,"1:DECEASED",NA,NA,"Poor","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","Cytarabine","Decitabine, Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA,NA
"187","aml_ohsu_2018_1533","aml_ohsu_2018_14-00528",4.54,"1:DECEASED",NA,NA,"Poor","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","Cytarabine","Decitabine, Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA,NA
"188","aml_ohsu_2018_1533","aml_ohsu_2018_14-00528",4.54,"1:DECEASED",NA,NA,"Poor","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","Cytarabine","Decitabine, Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA,NA
"189","aml_ohsu_2018_1536","aml_ohsu_2018_14-00242",32.89,"1:DECEASED",NA,NA,"Intermediate","Negative","Azacitidine","Decitabine","Rigosertib","Clofarabine, Cytarabine",NA,NA,NA,NA,NA,NA,NA,NA,NA
"190","aml_ohsu_2018_1540","aml_ohsu_2018_14-00240",1.22,"1:DECEASED",NA,NA,"Poor","Negative","Azacitidine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"191","aml_ohsu_2018_1545","aml_ohsu_2018_14-00253",9.31,"1:DECEASED","Negative","Negative","Poor","Negative","5+2 (Cytarabine, Idarubicin)","7+3 (Cytarabine, Idarubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"192","aml_ohsu_2018_1546","aml_ohsu_2018_14-00259",14.44,"1:DECEASED","Negative","p.R882H; MAF 50%","Intermediate","Positive","Fludarabine, Melphalan","7+3 (Cytarabine, Idarubicin)","Fludarabine","FLAG (Fludarabine, High-dose Cytarabine, G-CSF)","MiDAC",NA,NA,NA,NA,NA,NA,NA,NA
"193","aml_ohsu_2018_1552","aml_ohsu_2018_14-00268",26.15,"1:DECEASED",NA,NA,"Poor","Negative","Azacitidine","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"194","aml_ohsu_2018_1553","aml_ohsu_2018_14-00270",NA,NA,NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","Azacitidine","Clofarabine, Cytarabine",NA,NA,NA,NA,NA,NA,NA,NA,NA
"195","aml_ohsu_2018_1554","aml_ohsu_2018_14-00272",27.4,"0:LIVING","Negative",NA,"Good","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"196","aml_ohsu_2018_1554","aml_ohsu_2018_14-00272",27.4,"0:LIVING","Negative",NA,"Good","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"197","aml_ohsu_2018_1554","aml_ohsu_2018_14-00273",27.4,"0:LIVING","Negative",NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"198","aml_ohsu_2018_1554","aml_ohsu_2018_14-00273",27.4,"0:LIVING","Negative",NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"199","aml_ohsu_2018_1558","aml_ohsu_2018_14-00279",1.18,"0:LIVING","Negative",NA,"Good","Negative","SWOG S1203 (7+3 +/- Vorinostat)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"200","aml_ohsu_2018_1561","aml_ohsu_2018_14-00289",10.46,"1:DECEASED","p.G245S; MAF 87%","Negative","Poor","Negative","Trametinib","HAEP (Cytarabine, Etoposide, Cisplatin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"201","aml_ohsu_2018_1561","aml_ohsu_2018_14-00289",10.46,"1:DECEASED","p.G245S; MAF 87%","Negative","Poor","Negative","Trametinib","HAEP (Cytarabine, Etoposide, Cisplatin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"202","aml_ohsu_2018_1561","aml_ohsu_2018_14-00676",10.46,"1:DECEASED","p.G245S; MAF 96%",NA,"Poor","Negative","Trametinib","HAEP (Cytarabine, Etoposide, Cisplatin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"203","aml_ohsu_2018_1561","aml_ohsu_2018_14-00676",10.46,"1:DECEASED","p.G245S; MAF 96%",NA,"Poor","Negative","Trametinib","HAEP (Cytarabine, Etoposide, Cisplatin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"204","aml_ohsu_2018_1566","aml_ohsu_2018_13-00466",32.01,"1:DECEASED",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","Cytarabine","BL-8040",NA,NA,NA,NA,NA,NA,NA,NA,NA
"205","aml_ohsu_2018_1569","aml_ohsu_2018_14-00311",0.56,"1:DECEASED",NA,NA,"Poor","Negative","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"206","aml_ohsu_2018_1585","aml_ohsu_2018_14-00329",10.63,"0:LIVING",NA,NA,"Poor","Negative","MiDAC","FATE Trial RIC (Fludarabine, Melphalan, Rabbit ATG) ","7+3 (Cytarabine, Idarubicin) plus Sorafenib","ODSH (2 O, 3-O Desulfated Heparin) ","SGN-CD33A",NA,NA,NA,NA,NA,NA,NA,NA
"207","aml_ohsu_2018_1586","aml_ohsu_2018_14-00331",NA,NA,NA,NA,"Good","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"208","aml_ohsu_2018_1598","aml_ohsu_2018_14-00335",8.65,"1:DECEASED","Positive",NA,"Poor","Negative","Hydroxyurea","Azacitidine, MLN4924",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"209","aml_ohsu_2018_1602","aml_ohsu_2018_14-00355",23.19,"1:DECEASED","Negative","Negative","Poor","Negative","Azacitidine","Sorafenib","Decitabine, Midostaurin",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"210","aml_ohsu_2018_1604","aml_ohsu_2018_14-00359",25.03,"0:LIVING",NA,NA,"Good","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","ODSH (2 O, 3-O Desulfated Heparin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"211","aml_ohsu_2018_1604","aml_ohsu_2018_14-00359",25.03,"0:LIVING",NA,NA,"Good","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","ODSH (2 O, 3-O Desulfated Heparin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"212","aml_ohsu_2018_1604","aml_ohsu_2018_14-00597",25.03,"0:LIVING",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","ODSH (2 O, 3-O Desulfated Heparin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"213","aml_ohsu_2018_1604","aml_ohsu_2018_14-00597",25.03,"0:LIVING",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","ODSH (2 O, 3-O Desulfated Heparin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"214","aml_ohsu_2018_1612","aml_ohsu_2018_14-00369",1.28,"1:DECEASED","Negative",NA,"Intermediate","Negative","CPX-351 (Liposomal Cytarabine + Daunorubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"215","aml_ohsu_2018_1614","aml_ohsu_2018_14-00376",23.49,"0:LIVING","Negative","p.R882C; MAF 45%","Intermediate","Negative","Decitabine","Busulfan, Cyclophosphamide",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"216","aml_ohsu_2018_1616","aml_ohsu_2018_14-00380",0.99,"1:DECEASED",NA,NA,"Poor","Negative","Azacitidine","Decitabine","Clofarabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"217","aml_ohsu_2018_163","aml_ohsu_2018_09-00705",13.98,"1:DECEASED",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","MiDAC","AC220 (Ambit)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"218","aml_ohsu_2018_163","aml_ohsu_2018_09-00705",13.98,"1:DECEASED",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","MiDAC","AC220 (Ambit)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"219","aml_ohsu_2018_163","aml_ohsu_2018_10-00792",13.98,"1:DECEASED",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","MiDAC","AC220 (Ambit)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"220","aml_ohsu_2018_163","aml_ohsu_2018_10-00792",13.98,"1:DECEASED",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","MiDAC","AC220 (Ambit)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"221","aml_ohsu_2018_1630","aml_ohsu_2018_14-00401",31.91,"1:DECEASED",NA,"F609fs*3; MAF 42%","Poor","Negative","AG-221","Azacitidine","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"222","aml_ohsu_2018_1631","aml_ohsu_2018_14-00404",10.43,"1:DECEASED","p.T312fs*25 (one nucleotide insertion); MAF 30%",NA,"Poor","Negative","3+7 (Cytarabine, Daunorubicin)","Azacitidine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"223","aml_ohsu_2018_1644","aml_ohsu_2018_14-00423",26.15,"0:LIVING","Negative",NA,"Good","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","Stanford Protocol 9022 (BU/CY)",NA,NA,NA,NA,NA,NA,NA,NA,NA
"224","aml_ohsu_2018_1646","aml_ohsu_2018_14-00425",15.16,"0:LIVING","Negative","Negative","Good","Negative","ATRA, Arsenic Trioxide","APML4 Protocol (ATRA, Arsenic Trioxide, Idarubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"225","aml_ohsu_2018_1648","aml_ohsu_2018_14-00434",NA,"0:LIVING","Negative",NA,"Intermediate","Negative","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"226","aml_ohsu_2018_1651","aml_ohsu_2018_14-00430",2.63,"1:DECEASED","Negative","Negative","Poor","Negative","Azacitidine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"227","aml_ohsu_2018_1655","aml_ohsu_2018_14-00447",15.07,"0:LIVING","Negative","Negative","Intermediate","Negative","Fludarabine, Melphalan","Idarubicin and Cytarabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"228","aml_ohsu_2018_1656","aml_ohsu_2018_14-00448",5.3,"1:DECEASED","Negative",NA,"Intermediate","Negative","Azacitidine, MLN4924",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"229","aml_ohsu_2018_1656","aml_ohsu_2018_14-00448",5.3,"1:DECEASED","Negative",NA,"Intermediate","Negative","Azacitidine, MLN4924",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"230","aml_ohsu_2018_1656","aml_ohsu_2018_14-00449",5.3,"1:DECEASED","Negative",NA,"Intermediate","Negative","Azacitidine, MLN4924",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"231","aml_ohsu_2018_1656","aml_ohsu_2018_14-00449",5.3,"1:DECEASED","Negative",NA,"Intermediate","Negative","Azacitidine, MLN4924",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"232","aml_ohsu_2018_1657","aml_ohsu_2018_14-00451",5.99,"1:DECEASED","Negative","Negative","Poor","Negative","3+7 (Cytarabine, Daunorubicin)","FLAG (Fludarabine, High-dose Cytarabine, G-CSF)","5+2 (Ara-C, Daunorubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"233","aml_ohsu_2018_1662","aml_ohsu_2018_14-00458",9.41,"1:DECEASED","Negative","Negative","Intermediate","Negative","Fludarabine, Melphalan","Azacitidine, Lenalidomide",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"234","aml_ohsu_2018_1664","aml_ohsu_2018_14-00464",14.9,"0:LIVING","Negative",NA,"Intermediate","Negative","ATRA (Tretinoin)","Cyclophosphamide, TBI","3+7 (Cytarabine, Daunorubicin)","GCLAC (GCSF, Clofarabine & Cytarabine)",NA,NA,NA,NA,NA,NA,NA,NA,NA
"235","aml_ohsu_2018_1665","aml_ohsu_2018_14-00454",12.99,"1:DECEASED","Negative",NA,"Poor","Negative","HiDAC","AG-221","Gilteritinib (ASP2215)","3+7 (Cytarabine, Daunorubicin)","MEC (Cytarabine, Etoposide, Mitoxantrone)","Decitabine","MEC, Lenalidomide","Clofarabine, Cytarabine",NA,NA,NA,NA,NA
"236","aml_ohsu_2018_1666","aml_ohsu_2018_14-00473",5.49,"1:DECEASED","p.R280T;  MAF 36%","Negative","Poor","Negative","7+3 (Cytarabine, Idarubicin)","HAM (Cytarabine, Mitoxantrone)","MEC (Cytarabine, Etoposide, Mitoxantrone)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"237","aml_ohsu_2018_1670","aml_ohsu_2018_14-00476",7.5,"1:DECEASED",NA,NA,"Intermediate","Negative","HiDAC","Cytarabine","SWOG S1203 (7+3 +/- Vorinostat)","Hydroxyurea","MEC, Lenalidomide",NA,NA,NA,NA,NA,NA,NA,NA
"238","aml_ohsu_2018_1670","aml_ohsu_2018_14-00476",7.5,"1:DECEASED",NA,NA,"Intermediate","Negative","HiDAC","Cytarabine","SWOG S1203 (7+3 +/- Vorinostat)","Hydroxyurea","MEC, Lenalidomide",NA,NA,NA,NA,NA,NA,NA,NA
"239","aml_ohsu_2018_1670","aml_ohsu_2018_14-00477",7.5,"1:DECEASED",NA,NA,"Poor","Negative","HiDAC","Cytarabine","SWOG S1203 (7+3 +/- Vorinostat)","Hydroxyurea","MEC, Lenalidomide",NA,NA,NA,NA,NA,NA,NA,NA
"240","aml_ohsu_2018_1670","aml_ohsu_2018_14-00477",7.5,"1:DECEASED",NA,NA,"Poor","Negative","HiDAC","Cytarabine","SWOG S1203 (7+3 +/- Vorinostat)","Hydroxyurea","MEC, Lenalidomide",NA,NA,NA,NA,NA,NA,NA,NA
"241","aml_ohsu_2018_1672","aml_ohsu_2018_14-00484",3.98,"0:LIVING","Negative","Negative","Poor","Negative","3+7 (Cytarabine, Daunorubicin)","MEC (Cytarabine, Etoposide, Mitoxantrone)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"242","aml_ohsu_2018_1675","aml_ohsu_2018_14-00487",11.25,"1:DECEASED",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","Azacitidine","CLAG-M (Cladribine, Cytarabine, Mitoxantrone, Filgrastim)","7+3 (Cytarabine, Idarubicin) plus Sorafenib","Ponatinib",NA,NA,NA,NA,NA,NA,NA
"243","aml_ohsu_2018_1675","aml_ohsu_2018_14-00487",11.25,"1:DECEASED",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","Azacitidine","CLAG-M (Cladribine, Cytarabine, Mitoxantrone, Filgrastim)","7+3 (Cytarabine, Idarubicin) plus Sorafenib","Ponatinib",NA,NA,NA,NA,NA,NA,NA
"244","aml_ohsu_2018_1675","aml_ohsu_2018_14-00488",11.25,"1:DECEASED",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","Azacitidine","CLAG-M (Cladribine, Cytarabine, Mitoxantrone, Filgrastim)","7+3 (Cytarabine, Idarubicin) plus Sorafenib","Ponatinib",NA,NA,NA,NA,NA,NA,NA
"245","aml_ohsu_2018_1675","aml_ohsu_2018_14-00488",11.25,"1:DECEASED",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","Azacitidine","CLAG-M (Cladribine, Cytarabine, Mitoxantrone, Filgrastim)","7+3 (Cytarabine, Idarubicin) plus Sorafenib","Ponatinib",NA,NA,NA,NA,NA,NA,NA
"246","aml_ohsu_2018_1683","aml_ohsu_2018_14-00496",NA,NA,NA,NA,"Good","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","ODSH (2 O, 3-O Desulfated Heparin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"247","aml_ohsu_2018_1684","aml_ohsu_2018_14-00498",2.66,"1:DECEASED",NA,NA,"Poor","Negative","5+2 (Cytarabine, Idarubicin)","7+3 (Cytarabine, Idarubicin)","CLAG-M (Cladribine, Cytarabine, Mitoxantrone, Filgrastim)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"248","aml_ohsu_2018_1689","aml_ohsu_2018_14-00499",12.66,"1:DECEASED","Negative","Negative","Poor","Negative","HyperCVAD Course B (Cytarabine, Methotrexate)","EWALL Protocol","Bu/Cy/TBI","HyperCVAD Course A (Cyclophosphamide, Dexamethasone, Doxorubicin, Vincristine)",NA,NA,NA,NA,NA,NA,NA,NA,NA
"249","aml_ohsu_2018_1690","aml_ohsu_2018_15-00805",24.01,"0:LIVING",NA,NA,"Good","Positive","Fludarabine, Melphalan","7+3 (Cytarabine, Idarubicin)","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","MiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA
"250","aml_ohsu_2018_1691","aml_ohsu_2018_14-00502",NA,NA,NA,NA,"Intermediate","Negative",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"251","aml_ohsu_2018_1693","aml_ohsu_2018_14-00504",40.33,"0:LIVING",NA,NA,"Poor","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","Busulfan, Cyclophosphamide, Thymoglobulin",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"252","aml_ohsu_2018_1696","aml_ohsu_2018_14-00514",1.74,"1:DECEASED",NA,NA,"Intermediate","Negative","Azacitidine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"253","aml_ohsu_2018_17","aml_ohsu_2018_10-00669",48.13,"1:DECEASED",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","Fludarabine, TBI","Sorafenib","Hydroxyurea","Decitabine",NA,NA,NA,NA,NA,NA,NA
"254","aml_ohsu_2018_17","aml_ohsu_2018_10-00669",48.13,"1:DECEASED",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","Fludarabine, TBI","Sorafenib","Hydroxyurea","Decitabine",NA,NA,NA,NA,NA,NA,NA
"255","aml_ohsu_2018_17","aml_ohsu_2018_10-00669",48.13,"1:DECEASED",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","Fludarabine, TBI","Sorafenib","Hydroxyurea","Decitabine",NA,NA,NA,NA,NA,NA,NA
"256","aml_ohsu_2018_17","aml_ohsu_2018_10-00669",48.13,"1:DECEASED",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","Fludarabine, TBI","Sorafenib","Hydroxyurea","Decitabine",NA,NA,NA,NA,NA,NA,NA
"257","aml_ohsu_2018_17","aml_ohsu_2018_10-00669",48.13,"1:DECEASED",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","Fludarabine, TBI","Sorafenib","Hydroxyurea","Decitabine",NA,NA,NA,NA,NA,NA,NA
"258","aml_ohsu_2018_17","aml_ohsu_2018_14-00334",48.13,"1:DECEASED",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","Fludarabine, TBI","Sorafenib","Hydroxyurea","Decitabine",NA,NA,NA,NA,NA,NA,NA
"259","aml_ohsu_2018_17","aml_ohsu_2018_14-00334",48.13,"1:DECEASED",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","Fludarabine, TBI","Sorafenib","Hydroxyurea","Decitabine",NA,NA,NA,NA,NA,NA,NA
"260","aml_ohsu_2018_17","aml_ohsu_2018_14-00334",48.13,"1:DECEASED",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","Fludarabine, TBI","Sorafenib","Hydroxyurea","Decitabine",NA,NA,NA,NA,NA,NA,NA
"261","aml_ohsu_2018_17","aml_ohsu_2018_14-00334",48.13,"1:DECEASED",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","Fludarabine, TBI","Sorafenib","Hydroxyurea","Decitabine",NA,NA,NA,NA,NA,NA,NA
"262","aml_ohsu_2018_17","aml_ohsu_2018_14-00334",48.13,"1:DECEASED",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","Fludarabine, TBI","Sorafenib","Hydroxyurea","Decitabine",NA,NA,NA,NA,NA,NA,NA
"263","aml_ohsu_2018_17","aml_ohsu_2018_14-00395",48.13,"1:DECEASED",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","Fludarabine, TBI","Sorafenib","Hydroxyurea","Decitabine",NA,NA,NA,NA,NA,NA,NA
"264","aml_ohsu_2018_17","aml_ohsu_2018_14-00395",48.13,"1:DECEASED",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","Fludarabine, TBI","Sorafenib","Hydroxyurea","Decitabine",NA,NA,NA,NA,NA,NA,NA
"265","aml_ohsu_2018_17","aml_ohsu_2018_14-00395",48.13,"1:DECEASED",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","Fludarabine, TBI","Sorafenib","Hydroxyurea","Decitabine",NA,NA,NA,NA,NA,NA,NA
"266","aml_ohsu_2018_17","aml_ohsu_2018_14-00395",48.13,"1:DECEASED",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","Fludarabine, TBI","Sorafenib","Hydroxyurea","Decitabine",NA,NA,NA,NA,NA,NA,NA
"267","aml_ohsu_2018_17","aml_ohsu_2018_14-00395",48.13,"1:DECEASED",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","Fludarabine, TBI","Sorafenib","Hydroxyurea","Decitabine",NA,NA,NA,NA,NA,NA,NA
"268","aml_ohsu_2018_17","aml_ohsu_2018_14-00639",48.13,"1:DECEASED",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","Fludarabine, TBI","Sorafenib","Hydroxyurea","Decitabine",NA,NA,NA,NA,NA,NA,NA
"269","aml_ohsu_2018_17","aml_ohsu_2018_14-00639",48.13,"1:DECEASED",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","Fludarabine, TBI","Sorafenib","Hydroxyurea","Decitabine",NA,NA,NA,NA,NA,NA,NA
"270","aml_ohsu_2018_17","aml_ohsu_2018_14-00639",48.13,"1:DECEASED",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","Fludarabine, TBI","Sorafenib","Hydroxyurea","Decitabine",NA,NA,NA,NA,NA,NA,NA
"271","aml_ohsu_2018_17","aml_ohsu_2018_14-00639",48.13,"1:DECEASED",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","Fludarabine, TBI","Sorafenib","Hydroxyurea","Decitabine",NA,NA,NA,NA,NA,NA,NA
"272","aml_ohsu_2018_17","aml_ohsu_2018_14-00639",48.13,"1:DECEASED",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","Fludarabine, TBI","Sorafenib","Hydroxyurea","Decitabine",NA,NA,NA,NA,NA,NA,NA
"273","aml_ohsu_2018_17","aml_ohsu_2018_14-00640",48.13,"1:DECEASED",NA,NA,NA,"Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","Fludarabine, TBI","Sorafenib","Hydroxyurea","Decitabine",NA,NA,NA,NA,NA,NA,NA
"274","aml_ohsu_2018_17","aml_ohsu_2018_14-00640",48.13,"1:DECEASED",NA,NA,NA,"Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","Fludarabine, TBI","Sorafenib","Hydroxyurea","Decitabine",NA,NA,NA,NA,NA,NA,NA
"275","aml_ohsu_2018_17","aml_ohsu_2018_14-00640",48.13,"1:DECEASED",NA,NA,NA,"Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","Fludarabine, TBI","Sorafenib","Hydroxyurea","Decitabine",NA,NA,NA,NA,NA,NA,NA
"276","aml_ohsu_2018_17","aml_ohsu_2018_14-00640",48.13,"1:DECEASED",NA,NA,NA,"Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","Fludarabine, TBI","Sorafenib","Hydroxyurea","Decitabine",NA,NA,NA,NA,NA,NA,NA
"277","aml_ohsu_2018_17","aml_ohsu_2018_14-00640",48.13,"1:DECEASED",NA,NA,NA,"Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","Fludarabine, TBI","Sorafenib","Hydroxyurea","Decitabine",NA,NA,NA,NA,NA,NA,NA
"278","aml_ohsu_2018_1700","aml_ohsu_2018_14-00521",1.15,"0:LIVING","Negative",NA,"Intermediate","Negative","SWOG S1203 (7+3 +/- Vorinostat)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"279","aml_ohsu_2018_1702","aml_ohsu_2018_14-00527",17.57,"0:LIVING",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","MEC (Cytarabine, Etoposide, Mitoxantrone)","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA
"280","aml_ohsu_2018_1707","aml_ohsu_2018_14-00536",11.32,"1:DECEASED","p.I251M; MAF 34%","p.R882H; MAF 37%","Poor","Negative","7+3 (Cytarabine, Idarubicin)","Lenalidomide","Azacitidine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"281","aml_ohsu_2018_1708","aml_ohsu_2018_14-00537",2.43,"0:LIVING",NA,NA,"Intermediate","Negative","Bu/Cy/ATG","ADE (Cytarabine, Daunorubicin & Etoposide)","HiDAC + Midostaurin","Etoposide, Cytarabine",NA,NA,NA,NA,NA,NA,NA,NA,NA
"282","aml_ohsu_2018_1710","aml_ohsu_2018_14-00542",8.22,"0:LIVING","Negative",NA,"Good","Positive","HiDAC","SWOG S1203 (7+3 +/- Vorinostat)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"283","aml_ohsu_2018_1710","aml_ohsu_2018_14-00542",8.22,"0:LIVING","Negative",NA,"Good","Positive","HiDAC","SWOG S1203 (7+3 +/- Vorinostat)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"284","aml_ohsu_2018_1710","aml_ohsu_2018_14-00543",8.22,"0:LIVING","Negative",NA,"Good","Positive","HiDAC","SWOG S1203 (7+3 +/- Vorinostat)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"285","aml_ohsu_2018_1710","aml_ohsu_2018_14-00543",8.22,"0:LIVING","Negative",NA,"Good","Positive","HiDAC","SWOG S1203 (7+3 +/- Vorinostat)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"286","aml_ohsu_2018_1711","aml_ohsu_2018_14-00546",NA,NA,NA,NA,"Good","Negative","APML4 Protocol (ATRA, Arsenic Trioxide, Idarubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"287","aml_ohsu_2018_1717","aml_ohsu_2018_14-00555",12.83,"1:DECEASED",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","Azacitidine","MEC (Cytarabine, Etoposide, Mitoxantrone)",NA,NA,NA,NA,NA,NA,NA,NA,NA
"288","aml_ohsu_2018_1719","aml_ohsu_2018_14-00564",1.15,"1:DECEASED","p.R248Q; MAF 80%","Negative","Poor","Negative","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"289","aml_ohsu_2018_1721","aml_ohsu_2018_14-00559",32.11,"0:LIVING",NA,"R882C; MAF 50%","Good","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","Azacitidine","MEC (Cytarabine, Etoposide, Mitoxantrone)",NA,NA,NA,NA,NA,NA,NA,NA,NA
"290","aml_ohsu_2018_1721","aml_ohsu_2018_14-00559",32.11,"0:LIVING",NA,"R882C; MAF 50%","Good","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","Azacitidine","MEC (Cytarabine, Etoposide, Mitoxantrone)",NA,NA,NA,NA,NA,NA,NA,NA,NA
"291","aml_ohsu_2018_1721","aml_ohsu_2018_15-00140",32.11,"0:LIVING",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","Azacitidine","MEC (Cytarabine, Etoposide, Mitoxantrone)",NA,NA,NA,NA,NA,NA,NA,NA,NA
"292","aml_ohsu_2018_1721","aml_ohsu_2018_15-00140",32.11,"0:LIVING",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","Azacitidine","MEC (Cytarabine, Etoposide, Mitoxantrone)",NA,NA,NA,NA,NA,NA,NA,NA,NA
"293","aml_ohsu_2018_1723","aml_ohsu_2018_14-00567",15.2,"1:DECEASED","Negative","Negative","Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","MiDAC","Bu/Flu/TBI (Busulfan, Fludarabine, Total Body Irradiation)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"294","aml_ohsu_2018_1727","aml_ohsu_2018_14-00573",8.52,"1:DECEASED","Negative","Negative","Poor","Negative","GCLAM (G-CSF, Cladribine, Cytarabine, and Mitoxantrone) ","7+3 (Cytarabine, Idarubicin)","Azacitidine","MEC (Cytarabine, Etoposide, Mitoxantrone)","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA
"295","aml_ohsu_2018_1727","aml_ohsu_2018_14-00573",8.52,"1:DECEASED","Negative","Negative","Poor","Negative","GCLAM (G-CSF, Cladribine, Cytarabine, and Mitoxantrone) ","7+3 (Cytarabine, Idarubicin)","Azacitidine","MEC (Cytarabine, Etoposide, Mitoxantrone)","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA
"296","aml_ohsu_2018_1727","aml_ohsu_2018_14-00573",8.52,"1:DECEASED","Negative","Negative","Poor","Negative","GCLAM (G-CSF, Cladribine, Cytarabine, and Mitoxantrone) ","7+3 (Cytarabine, Idarubicin)","Azacitidine","MEC (Cytarabine, Etoposide, Mitoxantrone)","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA
"297","aml_ohsu_2018_1727","aml_ohsu_2018_14-00803",8.52,"1:DECEASED","Negative","Negative","Poor","Negative","GCLAM (G-CSF, Cladribine, Cytarabine, and Mitoxantrone) ","7+3 (Cytarabine, Idarubicin)","Azacitidine","MEC (Cytarabine, Etoposide, Mitoxantrone)","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA
"298","aml_ohsu_2018_1727","aml_ohsu_2018_14-00803",8.52,"1:DECEASED","Negative","Negative","Poor","Negative","GCLAM (G-CSF, Cladribine, Cytarabine, and Mitoxantrone) ","7+3 (Cytarabine, Idarubicin)","Azacitidine","MEC (Cytarabine, Etoposide, Mitoxantrone)","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA
"299","aml_ohsu_2018_1727","aml_ohsu_2018_14-00803",8.52,"1:DECEASED","Negative","Negative","Poor","Negative","GCLAM (G-CSF, Cladribine, Cytarabine, and Mitoxantrone) ","7+3 (Cytarabine, Idarubicin)","Azacitidine","MEC (Cytarabine, Etoposide, Mitoxantrone)","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA
"300","aml_ohsu_2018_1727","aml_ohsu_2018_15-00231",8.52,"1:DECEASED",NA,NA,"Intermediate","Negative","GCLAM (G-CSF, Cladribine, Cytarabine, and Mitoxantrone) ","7+3 (Cytarabine, Idarubicin)","Azacitidine","MEC (Cytarabine, Etoposide, Mitoxantrone)","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA
"301","aml_ohsu_2018_1727","aml_ohsu_2018_15-00231",8.52,"1:DECEASED",NA,NA,"Intermediate","Negative","GCLAM (G-CSF, Cladribine, Cytarabine, and Mitoxantrone) ","7+3 (Cytarabine, Idarubicin)","Azacitidine","MEC (Cytarabine, Etoposide, Mitoxantrone)","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA
"302","aml_ohsu_2018_1727","aml_ohsu_2018_15-00231",8.52,"1:DECEASED",NA,NA,"Intermediate","Negative","GCLAM (G-CSF, Cladribine, Cytarabine, and Mitoxantrone) ","7+3 (Cytarabine, Idarubicin)","Azacitidine","MEC (Cytarabine, Etoposide, Mitoxantrone)","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA
"303","aml_ohsu_2018_1730","aml_ohsu_2018_14-00578",10.76,"1:DECEASED","Negative","p.P777L; MAF 50%","Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","Cytarabine","Fludarabine, TBI","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA
"304","aml_ohsu_2018_1731","aml_ohsu_2018_14-00581",2.3,"1:DECEASED","Negative",NA,"Poor","Negative","CPX-351 (Liposomal Cytarabine + Daunorubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"305","aml_ohsu_2018_1737","aml_ohsu_2018_14-00588",4.51,"1:DECEASED",NA,"R882C; MAF 43%","Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","Busulfan, Cyclophosphamide, Thymoglobulin","Fludarabine, Cyclophosphamide, TBI",NA,NA,NA,NA,NA,NA,NA,NA,NA
"306","aml_ohsu_2018_1739","aml_ohsu_2018_14-00599",15.46,"1:DECEASED","Negative","Negative","Poor","Negative","5+2 (Cytarabine, Idarubicin)","7+3 (Cytarabine, Idarubicin)","MiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"307","aml_ohsu_2018_174","aml_ohsu_2018_10-00136",13.78,"1:DECEASED",NA,NA,"Poor","Negative","7+3 (Cytarabine, Idarubicin)","MiDAC","Hydroxyurea","AC220 (Ambit)",NA,NA,NA,NA,NA,NA,NA,NA,NA
"308","aml_ohsu_2018_174","aml_ohsu_2018_10-00136",13.78,"1:DECEASED",NA,NA,"Poor","Negative","7+3 (Cytarabine, Idarubicin)","MiDAC","Hydroxyurea","AC220 (Ambit)",NA,NA,NA,NA,NA,NA,NA,NA,NA
"309","aml_ohsu_2018_174","aml_ohsu_2018_10-00136",13.78,"1:DECEASED",NA,NA,"Poor","Negative","7+3 (Cytarabine, Idarubicin)","MiDAC","Hydroxyurea","AC220 (Ambit)",NA,NA,NA,NA,NA,NA,NA,NA,NA
"310","aml_ohsu_2018_174","aml_ohsu_2018_10-00542",13.78,"1:DECEASED",NA,NA,"Poor","Negative","7+3 (Cytarabine, Idarubicin)","MiDAC","Hydroxyurea","AC220 (Ambit)",NA,NA,NA,NA,NA,NA,NA,NA,NA
"311","aml_ohsu_2018_174","aml_ohsu_2018_10-00542",13.78,"1:DECEASED",NA,NA,"Poor","Negative","7+3 (Cytarabine, Idarubicin)","MiDAC","Hydroxyurea","AC220 (Ambit)",NA,NA,NA,NA,NA,NA,NA,NA,NA
"312","aml_ohsu_2018_174","aml_ohsu_2018_10-00542",13.78,"1:DECEASED",NA,NA,"Poor","Negative","7+3 (Cytarabine, Idarubicin)","MiDAC","Hydroxyurea","AC220 (Ambit)",NA,NA,NA,NA,NA,NA,NA,NA,NA
"313","aml_ohsu_2018_174","aml_ohsu_2018_11-00049",13.78,"1:DECEASED",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","MiDAC","Hydroxyurea","AC220 (Ambit)",NA,NA,NA,NA,NA,NA,NA,NA,NA
"314","aml_ohsu_2018_174","aml_ohsu_2018_11-00049",13.78,"1:DECEASED",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","MiDAC","Hydroxyurea","AC220 (Ambit)",NA,NA,NA,NA,NA,NA,NA,NA,NA
"315","aml_ohsu_2018_174","aml_ohsu_2018_11-00049",13.78,"1:DECEASED",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","MiDAC","Hydroxyurea","AC220 (Ambit)",NA,NA,NA,NA,NA,NA,NA,NA,NA
"316","aml_ohsu_2018_1745","aml_ohsu_2018_15-00974",17.53,"1:DECEASED",NA,NA,"Poor","Negative","GCLAM (G-CSF, Cladribine, Cytarabine, and Mitoxantrone) ","7+3 (Cytarabine, Idarubicin)","Donor Lymphocyte Infusion","Azacitidine","FLAG (Fludarabine, High-dose Cytarabine, G-CSF)","Decitabine","Busulfan, Cyclophosphamide",NA,NA,NA,NA,NA,NA
"317","aml_ohsu_2018_1746","aml_ohsu_2018_14-00602",10,"1:DECEASED","Negative",NA,"Intermediate","Negative","CPX-351 (Liposomal Cytarabine + Daunorubicin)","Decitabine, Midostaurin","FLAG-IDA, Gemtuzumab","MEC, Lenalidomide",NA,NA,NA,NA,NA,NA,NA,NA,NA
"318","aml_ohsu_2018_1746","aml_ohsu_2018_14-00602",10,"1:DECEASED","Negative",NA,"Intermediate","Negative","CPX-351 (Liposomal Cytarabine + Daunorubicin)","Decitabine, Midostaurin","FLAG-IDA, Gemtuzumab","MEC, Lenalidomide",NA,NA,NA,NA,NA,NA,NA,NA,NA
"319","aml_ohsu_2018_1746","aml_ohsu_2018_14-00603",10,"1:DECEASED","Negative",NA,"Good","Positive","CPX-351 (Liposomal Cytarabine + Daunorubicin)","Decitabine, Midostaurin","FLAG-IDA, Gemtuzumab","MEC, Lenalidomide",NA,NA,NA,NA,NA,NA,NA,NA,NA
"320","aml_ohsu_2018_1746","aml_ohsu_2018_14-00603",10,"1:DECEASED","Negative",NA,"Good","Positive","CPX-351 (Liposomal Cytarabine + Daunorubicin)","Decitabine, Midostaurin","FLAG-IDA, Gemtuzumab","MEC, Lenalidomide",NA,NA,NA,NA,NA,NA,NA,NA,NA
"321","aml_ohsu_2018_1749","aml_ohsu_2018_14-00608",37.3,"1:DECEASED",NA,NA,"Intermediate","Negative","Azacitidine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"322","aml_ohsu_2018_175","aml_ohsu_2018_10-00172",17.8,"1:DECEASED",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","Quizartinib","Busulfan, Cyclophosphamide",NA,NA,NA,NA,NA,NA,NA,NA
"323","aml_ohsu_2018_1752","aml_ohsu_2018_14-00613",NA,NA,NA,NA,"Good","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"324","aml_ohsu_2018_1754","aml_ohsu_2018_14-00618",NA,NA,NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","Cytarabine","Bortezomib","Decitabine","Fludarabine, Cytarabine",NA,NA,NA,NA,NA,NA,NA,NA
"325","aml_ohsu_2018_1757","aml_ohsu_2018_15-00081",14.57,"1:DECEASED",NA,NA,"Intermediate","Negative","Busulfan, Fludarabine, Thymoglobulin (Bu/Flu/ATG)","7+3 (Cytarabine, Idarubicin)","HiDAC","CLAG-M (Cladribine, Cytarabine, Mitoxantrone, Filgrastim)","FLAG-IDA, Gemtuzumab","Cytarabine, Methotrexate",NA,NA,NA,NA,NA,NA,NA
"326","aml_ohsu_2018_176","aml_ohsu_2018_11-00162",12.01,"1:DECEASED",NA,NA,"Good","Positive","7+3 (Cytarabine, Idarubicin)","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","Azacitidine","Quizartinib",NA,NA,NA,NA,NA,NA,NA,NA,NA
"327","aml_ohsu_2018_1761","aml_ohsu_2018_14-00632",18.72,"0:LIVING","Negative","Negative","Poor","Negative","5+2 (Cytarabine, Idarubicin)","7+3 (Cytarabine, Idarubicin)","R-CEOP (Cyclophosphamide, Etoposide, Prednisolone, Rituximab, Vincristine)","MiDAC","FATE Trial RIC (Fludarabine, Melphalan, Rabbit ATG) ","R-CHOP (Cyclophosphamide, Doxorubicin, Prednisolone, Rituximab,",NA,NA,NA,NA,NA,NA,NA
"328","aml_ohsu_2018_1763","aml_ohsu_2018_14-00643",18.62,"0:LIVING","Negative",NA,"Good","Negative","3+7 (Cytarabine, Daunorubicin)","MEC (Cytarabine, Etoposide, Mitoxantrone)","Etoposide, Mitoxantrone","Busulfan, Cyclophosphamide",NA,NA,NA,NA,NA,NA,NA,NA,NA
"329","aml_ohsu_2018_1775","aml_ohsu_2018_14-00658",8.36,"1:DECEASED",NA,NA,"Intermediate","Positive","Azacitidine, Sorafenib","Busulfan, Fludarabine, Thymoglobulin (Bu/Flu/ATG)","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA
"330","aml_ohsu_2018_1782","aml_ohsu_2018_14-00664",0.92,"1:DECEASED","Negative","Negative","Poor","Negative","7+3 (Cytarabine, Idarubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"331","aml_ohsu_2018_1783","aml_ohsu_2018_14-00667",8.06,"1:DECEASED","Negative","Negative","Poor","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","Fludarabine, Melphalan, TBI",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"332","aml_ohsu_2018_1786","aml_ohsu_2018_14-00672",174.51,"0:LIVING",NA,NA,"Intermediate","Negative","Ruxolitinib","Imatinib","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"333","aml_ohsu_2018_1787","aml_ohsu_2018_14-00670",34.84,"0:LIVING",NA,NA,"Poor","Negative","AG-221","Azacitidine","Fludarabine, Melphalan, TBI, ATG",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"334","aml_ohsu_2018_1797","aml_ohsu_2018_14-00681",10.63,"0:LIVING","Negative","p.R882H; MAF 44%","Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","Cytarabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"335","aml_ohsu_2018_1800","aml_ohsu_2018_14-00690",15.2,"0:LIVING",NA,NA,"Good","Positive","Busulfan, Fludarabine","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"336","aml_ohsu_2018_1810","aml_ohsu_2018_14-00712",5.2,"1:DECEASED","Negative","Negative","Poor","Negative","3+7 (Cytarabine, Daunorubicin)","Decitabine","5+2 (Ara-C, Daunorubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"337","aml_ohsu_2018_1811","aml_ohsu_2018_14-00714",63.75,"1:DECEASED","Negative","Negative","Poor","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","Azacitidine","Decitabine","MEC, Lenalidomide",NA,NA,NA,NA,NA,NA,NA,NA
"338","aml_ohsu_2018_1811","aml_ohsu_2018_14-00714",63.75,"1:DECEASED","Negative","Negative","Poor","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","Azacitidine","Decitabine","MEC, Lenalidomide",NA,NA,NA,NA,NA,NA,NA,NA
"339","aml_ohsu_2018_1811","aml_ohsu_2018_14-00715",63.75,"1:DECEASED","Negative","Negative","Poor","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","Azacitidine","Decitabine","MEC, Lenalidomide",NA,NA,NA,NA,NA,NA,NA,NA
"340","aml_ohsu_2018_1811","aml_ohsu_2018_14-00715",63.75,"1:DECEASED","Negative","Negative","Poor","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","Azacitidine","Decitabine","MEC, Lenalidomide",NA,NA,NA,NA,NA,NA,NA,NA
"341","aml_ohsu_2018_1813","aml_ohsu_2018_14-00720",32.99,"1:DECEASED",NA,"F827fs*4; MAF 35%","Poor","Negative","Crenolanib","HAM (Mitoxantrone, Cytarabine) plus Crenolanib","Azacitidine, Pracinostat",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"342","aml_ohsu_2018_1814","aml_ohsu_2018_14-00725",27.4,"0:LIVING",NA,NA,"Intermediate","Negative","Bu/Cy/ATG","7+3 (Cytarabine, Idarubicin)","MEC (Cytarabine, Etoposide, Mitoxantrone)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"343","aml_ohsu_2018_1814","aml_ohsu_2018_14-00725",27.4,"0:LIVING",NA,NA,"Intermediate","Negative","Bu/Cy/ATG","7+3 (Cytarabine, Idarubicin)","MEC (Cytarabine, Etoposide, Mitoxantrone)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"344","aml_ohsu_2018_1814","aml_ohsu_2018_14-00815",27.4,"0:LIVING",NA,NA,"Intermediate","Negative","Bu/Cy/ATG","7+3 (Cytarabine, Idarubicin)","MEC (Cytarabine, Etoposide, Mitoxantrone)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"345","aml_ohsu_2018_1814","aml_ohsu_2018_14-00815",27.4,"0:LIVING",NA,NA,"Intermediate","Negative","Bu/Cy/ATG","7+3 (Cytarabine, Idarubicin)","MEC (Cytarabine, Etoposide, Mitoxantrone)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"346","aml_ohsu_2018_1817","aml_ohsu_2018_14-00730",19.31,"0:LIVING","Negative","Negative","Good","Negative","ATRA, Arsenic Trioxide",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"347","aml_ohsu_2018_1818","aml_ohsu_2018_14-00735",1.55,"1:DECEASED","Negative","Negative","Intermediate","Positive","Azacitidine","Decitabine, Midostaurin",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"348","aml_ohsu_2018_1819","aml_ohsu_2018_14-00738",2.2,"1:DECEASED","p.V272M; MAF 88%","Negative","Poor","Negative","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"349","aml_ohsu_2018_1820","aml_ohsu_2018_14-00739",7.11,"1:DECEASED","Negative",NA,"Poor","Negative","5+2 (Cytarabine, Idarubicin)","7+3 (Cytarabine, Idarubicin)","MEC (Cytarabine, Etoposide, Mitoxantrone)","Methotrexate",NA,NA,NA,NA,NA,NA,NA,NA,NA
"350","aml_ohsu_2018_1821","aml_ohsu_2018_14-00742",NA,NA,NA,NA,"Poor","Negative","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"351","aml_ohsu_2018_1827","aml_ohsu_2018_14-00756",16.74,"0:LIVING","Negative","Negative","Poor","Negative","7+3 (Cytarabine, Idarubicin)","MEC (Cytarabine, Etoposide, Mitoxantrone)","Busulfan, Cyclophosphamide",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"352","aml_ohsu_2018_1833","aml_ohsu_2018_14-00761",13.72,"0:LIVING",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","Azacitidine","Decitabine, Midostaurin",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"353","aml_ohsu_2018_1843","aml_ohsu_2018_14-00774",2.2,"1:DECEASED","Negative","Negative","Poor","Negative","Decitabine, Midostaurin",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"354","aml_ohsu_2018_1845","aml_ohsu_2018_14-00777",2.96,"0:LIVING","Negative","Negative","Good","Negative","7+3 (Cytarabine, Idarubicin)","MiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"355","aml_ohsu_2018_1847","aml_ohsu_2018_14-00781",5.33,"1:DECEASED","Negative","Negative","Poor","Negative","7+3 (Cytarabine, Idarubicin)","MiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"356","aml_ohsu_2018_1848","aml_ohsu_2018_14-00787",14.54,"0:LIVING","Negative","Negative","Intermediate","Negative","Fludarabine, Melphalan","7+3 (Cytarabine, Idarubicin)","MiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"357","aml_ohsu_2018_1852","aml_ohsu_2018_14-00798",0.49,"1:DECEASED","Negative","Negative","Good","Negative","7+3 (Cytarabine, Idarubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"358","aml_ohsu_2018_1854","aml_ohsu_2018_14-00800",3.75,"1:DECEASED","Negative","Negative","Intermediate","Negative","CPX-351 (Liposomal Cytarabine + Daunorubicin)","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"359","aml_ohsu_2018_1855","aml_ohsu_2018_14-00801",19.61,"0:LIVING","Negative","Negative","Intermediate","Negative","Donor Lymphocyte Infusion","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","Azacitidine","MEC (Cytarabine, Etoposide, Mitoxantrone)","Busulfan, Cyclophosphamide",NA,NA,NA,NA,NA,NA,NA,NA
"360","aml_ohsu_2018_1863","aml_ohsu_2018_14-00793",NA,NA,NA,NA,"Intermediate","Negative",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"361","aml_ohsu_2018_1865","aml_ohsu_2018_14-00817",NA,NA,NA,NA,"Poor","Negative","7+3 (Cytarabine, Idarubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"362","aml_ohsu_2018_1866","aml_ohsu_2018_14-00831",NA,NA,NA,NA,"Good","Negative","ATRA, Arsenic Trioxide",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"363","aml_ohsu_2018_1868","aml_ohsu_2018_14-00832",14.8,"0:LIVING",NA,"Negative","Intermediate","Negative","Fludarabine, Melphalan","7+3 (Cytarabine, Idarubicin)","MiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"364","aml_ohsu_2018_1870","aml_ohsu_2018_14-00901",3.42,"1:DECEASED",NA,NA,"Intermediate","Negative","5+2 (Cytarabine, Idarubicin)","7+3 (Cytarabine, Idarubicin)","MiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"365","aml_ohsu_2018_1876","aml_ohsu_2018_15-00009",15.76,"0:LIVING",NA,NA,"Intermediate","Negative","Cyclophosphamide, Fludarabine, TBI","Azacitidine","Venetoclax (ABT-199)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"366","aml_ohsu_2018_1876","aml_ohsu_2018_15-00009",15.76,"0:LIVING",NA,NA,"Intermediate","Negative","Cyclophosphamide, Fludarabine, TBI","Azacitidine","Venetoclax (ABT-199)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"367","aml_ohsu_2018_1876","aml_ohsu_2018_15-00143",15.76,"0:LIVING",NA,NA,"Intermediate","Negative","Cyclophosphamide, Fludarabine, TBI","Azacitidine","Venetoclax (ABT-199)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"368","aml_ohsu_2018_1876","aml_ohsu_2018_15-00143",15.76,"0:LIVING",NA,NA,"Intermediate","Negative","Cyclophosphamide, Fludarabine, TBI","Azacitidine","Venetoclax (ABT-199)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"369","aml_ohsu_2018_1877","aml_ohsu_2018_15-00014",0.53,"1:DECEASED","Negative","Negative","Intermediate","Positive","Azacitidine","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"370","aml_ohsu_2018_1889","aml_ohsu_2018_15-00018",3.65,"1:DECEASED","Negative","Negative","Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","Binimetinib (MEK162)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"371","aml_ohsu_2018_191","aml_ohsu_2018_10-00791",12.96,"1:DECEASED",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","MEC (Cytarabine, Etoposide, Mitoxantrone)","Etoposide, Mitoxantrone","Quizartinib",NA,NA,NA,NA,NA,NA,NA,NA
"372","aml_ohsu_2018_191","aml_ohsu_2018_10-00791",12.96,"1:DECEASED",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","MEC (Cytarabine, Etoposide, Mitoxantrone)","Etoposide, Mitoxantrone","Quizartinib",NA,NA,NA,NA,NA,NA,NA,NA
"373","aml_ohsu_2018_191","aml_ohsu_2018_10-00791",12.96,"1:DECEASED",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","MEC (Cytarabine, Etoposide, Mitoxantrone)","Etoposide, Mitoxantrone","Quizartinib",NA,NA,NA,NA,NA,NA,NA,NA
"374","aml_ohsu_2018_191","aml_ohsu_2018_11-00178",12.96,"1:DECEASED",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","MEC (Cytarabine, Etoposide, Mitoxantrone)","Etoposide, Mitoxantrone","Quizartinib",NA,NA,NA,NA,NA,NA,NA,NA
"375","aml_ohsu_2018_191","aml_ohsu_2018_11-00178",12.96,"1:DECEASED",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","MEC (Cytarabine, Etoposide, Mitoxantrone)","Etoposide, Mitoxantrone","Quizartinib",NA,NA,NA,NA,NA,NA,NA,NA
"376","aml_ohsu_2018_191","aml_ohsu_2018_11-00178",12.96,"1:DECEASED",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","MEC (Cytarabine, Etoposide, Mitoxantrone)","Etoposide, Mitoxantrone","Quizartinib",NA,NA,NA,NA,NA,NA,NA,NA
"377","aml_ohsu_2018_191","aml_ohsu_2018_11-00254",12.96,"1:DECEASED",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","MEC (Cytarabine, Etoposide, Mitoxantrone)","Etoposide, Mitoxantrone","Quizartinib",NA,NA,NA,NA,NA,NA,NA,NA
"378","aml_ohsu_2018_191","aml_ohsu_2018_11-00254",12.96,"1:DECEASED",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","MEC (Cytarabine, Etoposide, Mitoxantrone)","Etoposide, Mitoxantrone","Quizartinib",NA,NA,NA,NA,NA,NA,NA,NA
"379","aml_ohsu_2018_191","aml_ohsu_2018_11-00254",12.96,"1:DECEASED",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","MEC (Cytarabine, Etoposide, Mitoxantrone)","Etoposide, Mitoxantrone","Quizartinib",NA,NA,NA,NA,NA,NA,NA,NA
"380","aml_ohsu_2018_1916","aml_ohsu_2018_15-00024",10.53,"1:DECEASED","Negative","Negative","Intermediate","Negative","Decitabine, Midostaurin",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"381","aml_ohsu_2018_1919","aml_ohsu_2018_15-00029",11.97,"1:DECEASED",NA,NA,"Intermediate","Negative","Decitabine, ABT-199","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"382","aml_ohsu_2018_1924","aml_ohsu_2018_15-00043",13.82,"0:LIVING",NA,NA,"Poor","Negative","7+3 (Cytarabine, Idarubicin)","GCLAC (GCSF, Clofarabine & Cytarabine)","Busulfan, Cyclophosphamide",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"383","aml_ohsu_2018_1925","aml_ohsu_2018_15-00045",28.09,"0:LIVING",NA,NA,"Good","Negative","HiDAC","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","MEC (Cytarabine, Etoposide, Mitoxantrone)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"384","aml_ohsu_2018_1929","aml_ohsu_2018_15-00051",17.57,"0:LIVING","Negative","Negative","Good","Positive","5+2 (Cytarabine, Idarubicin)","7+3 (Cytarabine, Idarubicin)","MiDAC","Bu/Flu/TBI (Busulfan, Fludarabine, Total Body Irradiation)",NA,NA,NA,NA,NA,NA,NA,NA,NA
"385","aml_ohsu_2018_1933","aml_ohsu_2018_15-00056",22.37,"1:DECEASED",NA,NA,"Intermediate","Negative","AG-221","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"386","aml_ohsu_2018_1933","aml_ohsu_2018_15-00056",22.37,"1:DECEASED",NA,NA,"Intermediate","Negative","AG-221","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"387","aml_ohsu_2018_1933","aml_ohsu_2018_15-00057",22.37,"1:DECEASED",NA,NA,"Intermediate","Negative","AG-221","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"388","aml_ohsu_2018_1933","aml_ohsu_2018_15-00057",22.37,"1:DECEASED",NA,NA,"Intermediate","Negative","AG-221","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"389","aml_ohsu_2018_1953","aml_ohsu_2018_15-00084",1.15,"1:DECEASED",NA,NA,"Poor","Negative","Azacitidine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"390","aml_ohsu_2018_1962","aml_ohsu_2018_15-00071",30.2,"1:DECEASED",NA,NA,"Poor","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","MEC (Cytarabine, Etoposide, Mitoxantrone)","Busulfan, Cyclophosphamide",NA,NA,NA,NA,NA,NA,NA,NA,NA
"391","aml_ohsu_2018_1963","aml_ohsu_2018_15-00073",2.37,"1:DECEASED",NA,NA,"Poor","Negative","AG-221","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"392","aml_ohsu_2018_1964","aml_ohsu_2018_15-00075",1.12,"1:DECEASED",NA,NA,"Poor","Negative","AG-221",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"393","aml_ohsu_2018_1967","aml_ohsu_2018_15-00312",NA,NA,NA,NA,"Poor","Negative","7+3 (Cytarabine, Idarubicin)","Azacitidine, Lenalidomide","Rituximab",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"394","aml_ohsu_2018_1969","aml_ohsu_2018_15-00123",27.37,"0:LIVING",NA,NA,"Intermediate","Positive","Bu/Cy/ATG","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"395","aml_ohsu_2018_1972","aml_ohsu_2018_15-00129",NA,NA,NA,NA,"Intermediate","Negative","Azacitidine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"396","aml_ohsu_2018_1973","aml_ohsu_2018_15-00194",17.2,"0:LIVING","Negative","Negative","Poor","Negative","7+3 (Cytarabine, Idarubicin)","Azacitidine","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"397","aml_ohsu_2018_1973","aml_ohsu_2018_15-00194",17.2,"0:LIVING","Negative","Negative","Poor","Negative","7+3 (Cytarabine, Idarubicin)","Azacitidine","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"398","aml_ohsu_2018_1973","aml_ohsu_2018_15-00194",17.2,"0:LIVING","Negative","Negative","Poor","Negative","7+3 (Cytarabine, Idarubicin)","Azacitidine","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"399","aml_ohsu_2018_1973","aml_ohsu_2018_15-00874",17.2,"0:LIVING",NA,NA,"Poor","Negative","7+3 (Cytarabine, Idarubicin)","Azacitidine","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"400","aml_ohsu_2018_1973","aml_ohsu_2018_15-00874",17.2,"0:LIVING",NA,NA,"Poor","Negative","7+3 (Cytarabine, Idarubicin)","Azacitidine","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"401","aml_ohsu_2018_1973","aml_ohsu_2018_15-00874",17.2,"0:LIVING",NA,NA,"Poor","Negative","7+3 (Cytarabine, Idarubicin)","Azacitidine","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"402","aml_ohsu_2018_1973","aml_ohsu_2018_16-00315",17.2,"0:LIVING",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","Azacitidine","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"403","aml_ohsu_2018_1973","aml_ohsu_2018_16-00315",17.2,"0:LIVING",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","Azacitidine","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"404","aml_ohsu_2018_1973","aml_ohsu_2018_16-00315",17.2,"0:LIVING",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","Azacitidine","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"405","aml_ohsu_2018_1981","aml_ohsu_2018_15-00147",27.73,"1:DECEASED",NA,NA,"Intermediate","Negative","GCLAM (G-CSF, Cladribine, Cytarabine, and Mitoxantrone) ","7+3 (Cytarabine, Idarubicin)","HiDAC","MEC (Cytarabine, Etoposide, Mitoxantrone)","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA
"406","aml_ohsu_2018_1988","aml_ohsu_2018_15-00148",6.58,"0:LIVING","Negative","Negative","Good","Positive","7+3 (Cytarabine, Idarubicin)","MiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"407","aml_ohsu_2018_1989","aml_ohsu_2018_14-00083",NA,NA,"Negative","Positive","Good","Positive","HiDAC","GCLAC (GCSF, Clofarabine & Cytarabine)","SWOG S1203 (7+3 +/- Vorinostat)","MEC, Lenalidomide","Etoposide, Cytarabine",NA,NA,NA,NA,NA,NA,NA,NA
"408","aml_ohsu_2018_1989","aml_ohsu_2018_14-00083",NA,NA,"Negative","Positive","Good","Positive","HiDAC","GCLAC (GCSF, Clofarabine & Cytarabine)","SWOG S1203 (7+3 +/- Vorinostat)","MEC, Lenalidomide","Etoposide, Cytarabine",NA,NA,NA,NA,NA,NA,NA,NA
"409","aml_ohsu_2018_1989","aml_ohsu_2018_15-00150",NA,NA,"Negative","p.R882C; MAF 47%","Intermediate","Positive","HiDAC","GCLAC (GCSF, Clofarabine & Cytarabine)","SWOG S1203 (7+3 +/- Vorinostat)","MEC, Lenalidomide","Etoposide, Cytarabine",NA,NA,NA,NA,NA,NA,NA,NA
"410","aml_ohsu_2018_1989","aml_ohsu_2018_15-00150",NA,NA,"Negative","p.R882C; MAF 47%","Intermediate","Positive","HiDAC","GCLAC (GCSF, Clofarabine & Cytarabine)","SWOG S1203 (7+3 +/- Vorinostat)","MEC, Lenalidomide","Etoposide, Cytarabine",NA,NA,NA,NA,NA,NA,NA,NA
"411","aml_ohsu_2018_1992","aml_ohsu_2018_15-00275",2.37,"1:DECEASED",NA,NA,"Poor","Negative","7+3 (Cytarabine, Idarubicin)","GCLAC (GCSF, Clofarabine & Cytarabine)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"412","aml_ohsu_2018_1993","aml_ohsu_2018_15-00159",NA,NA,NA,NA,"Intermediate","Negative",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"413","aml_ohsu_2018_1998","aml_ohsu_2018_15-00167",1.15,"1:DECEASED","Negative","Negative","Good","Positive","SWOG S1203 (7+3 +/- Vorinostat)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"414","aml_ohsu_2018_1999","aml_ohsu_2018_15-00175",3.26,"1:DECEASED","p.R273H; MAF 44%","Negative","Poor","Negative","7+3 (Cytarabine, Idarubicin)","MEC (Cytarabine, Etoposide, Mitoxantrone)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"415","aml_ohsu_2018_2001","aml_ohsu_2018_15-00169",14.77,"1:DECEASED",NA,NA,"Intermediate","Negative","AG-120","MEC (Cytarabine, Etoposide, Mitoxantrone)","Sorafenib","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA,NA
"416","aml_ohsu_2018_2001","aml_ohsu_2018_15-00169",14.77,"1:DECEASED",NA,NA,"Intermediate","Negative","AG-120","MEC (Cytarabine, Etoposide, Mitoxantrone)","Sorafenib","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA,NA
"417","aml_ohsu_2018_2001","aml_ohsu_2018_15-00829",14.77,"1:DECEASED","p.R283C; MAF 49%",NA,"Poor","Negative","AG-120","MEC (Cytarabine, Etoposide, Mitoxantrone)","Sorafenib","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA,NA
"418","aml_ohsu_2018_2001","aml_ohsu_2018_15-00829",14.77,"1:DECEASED","p.R283C; MAF 49%",NA,"Poor","Negative","AG-120","MEC (Cytarabine, Etoposide, Mitoxantrone)","Sorafenib","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA,NA
"419","aml_ohsu_2018_2002","aml_ohsu_2018_15-00171",10.16,"1:DECEASED","Negative","Negative","Poor","Negative","Cytarabine","Decitabine","PF-04449913 (Hedgehog Inhibitor), LDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"420","aml_ohsu_2018_2005","aml_ohsu_2018_15-00180",14.47,"1:DECEASED",NA,NA,"Poor","Negative","FLX925","Azacitidine, Lenalidomide","Venetoclax (ABT-199)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"421","aml_ohsu_2018_201","aml_ohsu_2018_10-00692",12.5,"0:LIVING",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","Hydroxyurea","Quizartinib","Busulfan, Cyclophosphamide",NA,NA,NA,NA,NA,NA,NA,NA,NA
"422","aml_ohsu_2018_2010","aml_ohsu_2018_15-00294",11.02,"1:DECEASED",NA,NA,"Intermediate","Negative","AG-221","Azacitidine","Clofarabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"423","aml_ohsu_2018_2013","aml_ohsu_2018_15-00196",0.79,"1:DECEASED",NA,NA,"Poor","Negative","AG-221",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"424","aml_ohsu_2018_2016","aml_ohsu_2018_15-00200",28.55,"0:LIVING",NA,NA,"Good","Positive","Azacitidine","Venetoclax (ABT-199), Azacitidine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"425","aml_ohsu_2018_2016","aml_ohsu_2018_15-00200",28.55,"0:LIVING",NA,NA,"Good","Positive","Azacitidine","Venetoclax (ABT-199), Azacitidine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"426","aml_ohsu_2018_2016","aml_ohsu_2018_15-00201",28.55,"0:LIVING",NA,NA,"Good","Positive","Azacitidine","Venetoclax (ABT-199), Azacitidine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"427","aml_ohsu_2018_2016","aml_ohsu_2018_15-00201",28.55,"0:LIVING",NA,NA,"Good","Positive","Azacitidine","Venetoclax (ABT-199), Azacitidine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"428","aml_ohsu_2018_2018","aml_ohsu_2018_15-00208",7.83,"1:DECEASED","loss exons 10-11",NA,"Poor","Negative","7+3 (Cytarabine, Idarubicin)","Azacitidine","Clofarabine, Cytarabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"429","aml_ohsu_2018_202","aml_ohsu_2018_14-00061",40.72,"1:DECEASED","Negative","Negative","Poor","Negative","7+3 (Cytarabine, Idarubicin)","MiDAC","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"430","aml_ohsu_2018_2024","aml_ohsu_2018_15-00229",0.92,"0:LIVING","Negative","Negative","Good","Negative","APML4 Protocol (ATRA, Arsenic Trioxide, Idarubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"431","aml_ohsu_2018_2028","aml_ohsu_2018_15-00237",15.66,"0:LIVING",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","Busulfan, Cyclophosphamide","Transplant",NA,NA,NA,NA,NA,NA,NA,NA,NA
"432","aml_ohsu_2018_203","aml_ohsu_2018_10-00715",13.16,"1:DECEASED",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","Quizartinib","Idarubicin and Cytarabine",NA,NA,NA,NA,NA,NA,NA,NA,NA
"433","aml_ohsu_2018_203","aml_ohsu_2018_10-00715",13.16,"1:DECEASED",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","Quizartinib","Idarubicin and Cytarabine",NA,NA,NA,NA,NA,NA,NA,NA,NA
"434","aml_ohsu_2018_203","aml_ohsu_2018_11-00170",13.16,"1:DECEASED",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","Quizartinib","Idarubicin and Cytarabine",NA,NA,NA,NA,NA,NA,NA,NA,NA
"435","aml_ohsu_2018_203","aml_ohsu_2018_11-00170",13.16,"1:DECEASED",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","Quizartinib","Idarubicin and Cytarabine",NA,NA,NA,NA,NA,NA,NA,NA,NA
"436","aml_ohsu_2018_2032","aml_ohsu_2018_15-00246",8.85,"1:DECEASED",NA,"W297*; MAF 44%","Good","Positive","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"437","aml_ohsu_2018_2033","aml_ohsu_2018_15-00248",NA,NA,NA,NA,"Poor","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","Azacitidine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"438","aml_ohsu_2018_2052","aml_ohsu_2018_15-00261",8.06,"1:DECEASED","Negative","Negative","Poor","Negative","7+3 (Cytarabine, Idarubicin)","Cytarabine","MEC (Cytarabine, Etoposide, Mitoxantrone)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"439","aml_ohsu_2018_2053","aml_ohsu_2018_15-00269",14.14,"1:DECEASED",NA,NA,"Good","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"440","aml_ohsu_2018_2059","aml_ohsu_2018_15-00276",28.62,"1:DECEASED",NA,NA,"Good","Positive","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","Azacitidine","SWOG S1203 (7+3 +/- Vorinostat)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"441","aml_ohsu_2018_2061","aml_ohsu_2018_15-00281",2.04,"1:DECEASED",NA,NA,"Poor","Negative","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"442","aml_ohsu_2018_2067","aml_ohsu_2018_15-00300",NA,NA,"Negative","p.F543C; MAF 35.7%","Poor","Negative",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"443","aml_ohsu_2018_2068","aml_ohsu_2018_15-00302",0.69,"1:DECEASED","Negative","Negative","Good","Positive","7+3 (Cytarabine, Idarubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"444","aml_ohsu_2018_2069","aml_ohsu_2018_15-00303",2.24,"0:LIVING","Negative","Negative","Good","Negative","7+3 (Cytarabine, Idarubicin)","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"445","aml_ohsu_2018_2073","aml_ohsu_2018_15-00287",5.49,"1:DECEASED","Negative","Negative","Intermediate","Negative","Azacitidine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"446","aml_ohsu_2018_2075","aml_ohsu_2018_15-00309",12.99,"1:DECEASED",NA,NA,"Intermediate","Positive","Busulfan, Fludarabine","7+3 (Cytarabine, Idarubicin)","HiDAC","Azacitidine","Sorafenib",NA,NA,NA,NA,NA,NA,NA,NA
"447","aml_ohsu_2018_2079","aml_ohsu_2018_15-00296",10.46,"0:LIVING","Negative","Negative","Poor","Negative","COG-AAML1031 (IT/IV Cytarabine, Daunorubicin, Etoposide, Mitoxantrone +/- Bortezomib or Sorafenib)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"448","aml_ohsu_2018_2084","aml_ohsu_2018_15-00320",2.66,"1:DECEASED",NA,"F290fs*24; MAF 40%","Intermediate","Positive","7+3 (Cytarabine, Idarubicin) plus Crenolanib",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"449","aml_ohsu_2018_2087","aml_ohsu_2018_15-00279",14.31,"0:LIVING","Negative","p.Arg882Cys; MAF 47.1%","Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","Cytarabine","TBI, VP-16",NA,NA,NA,NA,NA,NA,NA,NA,NA
"450","aml_ohsu_2018_2091","aml_ohsu_2018_15-00331",19.11,"1:DECEASED",NA,NA,"Good","Negative","HiDAC","7+3 (Cytarabine, Idarubicin) plus Sorafenib","Fludarabine, Cyclophosphamide, Thiotepa, TBI",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"451","aml_ohsu_2018_2094","aml_ohsu_2018_15-00338",5.1,"0:LIVING",NA,NA,"Good","Negative","ATRA, Arsenic Trioxide","ATRA, 6-MP, Methotrexate","Methotrexate",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"452","aml_ohsu_2018_2102","aml_ohsu_2018_15-00351",100.95,"1:DECEASED",NA,"p.R882H; MAF 15%","Poor","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","Donor Lymphocyte Infusion","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","MEC (Cytarabine, Etoposide, Mitoxantrone)","Cytarabine, Mitoxantrone","Busulfan, Cyclophosphamide",NA,NA,NA,NA,NA,NA
"453","aml_ohsu_2018_2104","aml_ohsu_2018_15-00353",6.71,"1:DECEASED",NA,NA,"Intermediate","Negative","Azacitidine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"454","aml_ohsu_2018_2106","aml_ohsu_2018_15-00357",NA,NA,NA,NA,"Intermediate","Negative","AG-221","Donor Lymphocyte Infusion","GCLAC (GCSF, Clofarabine & Cytarabine)","Azacitidine","7+3 (Cytarabine, Idarubicin) plus Sorafenib","Busulfan, Cyclophosphamide",NA,NA,NA,NA,NA,NA,NA
"455","aml_ohsu_2018_2106","aml_ohsu_2018_15-00357",NA,NA,NA,NA,"Intermediate","Negative","AG-221","Donor Lymphocyte Infusion","GCLAC (GCSF, Clofarabine & Cytarabine)","Azacitidine","7+3 (Cytarabine, Idarubicin) plus Sorafenib","Busulfan, Cyclophosphamide",NA,NA,NA,NA,NA,NA,NA
"456","aml_ohsu_2018_2106","aml_ohsu_2018_15-00358",NA,NA,NA,NA,"Intermediate","Negative","AG-221","Donor Lymphocyte Infusion","GCLAC (GCSF, Clofarabine & Cytarabine)","Azacitidine","7+3 (Cytarabine, Idarubicin) plus Sorafenib","Busulfan, Cyclophosphamide",NA,NA,NA,NA,NA,NA,NA
"457","aml_ohsu_2018_2106","aml_ohsu_2018_15-00358",NA,NA,NA,NA,"Intermediate","Negative","AG-221","Donor Lymphocyte Infusion","GCLAC (GCSF, Clofarabine & Cytarabine)","Azacitidine","7+3 (Cytarabine, Idarubicin) plus Sorafenib","Busulfan, Cyclophosphamide",NA,NA,NA,NA,NA,NA,NA
"458","aml_ohsu_2018_2108","aml_ohsu_2018_15-00361",0.95,"1:DECEASED",NA,NA,"Poor","Negative","Vincristine, Dexamethasone",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"459","aml_ohsu_2018_211","aml_ohsu_2018_11-00090",12.73,"1:DECEASED",NA,NA,"Intermediate","Positive","Fludarabine, Melphalan","7+3 (Cytarabine, Idarubicin)","MiDAC","Quizartinib","Methotrexate",NA,NA,NA,NA,NA,NA,NA,NA
"460","aml_ohsu_2018_211","aml_ohsu_2018_11-00090",12.73,"1:DECEASED",NA,NA,"Intermediate","Positive","Fludarabine, Melphalan","7+3 (Cytarabine, Idarubicin)","MiDAC","Quizartinib","Methotrexate",NA,NA,NA,NA,NA,NA,NA,NA
"461","aml_ohsu_2018_211","aml_ohsu_2018_11-00319",12.73,"1:DECEASED",NA,NA,"Intermediate","Positive","Fludarabine, Melphalan","7+3 (Cytarabine, Idarubicin)","MiDAC","Quizartinib","Methotrexate",NA,NA,NA,NA,NA,NA,NA,NA
"462","aml_ohsu_2018_211","aml_ohsu_2018_11-00319",12.73,"1:DECEASED",NA,NA,"Intermediate","Positive","Fludarabine, Melphalan","7+3 (Cytarabine, Idarubicin)","MiDAC","Quizartinib","Methotrexate",NA,NA,NA,NA,NA,NA,NA,NA
"463","aml_ohsu_2018_2113","aml_ohsu_2018_15-00371",10.66,"1:DECEASED",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"464","aml_ohsu_2018_2116","aml_ohsu_2018_15-00377",18.72,"0:LIVING","Negative","Negative","Intermediate","Negative","COG-AAML1031 (IT/IV Cytarabine, Daunorubicin, Etoposide, Mitoxantrone +/- Bortezomib or Sorafenib)","ADE (Cytarabine, Daunorubicin & Etoposide)","FLAG (Fludarabine, High-dose Cytarabine, G-CSF)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"465","aml_ohsu_2018_2116","aml_ohsu_2018_15-00377",18.72,"0:LIVING","Negative","Negative","Intermediate","Negative","COG-AAML1031 (IT/IV Cytarabine, Daunorubicin, Etoposide, Mitoxantrone +/- Bortezomib or Sorafenib)","ADE (Cytarabine, Daunorubicin & Etoposide)","FLAG (Fludarabine, High-dose Cytarabine, G-CSF)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"466","aml_ohsu_2018_2116","aml_ohsu_2018_16-01097",18.72,"0:LIVING",NA,NA,"Intermediate","Negative","COG-AAML1031 (IT/IV Cytarabine, Daunorubicin, Etoposide, Mitoxantrone +/- Bortezomib or Sorafenib)","ADE (Cytarabine, Daunorubicin & Etoposide)","FLAG (Fludarabine, High-dose Cytarabine, G-CSF)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"467","aml_ohsu_2018_2116","aml_ohsu_2018_16-01097",18.72,"0:LIVING",NA,NA,"Intermediate","Negative","COG-AAML1031 (IT/IV Cytarabine, Daunorubicin, Etoposide, Mitoxantrone +/- Bortezomib or Sorafenib)","ADE (Cytarabine, Daunorubicin & Etoposide)","FLAG (Fludarabine, High-dose Cytarabine, G-CSF)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"468","aml_ohsu_2018_2119","aml_ohsu_2018_15-00395",17.11,"1:DECEASED","Negative","Negative","Poor","Negative","CPX-351 (Liposomal Cytarabine + Daunorubicin)","Decitabine","Incyte trial (azacitidine and JAK 1 inhibitor)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"469","aml_ohsu_2018_2119","aml_ohsu_2018_15-00395",17.11,"1:DECEASED","Negative","Negative","Poor","Negative","CPX-351 (Liposomal Cytarabine + Daunorubicin)","Decitabine","Incyte trial (azacitidine and JAK 1 inhibitor)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"470","aml_ohsu_2018_2119","aml_ohsu_2018_15-00395",17.11,"1:DECEASED","Negative","Negative","Poor","Negative","CPX-351 (Liposomal Cytarabine + Daunorubicin)","Decitabine","Incyte trial (azacitidine and JAK 1 inhibitor)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"471","aml_ohsu_2018_2119","aml_ohsu_2018_16-00548",17.11,"1:DECEASED",NA,NA,"Poor","Negative","CPX-351 (Liposomal Cytarabine + Daunorubicin)","Decitabine","Incyte trial (azacitidine and JAK 1 inhibitor)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"472","aml_ohsu_2018_2119","aml_ohsu_2018_16-00548",17.11,"1:DECEASED",NA,NA,"Poor","Negative","CPX-351 (Liposomal Cytarabine + Daunorubicin)","Decitabine","Incyte trial (azacitidine and JAK 1 inhibitor)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"473","aml_ohsu_2018_2119","aml_ohsu_2018_16-00548",17.11,"1:DECEASED",NA,NA,"Poor","Negative","CPX-351 (Liposomal Cytarabine + Daunorubicin)","Decitabine","Incyte trial (azacitidine and JAK 1 inhibitor)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"474","aml_ohsu_2018_2119","aml_ohsu_2018_16-00733",17.11,"1:DECEASED",NA,NA,"Poor","Negative","CPX-351 (Liposomal Cytarabine + Daunorubicin)","Decitabine","Incyte trial (azacitidine and JAK 1 inhibitor)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"475","aml_ohsu_2018_2119","aml_ohsu_2018_16-00733",17.11,"1:DECEASED",NA,NA,"Poor","Negative","CPX-351 (Liposomal Cytarabine + Daunorubicin)","Decitabine","Incyte trial (azacitidine and JAK 1 inhibitor)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"476","aml_ohsu_2018_2119","aml_ohsu_2018_16-00733",17.11,"1:DECEASED",NA,NA,"Poor","Negative","CPX-351 (Liposomal Cytarabine + Daunorubicin)","Decitabine","Incyte trial (azacitidine and JAK 1 inhibitor)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"477","aml_ohsu_2018_2120","aml_ohsu_2018_15-00396",25.69,"1:DECEASED",NA,NA,"Poor","Negative","FLAG (Fludarabine, High-dose Cytarabine, G-CSF)","Busulfan, Cyclophosphamide, Thymoglobulin","Etoposide","COG-AAML0531 (Cytarabine, Daunorubicin, Etoposide, L-Asparaginase, Mitoxantrone +/- Gemtuzumab)","Doxorubicin",NA,NA,NA,NA,NA,NA,NA,NA
"478","aml_ohsu_2018_2127","aml_ohsu_2018_15-00383",0.26,"1:DECEASED",NA,NA,"Intermediate","Positive","Ruxolitinib","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"479","aml_ohsu_2018_2129","aml_ohsu_2018_15-00392",44.67,"1:DECEASED","Negative","Negative","Poor","Negative","Busulfan, Fludarabine","7+3 (Cytarabine, Idarubicin)","HiDAC","AG-221","Azacitidine",NA,NA,NA,NA,NA,NA,NA,NA
"480","aml_ohsu_2018_2130","aml_ohsu_2018_15-00406",NA,NA,NA,NA,"Poor","Negative","R-CVP (Rituximab, Cyclophosphamide, Vincristine, Prednisolone)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"481","aml_ohsu_2018_2130","aml_ohsu_2018_15-00406",NA,NA,NA,NA,"Poor","Negative","R-CVP (Rituximab, Cyclophosphamide, Vincristine, Prednisolone)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"482","aml_ohsu_2018_2130","aml_ohsu_2018_15-00407",NA,NA,NA,NA,"Poor","Negative","R-CVP (Rituximab, Cyclophosphamide, Vincristine, Prednisolone)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"483","aml_ohsu_2018_2130","aml_ohsu_2018_15-00407",NA,NA,NA,NA,"Poor","Negative","R-CVP (Rituximab, Cyclophosphamide, Vincristine, Prednisolone)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"484","aml_ohsu_2018_2133","aml_ohsu_2018_15-00416",NA,NA,"p.R43H; MAF 76.7%","p.V468M; MAF 51.2%","Poor","Negative","7+3 (Cytarabine, Idarubicin)","Clofarabine, Cytarabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"485","aml_ohsu_2018_2135","aml_ohsu_2018_15-00417",NA,NA,NA,NA,"Poor","Negative",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"486","aml_ohsu_2018_2140","aml_ohsu_2018_15-00492",11.41,"0:LIVING","Negative","Negative","Poor","Negative","Bellicum Trial (Flu/Cy/TBI + ATG + Rituximab then BPX-501)","7+3 (Cytarabine, Idarubicin)","HiDAC","MEC (Cytarabine, Etoposide, Mitoxantrone)",NA,NA,NA,NA,NA,NA,NA,NA,NA
"487","aml_ohsu_2018_2142","aml_ohsu_2018_15-00471",8.22,"1:DECEASED",NA,NA,"Good","Negative","Azacitidine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"488","aml_ohsu_2018_2144","aml_ohsu_2018_15-00470",9.61,"0:LIVING","Negative","Negative","Good","Negative","ATRA, Arsenic Trioxide",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"489","aml_ohsu_2018_2147","aml_ohsu_2018_15-00464",9.47,"1:DECEASED",NA,NA,"Poor","Negative","Azacitidine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"490","aml_ohsu_2018_2167","aml_ohsu_2018_15-00479",6.91,"1:DECEASED",NA,NA,"Poor","Negative","7+3 (Cytarabine, Idarubicin)","Azacitidine","Fludarabine, Cyclophosphamide, TBI ","Venetoclax (ABT-199)",NA,NA,NA,NA,NA,NA,NA,NA,NA
"491","aml_ohsu_2018_2172","aml_ohsu_2018_15-00491",1.64,"1:DECEASED",NA,NA,"Intermediate","Negative",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"492","aml_ohsu_2018_2188","aml_ohsu_2018_15-00514",21.41,"0:LIVING",NA,NA,"Poor","Negative","Azacitidine","Venetoclax (ABT-199)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"493","aml_ohsu_2018_2192","aml_ohsu_2018_15-00525",9.31,"0:LIVING","Negative","Negative","Good","Negative","ATRA, Arsenic Trioxide","APML4 Protocol (ATRA, Arsenic Trioxide, Idarubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"494","aml_ohsu_2018_2195","aml_ohsu_2018_15-00534",8.19,"1:DECEASED","p.N107D; MAF 97.6%",NA,"Poor","Negative","AG-120","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"495","aml_ohsu_2018_2196","aml_ohsu_2018_15-00539",15.3,"1:DECEASED",NA,NA,"Poor","Negative","Lenalidomide","Azacitidine","Decitabine","Clofarabine, Cytarabine",NA,NA,NA,NA,NA,NA,NA,NA,NA
"496","aml_ohsu_2018_2202","aml_ohsu_2018_15-00556",2.47,"0:LIVING","Negative","Negative","Intermediate","Negative","COG-AAML1031 (IT/IV Cytarabine, Daunorubicin, Etoposide, Mitoxantrone +/- Bortezomib or Sorafenib)","Cytarabine","MiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"497","aml_ohsu_2018_2204","aml_ohsu_2018_15-00563",14.08,"0:LIVING",NA,NA,"Poor","Negative","COG-AAML1031 (IT/IV Cytarabine, Daunorubicin, Etoposide, Mitoxantrone +/- Bortezomib or Sorafenib)","Cytarabine","FLAG (Fludarabine, High-dose Cytarabine, G-CSF)","Busulfan, Cyclophosphamide",NA,NA,NA,NA,NA,NA,NA,NA,NA
"498","aml_ohsu_2018_2204","aml_ohsu_2018_15-00563",14.08,"0:LIVING",NA,NA,"Poor","Negative","COG-AAML1031 (IT/IV Cytarabine, Daunorubicin, Etoposide, Mitoxantrone +/- Bortezomib or Sorafenib)","Cytarabine","FLAG (Fludarabine, High-dose Cytarabine, G-CSF)","Busulfan, Cyclophosphamide",NA,NA,NA,NA,NA,NA,NA,NA,NA
"499","aml_ohsu_2018_2204","aml_ohsu_2018_16-00684",14.08,"0:LIVING",NA,NA,"Poor","Negative","COG-AAML1031 (IT/IV Cytarabine, Daunorubicin, Etoposide, Mitoxantrone +/- Bortezomib or Sorafenib)","Cytarabine","FLAG (Fludarabine, High-dose Cytarabine, G-CSF)","Busulfan, Cyclophosphamide",NA,NA,NA,NA,NA,NA,NA,NA,NA
"500","aml_ohsu_2018_2204","aml_ohsu_2018_16-00684",14.08,"0:LIVING",NA,NA,"Poor","Negative","COG-AAML1031 (IT/IV Cytarabine, Daunorubicin, Etoposide, Mitoxantrone +/- Bortezomib or Sorafenib)","Cytarabine","FLAG (Fludarabine, High-dose Cytarabine, G-CSF)","Busulfan, Cyclophosphamide",NA,NA,NA,NA,NA,NA,NA,NA,NA
"501","aml_ohsu_2018_2205","aml_ohsu_2018_15-00559",14.74,"1:DECEASED",NA,"p.S307fs; MAF 45.6%","Poor","Negative","7+3 (Cytarabine, Idarubicin)","AG-221","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"502","aml_ohsu_2018_2213","aml_ohsu_2018_15-00571",1.18,"0:LIVING",NA,NA,"Poor","Negative","7+3 (Cytarabine, Idarubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"503","aml_ohsu_2018_2213","aml_ohsu_2018_15-00571",1.18,"0:LIVING",NA,NA,"Poor","Negative","7+3 (Cytarabine, Idarubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"504","aml_ohsu_2018_2213","aml_ohsu_2018_15-00572",1.18,"0:LIVING",NA,NA,"Poor","Negative","7+3 (Cytarabine, Idarubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"505","aml_ohsu_2018_2213","aml_ohsu_2018_15-00572",1.18,"0:LIVING",NA,NA,"Poor","Negative","7+3 (Cytarabine, Idarubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"506","aml_ohsu_2018_2214","aml_ohsu_2018_15-00578",0.89,"0:LIVING","Negative","Negative","Poor","Negative","3+7 (Cytarabine, Daunorubicin)","MiDAC","Hydroxyurea","Fludarabine, Melphalan, TBI, ATG",NA,NA,NA,NA,NA,NA,NA,NA,NA
"507","aml_ohsu_2018_2222","aml_ohsu_2018_15-00581",6.15,"1:DECEASED","Foundation; R337L",NA,"Poor","Negative","Lenalidomide","Azacitidine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"508","aml_ohsu_2018_2225","aml_ohsu_2018_15-00593",9.21,"1:DECEASED",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","Azacitidine","CLAG-M (Cladribine, Cytarabine, Mitoxantrone, Filgrastim)","Hydroxyurea","Mitoxantrone",NA,NA,NA,NA,NA,NA,NA,NA
"509","aml_ohsu_2018_2225","aml_ohsu_2018_15-00593",9.21,"1:DECEASED",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","Azacitidine","CLAG-M (Cladribine, Cytarabine, Mitoxantrone, Filgrastim)","Hydroxyurea","Mitoxantrone",NA,NA,NA,NA,NA,NA,NA,NA
"510","aml_ohsu_2018_2225","aml_ohsu_2018_16-00264",9.21,"1:DECEASED",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","Azacitidine","CLAG-M (Cladribine, Cytarabine, Mitoxantrone, Filgrastim)","Hydroxyurea","Mitoxantrone",NA,NA,NA,NA,NA,NA,NA,NA
"511","aml_ohsu_2018_2225","aml_ohsu_2018_16-00264",9.21,"1:DECEASED",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","Azacitidine","CLAG-M (Cladribine, Cytarabine, Mitoxantrone, Filgrastim)","Hydroxyurea","Mitoxantrone",NA,NA,NA,NA,NA,NA,NA,NA
"512","aml_ohsu_2018_2226","aml_ohsu_2018_15-00595",NA,NA,NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"513","aml_ohsu_2018_2232","aml_ohsu_2018_15-00608",15.26,"0:LIVING",NA,NA,"Poor","Negative","Cyclophosphamide, Fludarabine, TBI","7+3 (Cytarabine, Idarubicin) plus Sorafenib",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"514","aml_ohsu_2018_2233","aml_ohsu_2018_15-00610",16.61,"0:LIVING",NA,NA,"Poor","Negative","HiDAC","GCLAC (GCSF, Clofarabine & Cytarabine)","7+3 (Cytarabine, Idarubicin) plus Sorafenib","Fludarabine, Cyclophosphamide, TBI",NA,NA,NA,NA,NA,NA,NA,NA,NA
"515","aml_ohsu_2018_2234","aml_ohsu_2018_15-00614",9.74,"0:LIVING","Splice site (5' splice site mutation in intron 4); MAF 44%","Negative","Poor","Negative","HiDAC","SWOG S1203 (7+3 +/- Vorinostat)","Bu/Cy/TBI",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"516","aml_ohsu_2018_2235","aml_ohsu_2018_15-00615",20.82,"1:DECEASED",NA,NA,"Poor","Negative","Busulfan, Fludarabine","7+3 (Cytarabine, Idarubicin)","HiDAC","CLAG (Cladribine, Cytarabine, Filgrastim)","Azacitidine","CLAG-M (Cladribine, Cytarabine, Mitoxantrone, Filgrastim)",NA,NA,NA,NA,NA,NA,NA
"517","aml_ohsu_2018_2236","aml_ohsu_2018_15-00616",10.33,"1:DECEASED","p.I254N; MAF 40%","Negative","Poor","Negative","Fludarabine, Melphalan","3+7 (Cytarabine, Daunorubicin)","MiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"518","aml_ohsu_2018_2239","aml_ohsu_2018_15-00626",1.25,"1:DECEASED",NA,NA,"Poor","Negative","AG-221","Azacitidine","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"519","aml_ohsu_2018_2241","aml_ohsu_2018_15-00633",17.89,"0:LIVING",NA,NA,"Poor","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","Fludarabine, Melphalan, ATG, Methotrexate",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"520","aml_ohsu_2018_2251","aml_ohsu_2018_15-00650",2.63,"1:DECEASED",NA,NA,"Intermediate","Negative","Azacitidine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"521","aml_ohsu_2018_2254","aml_ohsu_2018_15-00653",20.82,"1:DECEASED",NA,NA,"Good","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","MEC (Cytarabine, Etoposide, Mitoxantrone)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"522","aml_ohsu_2018_2254","aml_ohsu_2018_15-00653",20.82,"1:DECEASED",NA,NA,"Good","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","MEC (Cytarabine, Etoposide, Mitoxantrone)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"523","aml_ohsu_2018_2254","aml_ohsu_2018_16-01094",20.82,"1:DECEASED",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","MEC (Cytarabine, Etoposide, Mitoxantrone)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"524","aml_ohsu_2018_2254","aml_ohsu_2018_16-01094",20.82,"1:DECEASED",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","MEC (Cytarabine, Etoposide, Mitoxantrone)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"525","aml_ohsu_2018_2260","aml_ohsu_2018_15-00655",17.86,"0:LIVING",NA,"c.2645G>A; MAF 41.8%","Poor","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","Treo/Flu/TBI (Treosulfan, Fludarabine, Total Body Irradiation)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"526","aml_ohsu_2018_2265","aml_ohsu_2018_15-00670",9.08,"0:LIVING","Negative","p.R882H; MAF ~50%","Intermediate","Negative","Fludarabine, Melphalan","3+7 (Cytarabine, Daunorubicin)","MiDAC","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA,NA
"527","aml_ohsu_2018_2269","aml_ohsu_2018_15-00674",1.18,"1:DECEASED",NA,NA,"Poor","Negative","7+3 (Cytarabine, Idarubicin) plus Sorafenib",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"528","aml_ohsu_2018_2272","aml_ohsu_2018_15-00680",14.7,"0:LIVING",NA,NA,"Intermediate","Positive","HiDAC","3+7 (Cytarabine, Daunorubicin)","Bu/Flu/TBI (Busulfan, Fludarabine, Total Body Irradiation)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"529","aml_ohsu_2018_2273","aml_ohsu_2018_15-00682",NA,NA,NA,NA,"Poor","Negative","AG-221",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"530","aml_ohsu_2018_2273","aml_ohsu_2018_15-00682",NA,NA,NA,NA,"Poor","Negative","AG-221",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"531","aml_ohsu_2018_2273","aml_ohsu_2018_15-00683",NA,NA,NA,NA,"Poor","Negative","AG-221",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"532","aml_ohsu_2018_2273","aml_ohsu_2018_15-00683",NA,NA,NA,NA,"Poor","Negative","AG-221",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"533","aml_ohsu_2018_2276","aml_ohsu_2018_15-00688",0.82,"1:DECEASED","p.R248Q; MAF 56%","Negative","Poor","Negative","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"534","aml_ohsu_2018_2277","aml_ohsu_2018_15-00692",18.59,"1:DECEASED","Foundation; splice site 560-2insA; MAF 44%",NA,"Poor","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","Azacitidine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"535","aml_ohsu_2018_2279","aml_ohsu_2018_15-00693",27.57,"0:LIVING",NA,NA,"Poor","Negative","Bortezomib","3+7 (Cytarabine, Daunorubicin)","MiDAC","Fludarabine, Cytarabine",NA,NA,NA,NA,NA,NA,NA,NA,NA
"536","aml_ohsu_2018_2280","aml_ohsu_2018_15-00701",9.93,"1:DECEASED",NA,NA,"Intermediate","Negative","5+2 (Cytarabine, Idarubicin)","7+3 (Cytarabine, Idarubicin)","HAM (Cytarabine, Mitoxantrone)","Azacitidine","MEC (Cytarabine, Etoposide, Mitoxantrone)","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA
"537","aml_ohsu_2018_2281","aml_ohsu_2018_15-00702",6.18,"0:LIVING","Negative","Negative","Good","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"538","aml_ohsu_2018_2282","aml_ohsu_2018_15-00704",106.61,"1:DECEASED",NA,NA,"Intermediate","Negative","Fludarabine, Melphalan","5+2 (Cytarabine, Idarubicin)","7+3 (Cytarabine, Idarubicin)","Donor Lymphocyte Infusion","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","Azacitidine","MEC (Cytarabine, Etoposide, Mitoxantrone)","Busulfan, Cyclophosphamide",NA,NA,NA,NA,NA
"539","aml_ohsu_2018_2287","aml_ohsu_2018_15-00724",14.87,"0:LIVING",NA,NA,"Intermediate","Positive","Busulfan, Fludarabine","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"540","aml_ohsu_2018_2288","aml_ohsu_2018_15-00726",6.68,"0:LIVING","Negative","Negative","Good","Positive","3+7 (Cytarabine, Daunorubicin)","MiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"541","aml_ohsu_2018_2290","aml_ohsu_2018_15-00731",6.02,"0:LIVING","Negative","Negative","Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","Azacitidine","FLAG (Fludarabine, High-dose Cytarabine, G-CSF)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"542","aml_ohsu_2018_2293","aml_ohsu_2018_15-00734",6.64,"0:LIVING",NA,NA,"Good","Positive","SWOG S1203 (7+3 +/- Vorinostat)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"543","aml_ohsu_2018_2295","aml_ohsu_2018_15-00717",4.05,"0:LIVING","Negative","p.S714C; MAF 35%","Good","Positive","7+3 (Cytarabine, Idarubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"544","aml_ohsu_2018_2300","aml_ohsu_2018_15-00742",NA,"0:LIVING","Negative","Negative","Good","Negative","ATRA, Arsenic Trioxide",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"545","aml_ohsu_2018_2304","aml_ohsu_2018_15-00755",8.42,"1:DECEASED",NA,"c.2251T>C; MAF 36.9% (33.1% on 3/13/15)","Intermediate","Positive","Azacitidine, Sorafenib","5+2 (Cytarabine, Idarubicin)","7+3 (Cytarabine, Idarubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"546","aml_ohsu_2018_2305","aml_ohsu_2018_15-00756",7.01,"0:LIVING",NA,NA,"Intermediate","Negative","HiDAC","3+7 (Cytarabine, Daunorubicin)","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"547","aml_ohsu_2018_2307","aml_ohsu_2018_15-00763",15.33,"0:LIVING",NA,NA,"Poor","Negative","7+3 (Cytarabine, Idarubicin)","Busulfan, Fludarabine, Cyclophosphamide, Thymoglobulin (Bu/Flu/Cy/ATG)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"548","aml_ohsu_2018_2308","aml_ohsu_2018_15-00764",23.59,"1:DECEASED",NA,NA,"Poor","Negative","Azacitidine, Sorafenib","Busulfan, Fludarabine","7+3 (Cytarabine, Idarubicin)","Gilteritinib (ASP2215)","Sorafenib","Cladribine, Cytarabine, Idarubicin",NA,NA,NA,NA,NA,NA,NA
"549","aml_ohsu_2018_231","aml_ohsu_2018_13-00106",27.57,"1:DECEASED",NA,NA,"Poor","Negative","Fludarabine, Melphalan","5+2 (Cytarabine, Idarubicin)","7+3 (Cytarabine, Idarubicin)","Donor Lymphocyte Infusion","HAM (Cytarabine, Mitoxantrone)","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","GCLAC (GCSF, Clofarabine & Cytarabine)","MEC (Cytarabine, Et",NA,NA,NA,NA,NA
"550","aml_ohsu_2018_2310","aml_ohsu_2018_15-00766",0.36,"1:DECEASED","p.P19H; MAF 8.9%","Negative","Poor","Negative","Lenalidomide","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"551","aml_ohsu_2018_2311","aml_ohsu_2018_15-00767",11.41,"1:DECEASED",NA,NA,"Intermediate","Negative","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"552","aml_ohsu_2018_2314","aml_ohsu_2018_15-00777",4.01,"1:DECEASED",NA,NA,"Poor","Negative","3+7 (Cytarabine, Daunorubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"553","aml_ohsu_2018_2314","aml_ohsu_2018_15-00777",4.01,"1:DECEASED",NA,NA,"Poor","Negative","3+7 (Cytarabine, Daunorubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"554","aml_ohsu_2018_2314","aml_ohsu_2018_15-00939",4.01,"1:DECEASED",NA,NA,"Intermediate","Negative","3+7 (Cytarabine, Daunorubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"555","aml_ohsu_2018_2314","aml_ohsu_2018_15-00939",4.01,"1:DECEASED",NA,NA,"Intermediate","Negative","3+7 (Cytarabine, Daunorubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"556","aml_ohsu_2018_2315","aml_ohsu_2018_15-00778",13.95,"1:DECEASED","p.G266V; MAF 55%","Negative","Poor","Negative","Decitabine","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"557","aml_ohsu_2018_2315","aml_ohsu_2018_15-00778",13.95,"1:DECEASED","p.G266V; MAF 55%","Negative","Poor","Negative","Decitabine","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"558","aml_ohsu_2018_2315","aml_ohsu_2018_16-01138",13.95,"1:DECEASED",NA,NA,"Poor","Negative","Decitabine","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"559","aml_ohsu_2018_2315","aml_ohsu_2018_16-01138",13.95,"1:DECEASED",NA,NA,"Poor","Negative","Decitabine","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"560","aml_ohsu_2018_2320","aml_ohsu_2018_15-00782",NA,NA,NA,NA,"Poor","Negative","7+3 (Cytarabine, Idarubicin)","MEC (Cytarabine, Etoposide, Mitoxantrone)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"561","aml_ohsu_2018_2322","aml_ohsu_2018_15-00786",5.39,"0:LIVING",NA,NA,"Good","Negative","HiDAC","3+7 (Cytarabine, Daunorubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"562","aml_ohsu_2018_2333","aml_ohsu_2018_15-00807",8.29,"0:LIVING",NA,NA,"Poor","Negative","COG-AAML1031 (IT/IV Cytarabine, Daunorubicin, Etoposide, Mitoxantrone +/- Bortezomib or Sorafenib)","Busulfan, Cyclophosphamide",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"563","aml_ohsu_2018_2337","aml_ohsu_2018_15-00811",5.53,"1:DECEASED",NA,"p.R882C; MAF 0.9%","Intermediate","Positive","HAM (Cytarabine, Mitoxantrone)","3+7 (Cytarabine, Daunorubicin)","Sorafenib","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA,NA
"564","aml_ohsu_2018_2337","aml_ohsu_2018_15-00811",5.53,"1:DECEASED",NA,"p.R882C; MAF 0.9%","Intermediate","Positive","HAM (Cytarabine, Mitoxantrone)","3+7 (Cytarabine, Daunorubicin)","Sorafenib","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA,NA
"565","aml_ohsu_2018_2337","aml_ohsu_2018_15-00811",5.53,"1:DECEASED",NA,"p.R882C; MAF 0.9%","Intermediate","Positive","HAM (Cytarabine, Mitoxantrone)","3+7 (Cytarabine, Daunorubicin)","Sorafenib","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA,NA
"566","aml_ohsu_2018_2337","aml_ohsu_2018_15-00811",5.53,"1:DECEASED",NA,"p.R882C; MAF 0.9%","Intermediate","Positive","HAM (Cytarabine, Mitoxantrone)","3+7 (Cytarabine, Daunorubicin)","Sorafenib","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA,NA
"567","aml_ohsu_2018_2337","aml_ohsu_2018_15-00864",5.53,"1:DECEASED",NA,"p.R882C, MAF 6%","Intermediate","Positive","HAM (Cytarabine, Mitoxantrone)","3+7 (Cytarabine, Daunorubicin)","Sorafenib","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA,NA
"568","aml_ohsu_2018_2337","aml_ohsu_2018_15-00864",5.53,"1:DECEASED",NA,"p.R882C, MAF 6%","Intermediate","Positive","HAM (Cytarabine, Mitoxantrone)","3+7 (Cytarabine, Daunorubicin)","Sorafenib","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA,NA
"569","aml_ohsu_2018_2337","aml_ohsu_2018_15-00864",5.53,"1:DECEASED",NA,"p.R882C, MAF 6%","Intermediate","Positive","HAM (Cytarabine, Mitoxantrone)","3+7 (Cytarabine, Daunorubicin)","Sorafenib","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA,NA
"570","aml_ohsu_2018_2337","aml_ohsu_2018_15-00864",5.53,"1:DECEASED",NA,"p.R882C, MAF 6%","Intermediate","Positive","HAM (Cytarabine, Mitoxantrone)","3+7 (Cytarabine, Daunorubicin)","Sorafenib","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA,NA
"571","aml_ohsu_2018_2337","aml_ohsu_2018_15-00936",5.53,"1:DECEASED",NA,"p.R882C; MAF 45%","Poor","Positive","HAM (Cytarabine, Mitoxantrone)","3+7 (Cytarabine, Daunorubicin)","Sorafenib","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA,NA
"572","aml_ohsu_2018_2337","aml_ohsu_2018_15-00936",5.53,"1:DECEASED",NA,"p.R882C; MAF 45%","Poor","Positive","HAM (Cytarabine, Mitoxantrone)","3+7 (Cytarabine, Daunorubicin)","Sorafenib","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA,NA
"573","aml_ohsu_2018_2337","aml_ohsu_2018_15-00936",5.53,"1:DECEASED",NA,"p.R882C; MAF 45%","Poor","Positive","HAM (Cytarabine, Mitoxantrone)","3+7 (Cytarabine, Daunorubicin)","Sorafenib","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA,NA
"574","aml_ohsu_2018_2337","aml_ohsu_2018_15-00936",5.53,"1:DECEASED",NA,"p.R882C; MAF 45%","Poor","Positive","HAM (Cytarabine, Mitoxantrone)","3+7 (Cytarabine, Daunorubicin)","Sorafenib","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA,NA
"575","aml_ohsu_2018_2337","aml_ohsu_2018_15-00964",5.53,"1:DECEASED",NA,"p.R882C; MAF 45%","Poor","Positive","HAM (Cytarabine, Mitoxantrone)","3+7 (Cytarabine, Daunorubicin)","Sorafenib","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA,NA
"576","aml_ohsu_2018_2337","aml_ohsu_2018_15-00964",5.53,"1:DECEASED",NA,"p.R882C; MAF 45%","Poor","Positive","HAM (Cytarabine, Mitoxantrone)","3+7 (Cytarabine, Daunorubicin)","Sorafenib","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA,NA
"577","aml_ohsu_2018_2337","aml_ohsu_2018_15-00964",5.53,"1:DECEASED",NA,"p.R882C; MAF 45%","Poor","Positive","HAM (Cytarabine, Mitoxantrone)","3+7 (Cytarabine, Daunorubicin)","Sorafenib","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA,NA
"578","aml_ohsu_2018_2337","aml_ohsu_2018_15-00964",5.53,"1:DECEASED",NA,"p.R882C; MAF 45%","Poor","Positive","HAM (Cytarabine, Mitoxantrone)","3+7 (Cytarabine, Daunorubicin)","Sorafenib","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA,NA
"579","aml_ohsu_2018_2339","aml_ohsu_2018_15-00813",3.91,"0:LIVING",NA,"p.R882H; MAF 45%","Intermediate","Negative","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","MEC (Cytarabine, Etoposide, Mitoxantrone)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"580","aml_ohsu_2018_2342","aml_ohsu_2018_15-00819",6.48,"0:LIVING","Negative","Negative","Good","Negative","7+3 (Cytarabine, Idarubicin)","MiDAC","Hydroxyurea","Cytarabine, Methotrexate",NA,NA,NA,NA,NA,NA,NA,NA,NA
"581","aml_ohsu_2018_2343","aml_ohsu_2018_15-00821",7.6,"1:DECEASED",NA,NA,"Intermediate","Negative","Fludarabine, Melphalan","7+3 (Cytarabine, Idarubicin)","MiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"582","aml_ohsu_2018_2347","aml_ohsu_2018_15-00839",1.09,"1:DECEASED",NA,NA,"Intermediate","Positive","ADE (Cytarabine, Daunorubicin & Etoposide)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"583","aml_ohsu_2018_2350","aml_ohsu_2018_15-00837",6.18,"1:DECEASED",NA,NA,"Good","Negative","Azacitidine","Momelotinib",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"584","aml_ohsu_2018_2357","aml_ohsu_2018_15-00850",NA,NA,"Negative","Negative","Good","Negative","7+3 (Cytarabine, Idarubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"585","aml_ohsu_2018_2360","aml_ohsu_2018_15-00855",5.66,"0:LIVING","Negative","Negative","Good","Positive","ADE (Cytarabine, Daunorubicin & Etoposide)","Cytarabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"586","aml_ohsu_2018_2362","aml_ohsu_2018_15-00858",0.86,"1:DECEASED","Negative","p.R736H; MAF 45%","Intermediate","Positive","5+2 (Cytarabine, Idarubicin)","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"587","aml_ohsu_2018_2364","aml_ohsu_2018_15-00870",1.68,"1:DECEASED",NA,NA,"Poor","Negative","Vidaza","Rituximab","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"588","aml_ohsu_2018_2367","aml_ohsu_2018_15-00872",5.95,"0:LIVING",NA,"p.R882C; MAF 44%","Intermediate","Positive","Fludarabine, Melphalan","7+3 (Cytarabine, Idarubicin)","MiDAC","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA,NA
"589","aml_ohsu_2018_2416","aml_ohsu_2018_15-00883",3.88,"1:DECEASED",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","Sorafenib","Ponatinib",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"590","aml_ohsu_2018_2416","aml_ohsu_2018_15-00883",3.88,"1:DECEASED",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","Sorafenib","Ponatinib",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"591","aml_ohsu_2018_2416","aml_ohsu_2018_15-00967",3.88,"1:DECEASED",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","Sorafenib","Ponatinib",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"592","aml_ohsu_2018_2416","aml_ohsu_2018_15-00967",3.88,"1:DECEASED",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","Sorafenib","Ponatinib",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"593","aml_ohsu_2018_2418","aml_ohsu_2018_15-00895",1.58,"0:LIVING","Negative","Negative","Good","Positive","3+7 (Cytarabine, Daunorubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"594","aml_ohsu_2018_2420","aml_ohsu_2018_15-00900",6.15,"0:LIVING",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","HAM (Cytarabine, Mitoxantrone)","Azacitidine","Decitabine","Busulfan, Cyclophosphamide",NA,NA,NA,NA,NA,NA,NA,NA
"595","aml_ohsu_2018_2420","aml_ohsu_2018_15-00900",6.15,"0:LIVING",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","HAM (Cytarabine, Mitoxantrone)","Azacitidine","Decitabine","Busulfan, Cyclophosphamide",NA,NA,NA,NA,NA,NA,NA,NA
"596","aml_ohsu_2018_2420","aml_ohsu_2018_15-00988",6.15,"0:LIVING",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","HAM (Cytarabine, Mitoxantrone)","Azacitidine","Decitabine","Busulfan, Cyclophosphamide",NA,NA,NA,NA,NA,NA,NA,NA
"597","aml_ohsu_2018_2420","aml_ohsu_2018_15-00988",6.15,"0:LIVING",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","HAM (Cytarabine, Mitoxantrone)","Azacitidine","Decitabine","Busulfan, Cyclophosphamide",NA,NA,NA,NA,NA,NA,NA,NA
"598","aml_ohsu_2018_2421","aml_ohsu_2018_15-00892",5.89,"1:DECEASED",NA,"c.2645G>A; MAF 45.4%","Good","Positive","SGN-CD33A",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"599","aml_ohsu_2018_2422","aml_ohsu_2018_15-00898",19.28,"0:LIVING",NA,NA,"Good","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"600","aml_ohsu_2018_2423","aml_ohsu_2018_15-00903",1.18,"1:DECEASED",NA,NA,"Poor","Negative","Azacitidine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"601","aml_ohsu_2018_2425","aml_ohsu_2018_15-00909",NA,NA,NA,NA,"Poor","Negative","Radiation",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"602","aml_ohsu_2018_2426","aml_ohsu_2018_15-00912",4.97,"1:DECEASED",NA,NA,"Poor","Negative","Azacitidine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"603","aml_ohsu_2018_2429","aml_ohsu_2018_15-00921",8.39,"0:LIVING",NA,NA,NA,NA,"5+2 (Cytarabine, Idarubicin)","7+3 (Cytarabine, Idarubicin)","ATRA (Tretinoin)","MiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA
"604","aml_ohsu_2018_2429","aml_ohsu_2018_15-00921",8.39,"0:LIVING",NA,NA,NA,NA,"Azacitidine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"605","aml_ohsu_2018_2429","aml_ohsu_2018_16-00135",8.39,"0:LIVING",NA,NA,"Intermediate","Negative","5+2 (Cytarabine, Idarubicin)","7+3 (Cytarabine, Idarubicin)","ATRA (Tretinoin)","MiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA
"606","aml_ohsu_2018_2429","aml_ohsu_2018_16-00135",8.39,"0:LIVING",NA,NA,"Intermediate","Negative","Azacitidine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"607","aml_ohsu_2018_2433","aml_ohsu_2018_15-00929",13.98,"1:DECEASED",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","Azacitidine","SWOG S1203 (7+3 +/- Vorinostat)","MiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA
"608","aml_ohsu_2018_2437","aml_ohsu_2018_15-00942",NA,NA,NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"609","aml_ohsu_2018_2437","aml_ohsu_2018_15-00942",NA,NA,NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"610","aml_ohsu_2018_2437","aml_ohsu_2018_16-00010",NA,NA,NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"611","aml_ohsu_2018_2437","aml_ohsu_2018_16-00010",NA,NA,NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"612","aml_ohsu_2018_2439","aml_ohsu_2018_15-00947",4.38,"0:LIVING","Negative","Negative","Poor","Negative","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"613","aml_ohsu_2018_2442","aml_ohsu_2018_16-00088",10.66,"1:DECEASED",NA,NA,"Poor","Negative","Azacitidine, Sorafenib","7+3 (Cytarabine, Idarubicin)","HiDAC","Cladribine, Cytarabine, Idarubicin",NA,NA,NA,NA,NA,NA,NA,NA,NA
"614","aml_ohsu_2018_2443","aml_ohsu_2018_16-00073",11.45,"1:DECEASED",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","Cytarabine","Azacitidine","Sorafenib","Decitabine","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA
"615","aml_ohsu_2018_2443","aml_ohsu_2018_16-00073",11.45,"1:DECEASED",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","Cytarabine","Azacitidine","Sorafenib","Decitabine","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA
"616","aml_ohsu_2018_2443","aml_ohsu_2018_16-00118",11.45,"1:DECEASED",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","Cytarabine","Azacitidine","Sorafenib","Decitabine","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA
"617","aml_ohsu_2018_2443","aml_ohsu_2018_16-00118",11.45,"1:DECEASED",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","Cytarabine","Azacitidine","Sorafenib","Decitabine","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA
"618","aml_ohsu_2018_2444","aml_ohsu_2018_15-00961",5.95,"0:LIVING",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"619","aml_ohsu_2018_2447","aml_ohsu_2018_15-00965",6.15,"0:LIVING",NA,NA,"Good","Positive","Fludarabine, Melphalan","7+3 (Cytarabine, Idarubicin)","FLAG (Fludarabine, High-dose Cytarabine, G-CSF)","MiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA
"620","aml_ohsu_2018_2452","aml_ohsu_2018_15-00975",NA,NA,NA,NA,"Poor","Negative","Azacitidine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"621","aml_ohsu_2018_2453","aml_ohsu_2018_15-00976",14.28,"1:DECEASED",NA,NA,"Intermediate","Negative","AG-221","Azacitidine, SGN-CD33A",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"622","aml_ohsu_2018_2454","aml_ohsu_2018_15-00981",0.56,"1:DECEASED",NA,NA,"Good","Positive","Hydroxyurea","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"623","aml_ohsu_2018_2455","aml_ohsu_2018_15-00979",10.49,"1:DECEASED",NA,"p.R882H; MAF 48%","Intermediate","Positive","Azacitidine","MEC (Cytarabine, Etoposide, Mitoxantrone)","Sorafenib","Hydroxyurea","Busulfan, Cyclophosphamide","7+3 (Cytarabine, Idarubicin) plus Dasatinib",NA,NA,NA,NA,NA,NA,NA
"624","aml_ohsu_2018_2459","aml_ohsu_2018_15-00990",0.46,"1:DECEASED",NA,NA,"Good","Positive","Azacitidine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"625","aml_ohsu_2018_2460","aml_ohsu_2018_16-00001",6.88,"0:LIVING",NA,NA,"Good","Negative","Dasatinib","7+3 (Cytarabine, Idarubicin)","HiDAC","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA,NA
"626","aml_ohsu_2018_2461","aml_ohsu_2018_16-00003",19.84,"0:LIVING",NA,NA,"Good","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"627","aml_ohsu_2018_2462","aml_ohsu_2018_16-00004",8.82,"1:DECEASED",NA,"p.R882H; MAF 39%","Intermediate","Negative",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"628","aml_ohsu_2018_2464","aml_ohsu_2018_16-00006",7.14,"0:LIVING",NA,NA,"Intermediate","Negative","Azacitidine, Sorafenib","Decitabine, Midostaurin",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"629","aml_ohsu_2018_2464","aml_ohsu_2018_16-00006",7.14,"0:LIVING",NA,NA,"Intermediate","Negative","Azacitidine, Sorafenib","Decitabine, Midostaurin",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"630","aml_ohsu_2018_2464","aml_ohsu_2018_16-00007",7.14,"0:LIVING",NA,NA,"Poor","Negative","Azacitidine, Sorafenib","Decitabine, Midostaurin",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"631","aml_ohsu_2018_2464","aml_ohsu_2018_16-00007",7.14,"0:LIVING",NA,NA,"Poor","Negative","Azacitidine, Sorafenib","Decitabine, Midostaurin",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"632","aml_ohsu_2018_2467","aml_ohsu_2018_16-00015",32.76,"0:LIVING",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","Donor Lymphocyte Infusion","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","Azacitidine","Sorafenib","MiDAC","Treo/Flu/TBI (Treosulfan, Fludarabine, Total Body Irradiation)",NA,NA,NA,NA,NA,NA
"633","aml_ohsu_2018_2468","aml_ohsu_2018_16-00017",6.18,"0:LIVING",NA,"p.R882H; MAF 34%","Good","Positive","7+3 (Cytarabine, Idarubicin)","MiDAC","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"634","aml_ohsu_2018_2472","aml_ohsu_2018_16-00026",17.07,"0:LIVING",NA,"p.Val716Asp; MAF 45%","Good","Positive","Busulfan, Fludarabine","7+3 (Cytarabine, Idarubicin)","HiDAC","CLAG (Cladribine, Cytarabine, Filgrastim)",NA,NA,NA,NA,NA,NA,NA,NA,NA
"635","aml_ohsu_2018_2473","aml_ohsu_2018_16-00027",12.93,"0:LIVING",NA,NA,"Poor","Negative","HiDAC","Cyclophosphamide","Fludarabine, Cyclophosphamide, TBI ","7+3 (Cytarabine, Idarubicin) plus Crenolanib",NA,NA,NA,NA,NA,NA,NA,NA,NA
"636","aml_ohsu_2018_2474","aml_ohsu_2018_16-00033",9.01,"0:LIVING",NA,NA,"Good","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","MEC (Cytarabine, Etoposide, Mitoxantrone)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"637","aml_ohsu_2018_2475","aml_ohsu_2018_16-00035",18.62,"0:LIVING",NA,NA,"Good","Positive","HiDAC","7+3 (Cytarabine, Idarubicin) plus Crenolanib",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"638","aml_ohsu_2018_2477","aml_ohsu_2018_16-00031",18.95,"0:LIVING",NA,NA,"Poor","Negative","Busulfan, Fludarabine","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"639","aml_ohsu_2018_2477","aml_ohsu_2018_16-00031",18.95,"0:LIVING",NA,NA,"Poor","Negative","Busulfan, Fludarabine","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"640","aml_ohsu_2018_2477","aml_ohsu_2018_16-00031",18.95,"0:LIVING",NA,NA,"Poor","Negative","Busulfan, Fludarabine","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"641","aml_ohsu_2018_2477","aml_ohsu_2018_16-00124",18.95,"0:LIVING",NA,"p.r882H; MAF 45%","Poor","Negative","Busulfan, Fludarabine","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"642","aml_ohsu_2018_2477","aml_ohsu_2018_16-00124",18.95,"0:LIVING",NA,"p.r882H; MAF 45%","Poor","Negative","Busulfan, Fludarabine","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"643","aml_ohsu_2018_2477","aml_ohsu_2018_16-00124",18.95,"0:LIVING",NA,"p.r882H; MAF 45%","Poor","Negative","Busulfan, Fludarabine","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"644","aml_ohsu_2018_2477","aml_ohsu_2018_16-00261",18.95,"0:LIVING",NA,NA,"Intermediate","Negative","Busulfan, Fludarabine","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"645","aml_ohsu_2018_2477","aml_ohsu_2018_16-00261",18.95,"0:LIVING",NA,NA,"Intermediate","Negative","Busulfan, Fludarabine","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"646","aml_ohsu_2018_2477","aml_ohsu_2018_16-00261",18.95,"0:LIVING",NA,NA,"Intermediate","Negative","Busulfan, Fludarabine","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"647","aml_ohsu_2018_2480","aml_ohsu_2018_16-00041",0.13,"1:DECEASED",NA,"p.R882H; MAF 50%","Intermediate","Positive","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"648","aml_ohsu_2018_2482","aml_ohsu_2018_16-00046",19.11,"1:DECEASED",NA,NA,"Poor","Negative","5+2 (Cytarabine, Idarubicin)","7+3 (Cytarabine, Idarubicin)","Azacitidine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"649","aml_ohsu_2018_2483","aml_ohsu_2018_16-00048",20.95,"1:DECEASED",NA,"p.I824V; VAF 50%","Poor","Negative","7+3 (Cytarabine, Idarubicin)","HAM (Cytarabine, Mitoxantrone)","Azacitidine","Hydroxyurea","Decitabine","ME (Etoposide, Mitoxantrone)","Fludarabine, Melphalan, ATG",NA,NA,NA,NA,NA,NA
"650","aml_ohsu_2018_2483","aml_ohsu_2018_16-00048",20.95,"1:DECEASED",NA,"p.I824V; VAF 50%","Poor","Negative","7+3 (Cytarabine, Idarubicin)","HAM (Cytarabine, Mitoxantrone)","Azacitidine","Hydroxyurea","Decitabine","ME (Etoposide, Mitoxantrone)","Fludarabine, Melphalan, ATG",NA,NA,NA,NA,NA,NA
"651","aml_ohsu_2018_2483","aml_ohsu_2018_16-00593",20.95,"1:DECEASED",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","HAM (Cytarabine, Mitoxantrone)","Azacitidine","Hydroxyurea","Decitabine","ME (Etoposide, Mitoxantrone)","Fludarabine, Melphalan, ATG",NA,NA,NA,NA,NA,NA
"652","aml_ohsu_2018_2483","aml_ohsu_2018_16-00593",20.95,"1:DECEASED",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","HAM (Cytarabine, Mitoxantrone)","Azacitidine","Hydroxyurea","Decitabine","ME (Etoposide, Mitoxantrone)","Fludarabine, Melphalan, ATG",NA,NA,NA,NA,NA,NA
"653","aml_ohsu_2018_2485","aml_ohsu_2018_16-00050",11.22,"1:DECEASED","p.V272_R273insL; MAF 75% (previously 71% in 4/21/15 peripheral blood)","p.E285D; MAF 40%","Poor","Negative","Azacitidine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"654","aml_ohsu_2018_2490","aml_ohsu_2018_16-00056",6.61,"0:LIVING",NA,NA,"Good","Positive","HiDAC","Hydroxyurea","7+3 (Cytarabine, Idarubicin) plus Sorafenib",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"655","aml_ohsu_2018_2492","aml_ohsu_2018_16-00062",NA,NA,"H193Y; MAF 65.0%",NA,"Poor","Negative","Azacitidine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"656","aml_ohsu_2018_2495","aml_ohsu_2018_16-00087",8.59,"0:LIVING",NA,NA,"Intermediate","Positive","ATRA (Tretinoin)","HiDAC","3+7 (Cytarabine, Daunorubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"657","aml_ohsu_2018_2496","aml_ohsu_2018_16-00067",17.01,"0:LIVING",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","Cyclophosphamide","Fludarabine, Cyclophosphamide, TBI",NA,NA,NA,NA,NA,NA,NA,NA,NA
"658","aml_ohsu_2018_2497","aml_ohsu_2018_16-00070",0.92,"0:LIVING",NA,NA,"Good","Negative","Hydroxyurea","APML4 Protocol (ATRA, Arsenic Trioxide, Idarubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"659","aml_ohsu_2018_2498","aml_ohsu_2018_16-00075",0.43,"0:LIVING",NA,NA,"Poor","Negative","7+3 (Cytarabine, Idarubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"660","aml_ohsu_2018_2499","aml_ohsu_2018_16-00078",NA,NA,NA,NA,"Good","Positive","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"661","aml_ohsu_2018_2500","aml_ohsu_2018_16-00077",19.9,"1:DECEASED",NA,NA,"Poor","Negative","AG-120","5+2 (Cytarabine, Idarubicin)","7+3 (Cytarabine, Idarubicin)","Azacitidine","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA
"662","aml_ohsu_2018_2501","aml_ohsu_2018_16-00094",0.56,"0:LIVING",NA,NA,"Poor","Negative","HiDAC","3+7 (Cytarabine, Daunorubicin)","Azacitidine","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA,NA
"663","aml_ohsu_2018_2503","aml_ohsu_2018_16-00226",1.74,"0:LIVING",NA,NA,"Intermediate","Negative","Azacitidine","Decitabine","Hydroxyurea","V212",NA,NA,NA,NA,NA,NA,NA,NA,NA
"664","aml_ohsu_2018_2508","aml_ohsu_2018_16-00102",3.13,"0:LIVING",NA,NA,"Good","Positive","CPX-351 (Liposomal Cytarabine + Daunorubicin)","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"665","aml_ohsu_2018_2511","aml_ohsu_2018_16-00109",0.26,"1:DECEASED",NA,NA,"Good","Positive","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"666","aml_ohsu_2018_2515","aml_ohsu_2018_16-00120",16.91,"0:LIVING",NA,NA,"Good","Negative","Methotrexate, Mercaptopurine, Tretinoin","ATRA, Idarubicin","ATRA, Cytarabine, Idarubicin",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"667","aml_ohsu_2018_2519","aml_ohsu_2018_16-00129",3.42,"0:LIVING","Negative","Negative","Good","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"668","aml_ohsu_2018_2521","aml_ohsu_2018_16-00113",NA,NA,"Negative","Negative","Intermediate","Negative",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"669","aml_ohsu_2018_2522","aml_ohsu_2018_16-00115",0.46,"1:DECEASED",NA,NA,"Poor","Negative",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"670","aml_ohsu_2018_2526","aml_ohsu_2018_16-00132",NA,NA,NA,NA,"Poor","Negative","Azacitidine, MLN4924",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"671","aml_ohsu_2018_2530","aml_ohsu_2018_16-00139",18.42,"1:DECEASED",NA,NA,"Good","Positive","Ruxolitinib",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"672","aml_ohsu_2018_2530","aml_ohsu_2018_16-00139",18.42,"1:DECEASED",NA,NA,"Good","Positive","Ruxolitinib",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"673","aml_ohsu_2018_2530","aml_ohsu_2018_16-00139",18.42,"1:DECEASED",NA,NA,"Good","Positive","Ruxolitinib",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"674","aml_ohsu_2018_2530","aml_ohsu_2018_16-00358",18.42,"1:DECEASED",NA,NA,"Good","Positive","Ruxolitinib",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"675","aml_ohsu_2018_2530","aml_ohsu_2018_16-00358",18.42,"1:DECEASED",NA,NA,"Good","Positive","Ruxolitinib",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"676","aml_ohsu_2018_2530","aml_ohsu_2018_16-00358",18.42,"1:DECEASED",NA,NA,"Good","Positive","Ruxolitinib",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"677","aml_ohsu_2018_2530","aml_ohsu_2018_16-01059",18.42,"1:DECEASED",NA,NA,"Intermediate","Negative","Ruxolitinib",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"678","aml_ohsu_2018_2530","aml_ohsu_2018_16-01059",18.42,"1:DECEASED",NA,NA,"Intermediate","Negative","Ruxolitinib",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"679","aml_ohsu_2018_2530","aml_ohsu_2018_16-01059",18.42,"1:DECEASED",NA,NA,"Intermediate","Negative","Ruxolitinib",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"680","aml_ohsu_2018_2532","aml_ohsu_2018_16-00143",6.32,"0:LIVING",NA,"Negative","Intermediate","Negative","Sorafenib","Hydroxyurea","7+3 (Cytarabine, Idarubicin) plus Sorafenib","Busulfan, Cyclophosphamide",NA,NA,NA,NA,NA,NA,NA,NA,NA
"681","aml_ohsu_2018_2533","aml_ohsu_2018_16-00145",5.23,"1:DECEASED",NA,NA,"Poor","Negative","Vidaza","Decitabine","Fludarabine, Cytarabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"682","aml_ohsu_2018_2538","aml_ohsu_2018_16-00157",17.37,"0:LIVING","Negative","p.R882H; MAF 46%","Good","Positive","AG-120","7+3 (Cytarabine, Idarubicin)","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","MiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA
"683","aml_ohsu_2018_2538","aml_ohsu_2018_16-00157",17.37,"0:LIVING","Negative","p.R882H; MAF 46%","Good","Positive","AG-120","7+3 (Cytarabine, Idarubicin)","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","MiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA
"684","aml_ohsu_2018_2538","aml_ohsu_2018_16-01127",17.37,"0:LIVING",NA,NA,"Good","Positive","AG-120","7+3 (Cytarabine, Idarubicin)","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","MiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA
"685","aml_ohsu_2018_2538","aml_ohsu_2018_16-01127",17.37,"0:LIVING",NA,NA,"Good","Positive","AG-120","7+3 (Cytarabine, Idarubicin)","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","MiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA
"686","aml_ohsu_2018_2543","aml_ohsu_2018_16-00161",6.22,"1:DECEASED",NA,NA,"Intermediate","Negative","5+2 (Cytarabine, Idarubicin)","7+3 (Cytarabine, Idarubicin)","MiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"687","aml_ohsu_2018_2546","aml_ohsu_2018_16-00150",3.68,"0:LIVING",NA,NA,"Poor","Negative","Vidaza","Cytarabine","3+7 (Cytarabine, Daunorubicin)","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA
"688","aml_ohsu_2018_2546","aml_ohsu_2018_16-00150",3.68,"0:LIVING",NA,NA,"Poor","Negative","Vidaza","Cytarabine","3+7 (Cytarabine, Daunorubicin)","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA
"689","aml_ohsu_2018_2546","aml_ohsu_2018_16-00359",3.68,"0:LIVING",NA,NA,"Poor","Negative","Vidaza","Cytarabine","3+7 (Cytarabine, Daunorubicin)","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA
"690","aml_ohsu_2018_2546","aml_ohsu_2018_16-00359",3.68,"0:LIVING",NA,NA,"Poor","Negative","Vidaza","Cytarabine","3+7 (Cytarabine, Daunorubicin)","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA
"691","aml_ohsu_2018_2547","aml_ohsu_2018_16-00151",NA,NA,"p.Y220C; MAF 35%",NA,"Poor","Negative","3+7 (Cytarabine, Daunorubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"692","aml_ohsu_2018_2547","aml_ohsu_2018_16-00151",NA,NA,"p.Y220C; MAF 35%",NA,"Poor","Negative","3+7 (Cytarabine, Daunorubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"693","aml_ohsu_2018_2547","aml_ohsu_2018_16-00294",NA,NA,NA,NA,"Intermediate","Negative","3+7 (Cytarabine, Daunorubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"694","aml_ohsu_2018_2547","aml_ohsu_2018_16-00294",NA,NA,NA,NA,"Intermediate","Negative","3+7 (Cytarabine, Daunorubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"695","aml_ohsu_2018_2569","aml_ohsu_2018_16-00217",19.61,"1:DECEASED",NA,"p.G707fs*72; MAF 45%","Intermediate","Negative","AG-221","Azacitidine","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"696","aml_ohsu_2018_2571","aml_ohsu_2018_16-00220",1.02,"0:LIVING",NA,NA,"Good","Positive","7+3 (Cytarabine, Idarubicin)","IDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"697","aml_ohsu_2018_2581","aml_ohsu_2018_16-00249",9.93,"0:LIVING",NA,NA,"Intermediate","Negative","Vidaza",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"698","aml_ohsu_2018_2584","aml_ohsu_2018_16-00232",8.88,"1:DECEASED",NA,NA,"Poor","Negative","7+3 (Cytarabine, Idarubicin)","CLAG (Cladribine, Cytarabine, Filgrastim)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"699","aml_ohsu_2018_2593","aml_ohsu_2018_16-00269",5.59,"0:LIVING",NA,NA,"Good","Positive","HiDAC","3+7 (Cytarabine, Daunorubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"700","aml_ohsu_2018_2594","aml_ohsu_2018_16-00271",15.26,"0:LIVING",NA,NA,"Intermediate","Positive","Fludarabine, Melphalan","Crenolanib","7+3 (Cytarabine, Idarubicin) plus Crenolanib",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"701","aml_ohsu_2018_2595","aml_ohsu_2018_16-00273",5.56,"1:DECEASED",NA,"c.2645G>A; MAF 43.9%","Intermediate","Negative","7+3 (Cytarabine, Idarubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"702","aml_ohsu_2018_2597","aml_ohsu_2018_16-00278",14.47,"0:LIVING","Negative","c.2645G>A; p.R882H","Good","Positive","7+3 (Cytarabine, Idarubicin)","Fludarabine, Cyclophosphamide, Thiotepa, TBI",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"703","aml_ohsu_2018_2606","aml_ohsu_2018_16-00289",4.67,"1:DECEASED",NA,NA,"Intermediate","Positive","Azacitidine","7+3 (Cytarabine, Idarubicin) plus Sorafenib",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"704","aml_ohsu_2018_2607","aml_ohsu_2018_16-00292",0.13,"1:DECEASED",NA,"p.R326P; MAF 50%","Good","Positive","7+3 (Cytarabine, Idarubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"705","aml_ohsu_2018_2611","aml_ohsu_2018_16-00303",10.63,"1:DECEASED","Negative","c.2644C>T; p.R882C","Good","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","GCLAC (GCSF, Clofarabine & Cytarabine)","Fludarabine, Cyclophosphamide, Thiotepa, TBI",NA,NA,NA,NA,NA,NA,NA,NA,NA
"706","aml_ohsu_2018_2611","aml_ohsu_2018_16-00303",10.63,"1:DECEASED","Negative","c.2644C>T; p.R882C","Good","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","GCLAC (GCSF, Clofarabine & Cytarabine)","Fludarabine, Cyclophosphamide, Thiotepa, TBI",NA,NA,NA,NA,NA,NA,NA,NA,NA
"707","aml_ohsu_2018_2611","aml_ohsu_2018_16-01118",10.63,"1:DECEASED",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","GCLAC (GCSF, Clofarabine & Cytarabine)","Fludarabine, Cyclophosphamide, Thiotepa, TBI",NA,NA,NA,NA,NA,NA,NA,NA,NA
"708","aml_ohsu_2018_2611","aml_ohsu_2018_16-01118",10.63,"1:DECEASED",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","GCLAC (GCSF, Clofarabine & Cytarabine)","Fludarabine, Cyclophosphamide, Thiotepa, TBI",NA,NA,NA,NA,NA,NA,NA,NA,NA
"709","aml_ohsu_2018_2612","aml_ohsu_2018_16-00307",13.22,"0:LIVING",NA,NA,"Poor","Negative",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"710","aml_ohsu_2018_2612","aml_ohsu_2018_16-00307",13.22,"0:LIVING",NA,NA,"Poor","Negative",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"711","aml_ohsu_2018_2612","aml_ohsu_2018_16-00483",13.22,"0:LIVING",NA,NA,"Intermediate","Negative",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"712","aml_ohsu_2018_2612","aml_ohsu_2018_16-00483",13.22,"0:LIVING",NA,NA,"Intermediate","Negative",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"713","aml_ohsu_2018_2615","aml_ohsu_2018_16-00316",NA,"0:LIVING",NA,NA,"Intermediate","Negative",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"714","aml_ohsu_2018_2621","aml_ohsu_2018_16-00332",9.61,"1:DECEASED",NA,NA,"Poor","Negative","Vidaza",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"715","aml_ohsu_2018_2626","aml_ohsu_2018_16-00339",0.03,"0:LIVING",NA,NA,"Intermediate","Negative","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"716","aml_ohsu_2018_2628","aml_ohsu_2018_16-00344",6.18,"0:LIVING",NA,"p.R882C; MAF 40%","Good","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"717","aml_ohsu_2018_2630","aml_ohsu_2018_16-00351",6.32,"0:LIVING",NA,NA,"Good","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"718","aml_ohsu_2018_2632","aml_ohsu_2018_16-00354",NA,NA,"p.?; MAF 91%",NA,"Poor","Negative",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"719","aml_ohsu_2018_2633","aml_ohsu_2018_16-00356",6.81,"1:DECEASED",NA,NA,"Intermediate","Negative","Lenalidomide","3+7 (Cytarabine, Daunorubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"720","aml_ohsu_2018_2640","aml_ohsu_2018_16-00366",5.49,"0:LIVING",NA,"p.R882C; MAF 20%","Poor","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","Busulfan, Cyclophosphamide",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"721","aml_ohsu_2018_2653","aml_ohsu_2018_16-00373",15.59,"0:LIVING",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","Radiation","Busulfan, Cyclophosphamide",NA,NA,NA,NA,NA,NA,NA,NA,NA
"722","aml_ohsu_2018_2654","aml_ohsu_2018_16-00374",14.74,"0:LIVING",NA,NA,"Intermediate","Negative","Radiation","Paclitaxel","Doxorubicin","Cisplatin","5-FU",NA,NA,NA,NA,NA,NA,NA,NA
"723","aml_ohsu_2018_2654","aml_ohsu_2018_16-00374",14.74,"0:LIVING",NA,NA,"Intermediate","Negative","Radiation","Paclitaxel","Doxorubicin","Cisplatin","5-FU",NA,NA,NA,NA,NA,NA,NA,NA
"724","aml_ohsu_2018_2654","aml_ohsu_2018_16-00783",14.74,"0:LIVING",NA,NA,"Intermediate","Negative","Radiation","Paclitaxel","Doxorubicin","Cisplatin","5-FU",NA,NA,NA,NA,NA,NA,NA,NA
"725","aml_ohsu_2018_2654","aml_ohsu_2018_16-00783",14.74,"0:LIVING",NA,NA,"Intermediate","Negative","Radiation","Paclitaxel","Doxorubicin","Cisplatin","5-FU",NA,NA,NA,NA,NA,NA,NA,NA
"726","aml_ohsu_2018_2664","aml_ohsu_2018_16-00392",0.79,"1:DECEASED",NA,NA,"Poor","Negative","Ruxolitinib","Hydroxyurea","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"727","aml_ohsu_2018_2665","aml_ohsu_2018_16-00400",4.61,"0:LIVING","p.R248W; MAF 57%",NA,"Poor","Negative","Azacitidine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"728","aml_ohsu_2018_2675","aml_ohsu_2018_16-00406",4.97,"0:LIVING",NA,"p.R882H; MAF 41%","Intermediate","Negative","Vidaza","7+3 (Cytarabine, Idarubicin)","Azacitidine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"729","aml_ohsu_2018_2678","aml_ohsu_2018_16-00410",10.53,"0:LIVING",NA,NA,"Good","Negative","ATRA, Arsenic Trioxide",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"730","aml_ohsu_2018_2685","aml_ohsu_2018_16-00466",2.37,"1:DECEASED",NA,NA,"Poor","Negative","Fludarabine, Melphalan","Azacitidine","Sorafenib",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"731","aml_ohsu_2018_2685","aml_ohsu_2018_16-00466",2.37,"1:DECEASED",NA,NA,"Poor","Negative","Fludarabine, Melphalan","Azacitidine","Sorafenib",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"732","aml_ohsu_2018_2685","aml_ohsu_2018_16-00533",2.37,"1:DECEASED",NA,NA,"Poor","Negative","Fludarabine, Melphalan","Azacitidine","Sorafenib",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"733","aml_ohsu_2018_2685","aml_ohsu_2018_16-00533",2.37,"1:DECEASED",NA,NA,"Poor","Negative","Fludarabine, Melphalan","Azacitidine","Sorafenib",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"734","aml_ohsu_2018_2687","aml_ohsu_2018_16-00459",8.65,"1:DECEASED",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","Sorafenib","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA
"735","aml_ohsu_2018_2687","aml_ohsu_2018_16-00459",8.65,"1:DECEASED",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","Sorafenib","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA
"736","aml_ohsu_2018_2687","aml_ohsu_2018_16-00486",8.65,"1:DECEASED",NA,"p.P777S; MAF 90%","Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","Sorafenib","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA
"737","aml_ohsu_2018_2687","aml_ohsu_2018_16-00486",8.65,"1:DECEASED",NA,"p.P777S; MAF 90%","Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","Sorafenib","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA
"738","aml_ohsu_2018_2688","aml_ohsu_2018_16-00460",9.14,"1:DECEASED",NA,"p.Trp297* (NM_175629.2); MAF 82.1%","Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","CLAG (Cladribine, Cytarabine, Filgrastim)","Azacitidine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"739","aml_ohsu_2018_2690","aml_ohsu_2018_16-00465",7.66,"0:LIVING",NA,NA,"Poor","Negative","Cytarabine","Sorafenib","Cytarabine, Daunorubicin, and Etoposide","Busulfan, Cyclophosphamide",NA,NA,NA,NA,NA,NA,NA,NA,NA
"740","aml_ohsu_2018_2694","aml_ohsu_2018_16-00474",13.95,"0:LIVING",NA,NA,"Good","Negative","HiDAC","3+7 (Cytarabine, Daunorubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"741","aml_ohsu_2018_2694","aml_ohsu_2018_16-00474",13.95,"0:LIVING",NA,NA,"Good","Negative","HiDAC","3+7 (Cytarabine, Daunorubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"742","aml_ohsu_2018_2694","aml_ohsu_2018_16-00474",13.95,"0:LIVING",NA,NA,"Good","Negative","HiDAC","3+7 (Cytarabine, Daunorubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"743","aml_ohsu_2018_2694","aml_ohsu_2018_16-00474",13.95,"0:LIVING",NA,NA,"Good","Negative","HiDAC","3+7 (Cytarabine, Daunorubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"744","aml_ohsu_2018_2694","aml_ohsu_2018_16-00538",13.95,"0:LIVING",NA,NA,"Good","Negative","HiDAC","3+7 (Cytarabine, Daunorubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"745","aml_ohsu_2018_2694","aml_ohsu_2018_16-00538",13.95,"0:LIVING",NA,NA,"Good","Negative","HiDAC","3+7 (Cytarabine, Daunorubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"746","aml_ohsu_2018_2694","aml_ohsu_2018_16-00538",13.95,"0:LIVING",NA,NA,"Good","Negative","HiDAC","3+7 (Cytarabine, Daunorubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"747","aml_ohsu_2018_2694","aml_ohsu_2018_16-00538",13.95,"0:LIVING",NA,NA,"Good","Negative","HiDAC","3+7 (Cytarabine, Daunorubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"748","aml_ohsu_2018_2694","aml_ohsu_2018_16-00710",13.95,"0:LIVING",NA,NA,"Intermediate","Negative","HiDAC","3+7 (Cytarabine, Daunorubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"749","aml_ohsu_2018_2694","aml_ohsu_2018_16-00710",13.95,"0:LIVING",NA,NA,"Intermediate","Negative","HiDAC","3+7 (Cytarabine, Daunorubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"750","aml_ohsu_2018_2694","aml_ohsu_2018_16-00710",13.95,"0:LIVING",NA,NA,"Intermediate","Negative","HiDAC","3+7 (Cytarabine, Daunorubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"751","aml_ohsu_2018_2694","aml_ohsu_2018_16-00710",13.95,"0:LIVING",NA,NA,"Intermediate","Negative","HiDAC","3+7 (Cytarabine, Daunorubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"752","aml_ohsu_2018_2694","aml_ohsu_2018_17-00059",13.95,"0:LIVING",NA,NA,"Intermediate","Negative","HiDAC","3+7 (Cytarabine, Daunorubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"753","aml_ohsu_2018_2694","aml_ohsu_2018_17-00059",13.95,"0:LIVING",NA,NA,"Intermediate","Negative","HiDAC","3+7 (Cytarabine, Daunorubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"754","aml_ohsu_2018_2694","aml_ohsu_2018_17-00059",13.95,"0:LIVING",NA,NA,"Intermediate","Negative","HiDAC","3+7 (Cytarabine, Daunorubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"755","aml_ohsu_2018_2694","aml_ohsu_2018_17-00059",13.95,"0:LIVING",NA,NA,"Intermediate","Negative","HiDAC","3+7 (Cytarabine, Daunorubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"756","aml_ohsu_2018_2695","aml_ohsu_2018_16-00477",27.4,"0:LIVING",NA,NA,"Intermediate","Negative","HiDAC","Donor Lymphocyte Infusion","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","SWOG S1203 (7+3 +/- Vorinostat)","Hydroxyurea","Decitabine","Bu/Flu/TBI (Busulfan, Fludarabine, Total Body Irradiation)",NA,NA,NA,NA,NA,NA
"757","aml_ohsu_2018_2695","aml_ohsu_2018_16-00477",27.4,"0:LIVING",NA,NA,"Intermediate","Negative","HiDAC","Donor Lymphocyte Infusion","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","SWOG S1203 (7+3 +/- Vorinostat)","Hydroxyurea","Decitabine","Bu/Flu/TBI (Busulfan, Fludarabine, Total Body Irradiation)",NA,NA,NA,NA,NA,NA
"758","aml_ohsu_2018_2695","aml_ohsu_2018_16-00477",27.4,"0:LIVING",NA,NA,"Intermediate","Negative","HiDAC","Donor Lymphocyte Infusion","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","SWOG S1203 (7+3 +/- Vorinostat)","Hydroxyurea","Decitabine","Bu/Flu/TBI (Busulfan, Fludarabine, Total Body Irradiation)",NA,NA,NA,NA,NA,NA
"759","aml_ohsu_2018_2695","aml_ohsu_2018_16-00611",27.4,"0:LIVING",NA,NA,"Good","Positive","HiDAC","Donor Lymphocyte Infusion","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","SWOG S1203 (7+3 +/- Vorinostat)","Hydroxyurea","Decitabine","Bu/Flu/TBI (Busulfan, Fludarabine, Total Body Irradiation)",NA,NA,NA,NA,NA,NA
"760","aml_ohsu_2018_2695","aml_ohsu_2018_16-00611",27.4,"0:LIVING",NA,NA,"Good","Positive","HiDAC","Donor Lymphocyte Infusion","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","SWOG S1203 (7+3 +/- Vorinostat)","Hydroxyurea","Decitabine","Bu/Flu/TBI (Busulfan, Fludarabine, Total Body Irradiation)",NA,NA,NA,NA,NA,NA
"761","aml_ohsu_2018_2695","aml_ohsu_2018_16-00611",27.4,"0:LIVING",NA,NA,"Good","Positive","HiDAC","Donor Lymphocyte Infusion","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","SWOG S1203 (7+3 +/- Vorinostat)","Hydroxyurea","Decitabine","Bu/Flu/TBI (Busulfan, Fludarabine, Total Body Irradiation)",NA,NA,NA,NA,NA,NA
"762","aml_ohsu_2018_2695","aml_ohsu_2018_16-00883",27.4,"0:LIVING",NA,NA,"Good","Positive","HiDAC","Donor Lymphocyte Infusion","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","SWOG S1203 (7+3 +/- Vorinostat)","Hydroxyurea","Decitabine","Bu/Flu/TBI (Busulfan, Fludarabine, Total Body Irradiation)",NA,NA,NA,NA,NA,NA
"763","aml_ohsu_2018_2695","aml_ohsu_2018_16-00883",27.4,"0:LIVING",NA,NA,"Good","Positive","HiDAC","Donor Lymphocyte Infusion","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","SWOG S1203 (7+3 +/- Vorinostat)","Hydroxyurea","Decitabine","Bu/Flu/TBI (Busulfan, Fludarabine, Total Body Irradiation)",NA,NA,NA,NA,NA,NA
"764","aml_ohsu_2018_2695","aml_ohsu_2018_16-00883",27.4,"0:LIVING",NA,NA,"Good","Positive","HiDAC","Donor Lymphocyte Infusion","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","SWOG S1203 (7+3 +/- Vorinostat)","Hydroxyurea","Decitabine","Bu/Flu/TBI (Busulfan, Fludarabine, Total Body Irradiation)",NA,NA,NA,NA,NA,NA
"765","aml_ohsu_2018_2697","aml_ohsu_2018_16-00479",NA,NA,NA,NA,"Intermediate","Negative","Busulfan, Fludarabine","7+3 (Cytarabine, Idarubicin)","Azacitidine","CLAG-M (Cladribine, Cytarabine, Mitoxantrone, Filgrastim)",NA,NA,NA,NA,NA,NA,NA,NA,NA
"766","aml_ohsu_2018_2699","aml_ohsu_2018_16-00481",11.05,"1:DECEASED",NA,NA,"Good","Negative","7+3 (Cytarabine, Idarubicin)","IDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"767","aml_ohsu_2018_2701","aml_ohsu_2018_16-00484",NA,NA,NA,NA,"Intermediate","Negative",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"768","aml_ohsu_2018_2704","aml_ohsu_2018_16-00491",4.24,"1:DECEASED",NA,NA,"Poor","Positive","FLAG (Fludarabine, High-dose Cytarabine, G-CSF)","Hydroxyurea","Decitabine","Fludarabine, Cyclophosphamide, TBI ","Trametinib",NA,NA,NA,NA,NA,NA,NA,NA
"769","aml_ohsu_2018_2704","aml_ohsu_2018_16-00491",4.24,"1:DECEASED",NA,NA,"Poor","Positive","FLAG (Fludarabine, High-dose Cytarabine, G-CSF)","Hydroxyurea","Decitabine","Fludarabine, Cyclophosphamide, TBI ","Trametinib",NA,NA,NA,NA,NA,NA,NA,NA
"770","aml_ohsu_2018_2704","aml_ohsu_2018_16-00491",4.24,"1:DECEASED",NA,NA,"Poor","Positive","FLAG (Fludarabine, High-dose Cytarabine, G-CSF)","Hydroxyurea","Decitabine","Fludarabine, Cyclophosphamide, TBI ","Trametinib",NA,NA,NA,NA,NA,NA,NA,NA
"771","aml_ohsu_2018_2704","aml_ohsu_2018_16-00765",4.24,"1:DECEASED",NA,NA,"Poor","Positive","FLAG (Fludarabine, High-dose Cytarabine, G-CSF)","Hydroxyurea","Decitabine","Fludarabine, Cyclophosphamide, TBI ","Trametinib",NA,NA,NA,NA,NA,NA,NA,NA
"772","aml_ohsu_2018_2704","aml_ohsu_2018_16-00765",4.24,"1:DECEASED",NA,NA,"Poor","Positive","FLAG (Fludarabine, High-dose Cytarabine, G-CSF)","Hydroxyurea","Decitabine","Fludarabine, Cyclophosphamide, TBI ","Trametinib",NA,NA,NA,NA,NA,NA,NA,NA
"773","aml_ohsu_2018_2704","aml_ohsu_2018_16-00765",4.24,"1:DECEASED",NA,NA,"Poor","Positive","FLAG (Fludarabine, High-dose Cytarabine, G-CSF)","Hydroxyurea","Decitabine","Fludarabine, Cyclophosphamide, TBI ","Trametinib",NA,NA,NA,NA,NA,NA,NA,NA
"774","aml_ohsu_2018_2704","aml_ohsu_2018_16-00886",4.24,"1:DECEASED",NA,NA,"Poor","Positive","FLAG (Fludarabine, High-dose Cytarabine, G-CSF)","Hydroxyurea","Decitabine","Fludarabine, Cyclophosphamide, TBI ","Trametinib",NA,NA,NA,NA,NA,NA,NA,NA
"775","aml_ohsu_2018_2704","aml_ohsu_2018_16-00886",4.24,"1:DECEASED",NA,NA,"Poor","Positive","FLAG (Fludarabine, High-dose Cytarabine, G-CSF)","Hydroxyurea","Decitabine","Fludarabine, Cyclophosphamide, TBI ","Trametinib",NA,NA,NA,NA,NA,NA,NA,NA
"776","aml_ohsu_2018_2704","aml_ohsu_2018_16-00886",4.24,"1:DECEASED",NA,NA,"Poor","Positive","FLAG (Fludarabine, High-dose Cytarabine, G-CSF)","Hydroxyurea","Decitabine","Fludarabine, Cyclophosphamide, TBI ","Trametinib",NA,NA,NA,NA,NA,NA,NA,NA
"777","aml_ohsu_2018_2705","aml_ohsu_2018_16-00494",4.87,"1:DECEASED",NA,"p.E283*; MAF 30%","Poor","Negative","3+7 (Cytarabine, Daunorubicin)","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","FLAG (Fludarabine, High-dose Cytarabine, G-CSF)","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA,NA
"778","aml_ohsu_2018_2706","aml_ohsu_2018_16-00498",15.39,"0:LIVING",NA,NA,"Good","Negative","ATRA, Arsenic Trioxide",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"779","aml_ohsu_2018_2708","aml_ohsu_2018_16-00504",8.52,"1:DECEASED",NA,NA,"Good","Positive","HiDAC","AG-221","3+7 (Cytarabine, Daunorubicin)","Azacitidine","MEC (Cytarabine, Etoposide, Mitoxantrone)",NA,NA,NA,NA,NA,NA,NA,NA
"780","aml_ohsu_2018_2712","aml_ohsu_2018_16-00510",9.57,"1:DECEASED",NA,NA,"Poor","Negative","7+3 (Cytarabine, Idarubicin)","ATRA (Tretinoin)","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","anti-CD33","Azacitidine",NA,NA,NA,NA,NA,NA,NA,NA
"781","aml_ohsu_2018_2713","aml_ohsu_2018_16-00519",12.53,"0:LIVING",NA,NA,"Intermediate","Negative","HiDAC","Cyclophosphamide, Fludarabine, TBI","3+7 (Cytarabine, Daunorubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"782","aml_ohsu_2018_2714","aml_ohsu_2018_16-00524",6.64,"0:LIVING","Negative","Negative","Good","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"783","aml_ohsu_2018_2715","aml_ohsu_2018_16-00525",11.58,"0:LIVING",NA,NA,"Poor","Negative","HiDAC","Cyclophosphamide, Fludarabine, TBI","3+7 (Cytarabine, Daunorubicin)","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA
"784","aml_ohsu_2018_2720","aml_ohsu_2018_16-00541",NA,"0:LIVING",NA,NA,"Poor","Negative","CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone)","RVD (Bortezomib, Dexamethasone, Lenalidomide)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"785","aml_ohsu_2018_2721","aml_ohsu_2018_16-00540",NA,NA,NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"786","aml_ohsu_2018_2723","aml_ohsu_2018_16-00547",2.14,"1:DECEASED",NA,NA,"Poor","Negative","HiDAC","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"787","aml_ohsu_2018_2737","aml_ohsu_2018_13-00650",NA,NA,NA,NA,"Good","Positive",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"788","aml_ohsu_2018_2739","aml_ohsu_2018_16-00562",6.22,"0:LIVING",NA,NA,"Poor","Negative","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"789","aml_ohsu_2018_2739","aml_ohsu_2018_16-00562",6.22,"0:LIVING",NA,NA,"Poor","Negative","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"790","aml_ohsu_2018_2739","aml_ohsu_2018_16-01018",6.22,"0:LIVING",NA,NA,"Intermediate","Negative","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"791","aml_ohsu_2018_2739","aml_ohsu_2018_16-01018",6.22,"0:LIVING",NA,NA,"Intermediate","Negative","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"792","aml_ohsu_2018_2740","aml_ohsu_2018_16-00564",NA,"0:LIVING",NA,NA,"Poor","Negative","Radiation",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"793","aml_ohsu_2018_2741","aml_ohsu_2018_16-00566",NA,NA,"Negative","Negative","Intermediate","Positive","GCLAC (GCSF, Clofarabine & Cytarabine)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"794","aml_ohsu_2018_2747","aml_ohsu_2018_16-00701",8.42,"0:LIVING",NA,NA,"Intermediate","Negative","Azacitidine","Fludarabine, Melphalan, ATG",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"795","aml_ohsu_2018_2747","aml_ohsu_2018_16-00701",8.42,"0:LIVING",NA,NA,"Intermediate","Negative","Azacitidine","Fludarabine, Melphalan, ATG",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"796","aml_ohsu_2018_2747","aml_ohsu_2018_16-00701",8.42,"0:LIVING",NA,NA,"Intermediate","Negative","Azacitidine","Fludarabine, Melphalan, ATG",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"797","aml_ohsu_2018_2747","aml_ohsu_2018_16-00822",8.42,"0:LIVING",NA,NA,"Intermediate","Negative","Azacitidine","Fludarabine, Melphalan, ATG",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"798","aml_ohsu_2018_2747","aml_ohsu_2018_16-00822",8.42,"0:LIVING",NA,NA,"Intermediate","Negative","Azacitidine","Fludarabine, Melphalan, ATG",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"799","aml_ohsu_2018_2747","aml_ohsu_2018_16-00822",8.42,"0:LIVING",NA,NA,"Intermediate","Negative","Azacitidine","Fludarabine, Melphalan, ATG",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"800","aml_ohsu_2018_2747","aml_ohsu_2018_17-00096",8.42,"0:LIVING",NA,NA,"Intermediate","Negative","Azacitidine","Fludarabine, Melphalan, ATG",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"801","aml_ohsu_2018_2747","aml_ohsu_2018_17-00096",8.42,"0:LIVING",NA,NA,"Intermediate","Negative","Azacitidine","Fludarabine, Melphalan, ATG",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"802","aml_ohsu_2018_2747","aml_ohsu_2018_17-00096",8.42,"0:LIVING",NA,NA,"Intermediate","Negative","Azacitidine","Fludarabine, Melphalan, ATG",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"803","aml_ohsu_2018_2754","aml_ohsu_2018_16-00595",2.07,"1:DECEASED",NA,NA,"Poor","Negative","7+3 (Cytarabine, Idarubicin)","CLAG (Cladribine, Cytarabine, Filgrastim)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"804","aml_ohsu_2018_2760","aml_ohsu_2018_16-00599",9.21,"0:LIVING",NA,NA,"Intermediate","Negative","Vidaza","Fludarabine, Melphalan","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"805","aml_ohsu_2018_2780","aml_ohsu_2018_16-00618",12.66,"1:DECEASED","Negative","Negative","Intermediate","Negative","FLX925","7+3 (Cytarabine, Idarubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"806","aml_ohsu_2018_2785","aml_ohsu_2018_16-00627",NA,NA,NA,NA,"Poor","Negative","Cytarabine","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"807","aml_ohsu_2018_2786","aml_ohsu_2018_16-00632",NA,NA,NA,"p.Arg882His","Intermediate","Positive",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"808","aml_ohsu_2018_29","aml_ohsu_2018_13-00007",19.57,"1:DECEASED",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","MEC (Cytarabine, Etoposide, Mitoxantrone)",NA,NA,NA,NA,NA,NA,NA,NA,NA
"809","aml_ohsu_2018_3975","aml_ohsu_2018_16-00699",0.3,"1:DECEASED",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"810","aml_ohsu_2018_3976","aml_ohsu_2018_16-00702",NA,NA,NA,NA,"Intermediate","Positive","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"811","aml_ohsu_2018_3978","aml_ohsu_2018_16-00705",60,"1:DECEASED",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","Fludarabine, Cyclophosphamide, TBI",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"812","aml_ohsu_2018_3979","aml_ohsu_2018_16-00708",NA,NA,NA,"Foundation; R882H; MAFs: 44%","Poor","Negative","Azacitidine","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"813","aml_ohsu_2018_3980","aml_ohsu_2018_16-00709",NA,"0:LIVING",NA,NA,"Good","Positive",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"814","aml_ohsu_2018_3986","aml_ohsu_2018_16-00724",6.51,"1:DECEASED","R213fs; MAF 34%",NA,"Poor","Negative","Vidaza","7+3 (Cytarabine, Idarubicin)","Lenalidomide","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA,NA
"815","aml_ohsu_2018_3990","aml_ohsu_2018_16-00731",14.54,"0:LIVING",NA,NA,"Poor","Negative","7+3 (Cytarabine, Idarubicin)","Azacitidine, Midostaurin","Sorafenib","MEC (Cytarabine, Etoposide, Mitoxantrone)","MiDAC","Fludarabine, Cyclophosphamide, Thiotepa, TBI","ALRN-6924",NA,NA,NA,NA,NA,NA
"816","aml_ohsu_2018_3990","aml_ohsu_2018_16-00731",14.54,"0:LIVING",NA,NA,"Poor","Negative","7+3 (Cytarabine, Idarubicin)","Azacitidine, Midostaurin","Sorafenib","MEC (Cytarabine, Etoposide, Mitoxantrone)","MiDAC","Fludarabine, Cyclophosphamide, Thiotepa, TBI","ALRN-6924",NA,NA,NA,NA,NA,NA
"817","aml_ohsu_2018_3990","aml_ohsu_2018_16-00852",14.54,"0:LIVING",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","Azacitidine, Midostaurin","Sorafenib","MEC (Cytarabine, Etoposide, Mitoxantrone)","MiDAC","Fludarabine, Cyclophosphamide, Thiotepa, TBI","ALRN-6924",NA,NA,NA,NA,NA,NA
"818","aml_ohsu_2018_3990","aml_ohsu_2018_16-00852",14.54,"0:LIVING",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","Azacitidine, Midostaurin","Sorafenib","MEC (Cytarabine, Etoposide, Mitoxantrone)","MiDAC","Fludarabine, Cyclophosphamide, Thiotepa, TBI","ALRN-6924",NA,NA,NA,NA,NA,NA
"819","aml_ohsu_2018_4001","aml_ohsu_2018_16-00755",5.16,"0:LIVING",NA,NA,"Poor","Negative","SWOG S0919 (Ida/Ara+Pravastatin) ","Busulfan, Cyclophosphamide",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"820","aml_ohsu_2018_4006","aml_ohsu_2018_16-00766",3.19,"1:DECEASED","Foundation; L206fs*41; MAFs: 31%",NA,"Poor","Negative","Vidaza","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"821","aml_ohsu_2018_4006","aml_ohsu_2018_16-00766",3.19,"1:DECEASED","Foundation; L206fs*41; MAFs: 31%",NA,"Poor","Negative","Vidaza","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"822","aml_ohsu_2018_4006","aml_ohsu_2018_16-00882",3.19,"1:DECEASED",NA,NA,"Poor","Negative","Vidaza","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"823","aml_ohsu_2018_4006","aml_ohsu_2018_16-00882",3.19,"1:DECEASED",NA,NA,"Poor","Negative","Vidaza","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"824","aml_ohsu_2018_4007","aml_ohsu_2018_16-00770",18.26,"0:LIVING",NA,NA,"Intermediate","Negative","Busulfan, Fludarabine","5+2 (Cytarabine, Idarubicin)","HiDAC","7+3 (Cytarabine, Idarubicin, Bortezomib",NA,NA,NA,NA,NA,NA,NA,NA,NA
"825","aml_ohsu_2018_4008","aml_ohsu_2018_16-00771",5.16,"1:DECEASED","p.R282Q, MAF 51%","p.R882C, MAF 51%","Poor","Negative","7+3 (Cytarabine, Idarubicin)","Cytarabine","Etoposide, Mitoxantrone",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"826","aml_ohsu_2018_4028","aml_ohsu_2018_16-00810",6.22,"0:LIVING",NA,NA,"Good","Positive","Fludarabine, Melphalan","MiDAC","7+3 (Cytarabine, Idarubicin) plus Sorafenib",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"827","aml_ohsu_2018_4028","aml_ohsu_2018_16-00810",6.22,"0:LIVING",NA,NA,"Good","Positive","Fludarabine, Melphalan","MiDAC","7+3 (Cytarabine, Idarubicin) plus Sorafenib",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"828","aml_ohsu_2018_4028","aml_ohsu_2018_16-01009",6.22,"0:LIVING",NA,NA,"Intermediate","Negative","Fludarabine, Melphalan","MiDAC","7+3 (Cytarabine, Idarubicin) plus Sorafenib",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"829","aml_ohsu_2018_4028","aml_ohsu_2018_16-01009",6.22,"0:LIVING",NA,NA,"Intermediate","Negative","Fludarabine, Melphalan","MiDAC","7+3 (Cytarabine, Idarubicin) plus Sorafenib",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"830","aml_ohsu_2018_4029","aml_ohsu_2018_16-00818",NA,NA,NA,"p.Ala571Pro; MAF 51.5%","Poor","Negative",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"831","aml_ohsu_2018_4030","aml_ohsu_2018_16-00815",6.48,"0:LIVING",NA,NA,"Good","Positive","Fludarabine, Melphalan","7+3 (Cytarabine, Idarubicin)","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","MiDAC","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA
"832","aml_ohsu_2018_4032","aml_ohsu_2018_16-00820",5.89,"0:LIVING","p.K132R; MAF 45%","p.G570E; MAF 44%","Poor","Negative","Fludarabine, Melphalan","Azacitidine","Hydroxyurea","Idarubicin and Cytarabine",NA,NA,NA,NA,NA,NA,NA,NA,NA
"833","aml_ohsu_2018_4038","aml_ohsu_2018_16-00831",49.01,"1:DECEASED",NA,NA,"Poor","Negative","Vidaza","AG-221","Bortezomib","Cytarabine","Lenalidomide","Decitabine",NA,NA,NA,NA,NA,NA,NA
"834","aml_ohsu_2018_4039","aml_ohsu_2018_16-00836",0.92,"1:DECEASED",NA,"p.R882H; MAF 42%","Intermediate","Positive","S0919 Trial (Pravastatin, Idarubicin, Cytarabine)","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"835","aml_ohsu_2018_4042","aml_ohsu_2018_16-00867",0.26,"1:DECEASED",NA,NA,"Intermediate","Positive","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"836","aml_ohsu_2018_4043","aml_ohsu_2018_16-00846",14.61,"0:LIVING",NA,NA,"Intermediate","Negative","Bu/Cy/ATG","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"837","aml_ohsu_2018_4043","aml_ohsu_2018_16-00846",14.61,"0:LIVING",NA,NA,"Intermediate","Negative","Bu/Cy/ATG","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"838","aml_ohsu_2018_4043","aml_ohsu_2018_16-01017",14.61,"0:LIVING",NA,NA,"Poor","Negative","Bu/Cy/ATG","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"839","aml_ohsu_2018_4043","aml_ohsu_2018_16-01017",14.61,"0:LIVING",NA,NA,"Poor","Negative","Bu/Cy/ATG","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"840","aml_ohsu_2018_4052","aml_ohsu_2018_16-00875",15.3,"0:LIVING",NA,NA,"Poor","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","Cyclophosphamide","CLAG (Cladribine, Cytarabine, Filgrastim)",NA,NA,NA,NA,NA,NA,NA,NA,NA
"841","aml_ohsu_2018_4055","aml_ohsu_2018_16-00880",5.89,"0:LIVING",NA,"p.Arg882His; MAF 39.1%","Good","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"842","aml_ohsu_2018_4074","aml_ohsu_2018_16-00950",19.87,"1:DECEASED",NA,NA,"Good","Positive","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"843","aml_ohsu_2018_4075","aml_ohsu_2018_16-00951",7.34,"0:LIVING",NA,NA,"Poor","Negative","Busulfan, Fludarabine","7+3 (Cytarabine, Idarubicin)","HiDAC","CLAG-M (Cladribine, Cytarabine, Mitoxantrone, Filgrastim)",NA,NA,NA,NA,NA,NA,NA,NA,NA
"844","aml_ohsu_2018_4077","aml_ohsu_2018_16-00968",61.64,"0:LIVING",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"845","aml_ohsu_2018_4078","aml_ohsu_2018_16-00970",0.33,"1:DECEASED",NA,NA,"Poor","Negative","7+3 (Cytarabine, Idarubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"846","aml_ohsu_2018_4083","aml_ohsu_2018_16-00981",8.39,"0:LIVING",NA,NA,"Intermediate","Negative","Busulfan, Fludarabine","7+3 (Cytarabine, Idarubicin) plus CX-01","IDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"847","aml_ohsu_2018_4195","aml_ohsu_2018_16-01004",3.13,"0:LIVING",NA,NA,"Intermediate","Negative","Vidaza","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"848","aml_ohsu_2018_4196","aml_ohsu_2018_16-01005",5.03,"0:LIVING","Negative","Negative","Poor","Negative","7+3 (Cytarabine, Idarubicin) plus Enasidenib","Busulfan, Cyclophosphamide",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"849","aml_ohsu_2018_4197","aml_ohsu_2018_16-01010",20.86,"1:DECEASED",NA,NA,"Good","Positive","7+3 (Cytarabine, Idarubicin)","Sunitinib","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","7+3 (Cytarabine, Idarubicin) plus Sorafenib","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA
"850","aml_ohsu_2018_4197","aml_ohsu_2018_16-01010",20.86,"1:DECEASED",NA,NA,"Good","Positive","7+3 (Cytarabine, Idarubicin)","Sunitinib","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","7+3 (Cytarabine, Idarubicin) plus Sorafenib","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA
"851","aml_ohsu_2018_4197","aml_ohsu_2018_16-01010",20.86,"1:DECEASED",NA,NA,"Good","Positive","7+3 (Cytarabine, Idarubicin)","Sunitinib","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","7+3 (Cytarabine, Idarubicin) plus Sorafenib","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA
"852","aml_ohsu_2018_4197","aml_ohsu_2018_16-01061",20.86,"1:DECEASED",NA,NA,"Good","Positive","7+3 (Cytarabine, Idarubicin)","Sunitinib","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","7+3 (Cytarabine, Idarubicin) plus Sorafenib","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA
"853","aml_ohsu_2018_4197","aml_ohsu_2018_16-01061",20.86,"1:DECEASED",NA,NA,"Good","Positive","7+3 (Cytarabine, Idarubicin)","Sunitinib","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","7+3 (Cytarabine, Idarubicin) plus Sorafenib","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA
"854","aml_ohsu_2018_4197","aml_ohsu_2018_16-01061",20.86,"1:DECEASED",NA,NA,"Good","Positive","7+3 (Cytarabine, Idarubicin)","Sunitinib","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","7+3 (Cytarabine, Idarubicin) plus Sorafenib","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA
"855","aml_ohsu_2018_4197","aml_ohsu_2018_16-01103",20.86,"1:DECEASED",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","Sunitinib","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","7+3 (Cytarabine, Idarubicin) plus Sorafenib","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA
"856","aml_ohsu_2018_4197","aml_ohsu_2018_16-01103",20.86,"1:DECEASED",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","Sunitinib","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","7+3 (Cytarabine, Idarubicin) plus Sorafenib","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA
"857","aml_ohsu_2018_4197","aml_ohsu_2018_16-01103",20.86,"1:DECEASED",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","Sunitinib","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","7+3 (Cytarabine, Idarubicin) plus Sorafenib","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA
"858","aml_ohsu_2018_4201","aml_ohsu_2018_16-01022",13.62,"0:LIVING",NA,"p.R882C; MAF 45%","Good","Positive","MiDAC","FLAG-IDA plus Midostaurin","7+3 (Cytarabine, Idarubicin) plus Dasatinib",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"859","aml_ohsu_2018_4201","aml_ohsu_2018_16-01022",13.62,"0:LIVING",NA,"p.R882C; MAF 45%","Good","Positive","MiDAC","FLAG-IDA plus Midostaurin","7+3 (Cytarabine, Idarubicin) plus Dasatinib",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"860","aml_ohsu_2018_4201","aml_ohsu_2018_16-01192",13.62,"0:LIVING","Negative","p.R882C; MAF 14%","Intermediate","Negative","MiDAC","FLAG-IDA plus Midostaurin","7+3 (Cytarabine, Idarubicin) plus Dasatinib",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"861","aml_ohsu_2018_4201","aml_ohsu_2018_16-01192",13.62,"0:LIVING","Negative","p.R882C; MAF 14%","Intermediate","Negative","MiDAC","FLAG-IDA plus Midostaurin","7+3 (Cytarabine, Idarubicin) plus Dasatinib",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"862","aml_ohsu_2018_4202","aml_ohsu_2018_16-01024",4.9,"1:DECEASED",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"863","aml_ohsu_2018_4205","aml_ohsu_2018_16-01047",30.49,"0:LIVING",NA,NA,"Intermediate","Positive","Cytarabine","Idarubicin and Cytarabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"864","aml_ohsu_2018_4207","aml_ohsu_2018_16-01049",12.24,"1:DECEASED",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","Decitabine","7+3 (Cytarabine, Idarubicin) plus Azacitidine","IDAC","Etoposide, Cytarabine",NA,NA,NA,NA,NA,NA,NA,NA
"865","aml_ohsu_2018_4210","aml_ohsu_2018_16-01055",6.02,"0:LIVING",NA,"p.R882H; MAF 46%","Poor","Negative","7+3 (Cytarabine, Idarubicin)","MEC (Cytarabine, Etoposide, Mitoxantrone)","Busulfan, Cyclophosphamide",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"866","aml_ohsu_2018_4225","aml_ohsu_2018_16-01080",NA,NA,"Negative","Negative","Good","Negative","ATRA, Idarubicin",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"867","aml_ohsu_2018_4226","aml_ohsu_2018_16-01082",NA,NA,NA,NA,"Good","Negative","7+3 (Cytarabine, Idarubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"868","aml_ohsu_2018_4229","aml_ohsu_2018_16-01093",NA,NA,NA,NA,"Intermediate","Negative",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"869","aml_ohsu_2018_4230","aml_ohsu_2018_16-01098",7.11,"0:LIVING",NA,NA,"Intermediate","Positive","HiDAC","7+3 (Cytarabine, Idarubicin) plus Crenolanib","Busulfan, Cyclophosphamide",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"870","aml_ohsu_2018_4231","aml_ohsu_2018_16-01100",0.07,"1:DECEASED",NA,NA,"Good","Positive","Cytarabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"871","aml_ohsu_2018_4232","aml_ohsu_2018_16-01102",11.78,"0:LIVING",NA,NA,"Poor","Negative","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"872","aml_ohsu_2018_4235","aml_ohsu_2018_16-01109",3.82,"0:LIVING","Negative","Negative","Good","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"873","aml_ohsu_2018_4239","aml_ohsu_2018_16-01121",6.05,"0:LIVING",NA,"p.Arg326Cys; MAF 44.5%","Good","Positive","Busulfan, Fludarabine","IDAC plus Midostaurin","7+3 (Cytarabine, Daunorubicin) plus Sorafenib",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"874","aml_ohsu_2018_4240","aml_ohsu_2018_16-01123",11.84,"1:DECEASED",NA,"p.R882H; MAF 35% (previously 32% on 10/10/16)","Intermediate","Positive","Bellicum Trial (Flu/Cy/TBI + ATG + Rituximab then BPX-501)","Dasatinib","7+3 (Cytarabine, Idarubicin)","HiDAC","MEC (Cytarabine, Etoposide, Mitoxantrone)","Sorafenib","Methotrexate",NA,NA,NA,NA,NA,NA
"875","aml_ohsu_2018_4245","aml_ohsu_2018_16-01139",NA,NA,NA,NA,"Intermediate","Negative","Lenalidomide","Azacitidine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"876","aml_ohsu_2018_4247","aml_ohsu_2018_16-01142",15.53,"0:LIVING",NA,NA,"Good","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","MEC (Cytarabine, Etoposide, Mitoxantrone)","Fludarabine, Cyclophosphamide, TBI, Rituximab",NA,NA,NA,NA,NA,NA,NA,NA
"877","aml_ohsu_2018_4248","aml_ohsu_2018_16-01151",11.68,"0:LIVING","Negative","Negative","Good","Positive","Vidaza, BI836858 (anti-CD33)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"878","aml_ohsu_2018_4252","aml_ohsu_2018_16-01185",6.61,"1:DECEASED","Negative","Negative","Poor","Negative","GCLAC (GCSF, Clofarabine & Cytarabine)","Fludarabine, Cyclophosphamide, Thiotepa, TBI",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"879","aml_ohsu_2018_4256","aml_ohsu_2018_16-01191",8.09,"0:LIVING",NA,"p.Gln231fs; MAF 33.2%","Poor","Negative","Vidaza","Fludarabine, Melphalan","7+3 (Cytarabine, Idarubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"880","aml_ohsu_2018_4260","aml_ohsu_2018_16-01201",17.86,"1:DECEASED","Negative","p.R882H; MAF 49%","Poor","Negative","AG-120","7+3 (Cytarabine, Idarubicin)","Azacitidine","MGD006 (CD123 x CD3) ","MEC (Cytarabine, Etoposide, Mitoxantrone)","Decitabine","Incyte trial (azacitidine and JAK 1 inhibitor)",NA,NA,NA,NA,NA,NA
"881","aml_ohsu_2018_4263","aml_ohsu_2018_16-01210",12.99,"0:LIVING",NA,"p.Thr835Met; MAF 47%","Intermediate","Negative","Busulfan, Fludarabine","7+3 (Cytarabine, Idarubicin) plus Crenolanib","IDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"882","aml_ohsu_2018_4263","aml_ohsu_2018_16-01210",12.99,"0:LIVING",NA,"p.Thr835Met; MAF 47%","Intermediate","Negative","Busulfan, Fludarabine","7+3 (Cytarabine, Idarubicin) plus Crenolanib","IDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"883","aml_ohsu_2018_4263","aml_ohsu_2018_16-01216",12.99,"0:LIVING",NA,"p.Thr835Met; MAF 47%","Intermediate","Negative","Busulfan, Fludarabine","7+3 (Cytarabine, Idarubicin) plus Crenolanib","IDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"884","aml_ohsu_2018_4263","aml_ohsu_2018_16-01216",12.99,"0:LIVING",NA,"p.Thr835Met; MAF 47%","Intermediate","Negative","Busulfan, Fludarabine","7+3 (Cytarabine, Idarubicin) plus Crenolanib","IDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"885","aml_ohsu_2018_4271","aml_ohsu_2018_16-01219",10.43,"0:LIVING","Negative","Negative","Good","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"886","aml_ohsu_2018_4273","aml_ohsu_2018_16-01223",1.02,"1:DECEASED",NA,NA,"Intermediate","Negative","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"887","aml_ohsu_2018_4274","aml_ohsu_2018_16-01225",10.39,"1:DECEASED","Negative","Negative","Intermediate","Positive","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"888","aml_ohsu_2018_4275","aml_ohsu_2018_16-01227",13.13,"0:LIVING",NA,NA,"Good","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"889","aml_ohsu_2018_4291","aml_ohsu_2018_16-01237",4.01,"0:LIVING",NA,NA,"Poor","Negative","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"890","aml_ohsu_2018_4299","aml_ohsu_2018_16-01254",9.97,"0:LIVING","Negative","p.R882H; MAF 46%","Good","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"891","aml_ohsu_2018_4303","aml_ohsu_2018_16-01262",0.92,"0:LIVING","Negative","Negative","Good","Negative","ATRA, Arsenic Trioxide, Idarubicin",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"892","aml_ohsu_2018_4307","aml_ohsu_2018_16-01267",11.88,"0:LIVING",NA,"VAF: 42.8%","Good","Positive",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"893","aml_ohsu_2018_4310","aml_ohsu_2018_16-01272",2.63,"1:DECEASED","c.610G>T;p.E204*    MAF 51%","c.2635_2651delAACATGAGCCGCTTGGC; p.N879Efs*36         c.2656C>T; pQ886*    MAF 43%, 36%","Poor","Negative","7+3 (Cytarabine, Idarubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"894","aml_ohsu_2018_4317","aml_ohsu_2018_16-01270",NA,NA,NA,NA,"Intermediate","Negative","Dasatinib",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"895","aml_ohsu_2018_4317","aml_ohsu_2018_16-01270",NA,NA,NA,NA,"Intermediate","Negative","Dasatinib",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"896","aml_ohsu_2018_4317","aml_ohsu_2018_17-00077",NA,NA,"Negative","Negative","Good","Negative","Dasatinib",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"897","aml_ohsu_2018_4317","aml_ohsu_2018_17-00077",NA,NA,"Negative","Negative","Good","Negative","Dasatinib",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"898","aml_ohsu_2018_4324","aml_ohsu_2018_17-00021",9.87,"0:LIVING",NA,NA,"Good","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"899","aml_ohsu_2018_4325","aml_ohsu_2018_17-00025",5.69,"0:LIVING",NA,"p.Arg882His; MAF 41.8%","Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC + Midostaurin","Fludarabine, TBI",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"900","aml_ohsu_2018_4336","aml_ohsu_2018_17-00029",17.24,"0:LIVING",NA,NA,"Poor","Negative","Busulfan, Fludarabine, Thymoglobulin (Bu/Flu/ATG)","HiDAC","3+7 (Cytarabine, Daunorubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"901","aml_ohsu_2018_4359","aml_ohsu_2018_17-00033",1.91,"1:DECEASED",NA,NA,"Good","Positive","7+3 (Cytarabine, Idarubicin)","Azacitidine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"902","aml_ohsu_2018_4363","aml_ohsu_2018_17-00064",9.28,"1:DECEASED","Negative","Negative","Intermediate","Positive","Midostaurin","Fludarabine, Cyclophosphamide, Thiotepa, TBI","7+3 (Cytarabine, Idarubicin) plus Enasidenib",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"903","aml_ohsu_2018_4366","aml_ohsu_2018_17-00072",11.91,"1:DECEASED","Negative","Negative","Intermediate","Negative","Imatinib","Cytarabine","MEC (Cytarabine, Etoposide, Mitoxantrone)","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA
"904","aml_ohsu_2018_4379","aml_ohsu_2018_17-00093",NA,NA,NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"905","aml_ohsu_2018_4380","aml_ohsu_2018_17-00094",5.03,"0:LIVING",NA,"c.2644C>T; p.R882C     MAF 47%","Poor","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"906","aml_ohsu_2018_45","aml_ohsu_2018_10-00507",16.81,"1:DECEASED",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","MiDAC","Cytarabine, Methotrexate",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"907","aml_ohsu_2018_45","aml_ohsu_2018_10-00507",16.81,"1:DECEASED",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","MiDAC","Cytarabine, Methotrexate",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"908","aml_ohsu_2018_45","aml_ohsu_2018_11-00295",16.81,"1:DECEASED",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","MiDAC","Cytarabine, Methotrexate",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"909","aml_ohsu_2018_45","aml_ohsu_2018_11-00295",16.81,"1:DECEASED",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","MiDAC","Cytarabine, Methotrexate",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"910","aml_ohsu_2018_50","aml_ohsu_2018_12-00426",54.44,"1:DECEASED",NA,NA,"Poor",NA,"Cyclophosphamide, TBI","HAM (Cytarabine, Mitoxantrone)","MEC (Cytarabine, Etoposide, Mitoxantrone)","Decitabine","Cytarabine, Mitoxantrone, Sorafenib","ADE (Cytarabine, Daunorubicin & Etoposide)","Donor Lymphocyte Infusion","Cytarabine","Sorafenib","FLAG (Fludarabine, High",NA,NA,NA
"911","aml_ohsu_2018_550","aml_ohsu_2018_12-00023",13.06,"1:DECEASED",NA,NA,"Intermediate","Negative","5+2 (Cytarabine, Idarubicin)","7+3 (Cytarabine, Idarubicin)","MiDAC","Bu/Flu/TBI (Busulfan, Fludarabine, Total Body Irradiation)",NA,NA,NA,NA,NA,NA,NA,NA,NA
"912","aml_ohsu_2018_555","aml_ohsu_2018_12-00371",57.07,"1:DECEASED",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","Cytarabine","3+7 (Cytarabine, Daunorubicin)","Azacitidine","Sorafenib","Clofarabine","Clofarabine, Cytarabine",NA,NA,NA,NA,NA
"913","aml_ohsu_2018_555","aml_ohsu_2018_12-00371",57.07,"1:DECEASED",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","Cytarabine","3+7 (Cytarabine, Daunorubicin)","Azacitidine","Sorafenib","Clofarabine","Clofarabine, Cytarabine",NA,NA,NA,NA,NA
"914","aml_ohsu_2018_555","aml_ohsu_2018_12-00372",57.07,"1:DECEASED",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","Cytarabine","3+7 (Cytarabine, Daunorubicin)","Azacitidine","Sorafenib","Clofarabine","Clofarabine, Cytarabine",NA,NA,NA,NA,NA
"915","aml_ohsu_2018_555","aml_ohsu_2018_12-00372",57.07,"1:DECEASED",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","Cytarabine","3+7 (Cytarabine, Daunorubicin)","Azacitidine","Sorafenib","Clofarabine","Clofarabine, Cytarabine",NA,NA,NA,NA,NA
"916","aml_ohsu_2018_559","aml_ohsu_2018_12-00066",10.23,"1:DECEASED",NA,NA,"Intermediate","Negative","Dasatinib","7+3 (Cytarabine, Idarubicin)","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","Azacitidine",NA,NA,NA,NA,NA,NA,NA,NA,NA
"917","aml_ohsu_2018_584","aml_ohsu_2018_14-00111",42.04,"1:DECEASED","Negative","Negative","Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","Cyclophosphamide, Fludarabine, TBI",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"918","aml_ohsu_2018_635","aml_ohsu_2018_12-00051",23.26,"1:DECEASED",NA,NA,"Intermediate","Positive","Fludarabine, Melphalan","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"919","aml_ohsu_2018_652","aml_ohsu_2018_12-00069",10.16,"1:DECEASED",NA,NA,"Poor","Negative","5+2 (Cytarabine, Idarubicin)","Dasatinib","7+3 (Cytarabine, Idarubicin)","Azacitidine","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA
"920","aml_ohsu_2018_652","aml_ohsu_2018_12-00069",10.16,"1:DECEASED",NA,NA,"Poor","Negative","5+2 (Cytarabine, Idarubicin)","Dasatinib","7+3 (Cytarabine, Idarubicin)","Azacitidine","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA
"921","aml_ohsu_2018_652","aml_ohsu_2018_12-00069",10.16,"1:DECEASED",NA,NA,"Poor","Negative","5+2 (Cytarabine, Idarubicin)","Dasatinib","7+3 (Cytarabine, Idarubicin)","Azacitidine","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA
"922","aml_ohsu_2018_652","aml_ohsu_2018_12-00362",10.16,"1:DECEASED",NA,NA,"Poor","Negative","5+2 (Cytarabine, Idarubicin)","Dasatinib","7+3 (Cytarabine, Idarubicin)","Azacitidine","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA
"923","aml_ohsu_2018_652","aml_ohsu_2018_12-00362",10.16,"1:DECEASED",NA,NA,"Poor","Negative","5+2 (Cytarabine, Idarubicin)","Dasatinib","7+3 (Cytarabine, Idarubicin)","Azacitidine","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA
"924","aml_ohsu_2018_652","aml_ohsu_2018_12-00362",10.16,"1:DECEASED",NA,NA,"Poor","Negative","5+2 (Cytarabine, Idarubicin)","Dasatinib","7+3 (Cytarabine, Idarubicin)","Azacitidine","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA
"925","aml_ohsu_2018_652","aml_ohsu_2018_13-00004",10.16,"1:DECEASED",NA,NA,"Poor","Negative","5+2 (Cytarabine, Idarubicin)","Dasatinib","7+3 (Cytarabine, Idarubicin)","Azacitidine","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA
"926","aml_ohsu_2018_652","aml_ohsu_2018_13-00004",10.16,"1:DECEASED",NA,NA,"Poor","Negative","5+2 (Cytarabine, Idarubicin)","Dasatinib","7+3 (Cytarabine, Idarubicin)","Azacitidine","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA
"927","aml_ohsu_2018_652","aml_ohsu_2018_13-00004",10.16,"1:DECEASED",NA,NA,"Poor","Negative","5+2 (Cytarabine, Idarubicin)","Dasatinib","7+3 (Cytarabine, Idarubicin)","Azacitidine","Hydroxyurea",NA,NA,NA,NA,NA,NA,NA,NA
"928","aml_ohsu_2018_685","aml_ohsu_2018_13-00118",45.33,"1:DECEASED",NA,NA,"Good","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","Azacitidine","GCLAC (GCSF, Clofarabine & Cytarabine)","MEC (Cytarabine, Etoposide, Mitoxantrone)","Decitabine",NA,NA,NA,NA,NA,NA
"929","aml_ohsu_2018_707","aml_ohsu_2018_12-00127",24.34,"1:DECEASED",NA,NA,"Good","Positive","Fludarabine, Melphalan","7+3 (Cytarabine, Idarubicin)","HiDAC","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","MEC (Cytarabine, Etoposide, Mitoxantrone)",NA,NA,NA,NA,NA,NA,NA,NA
"930","aml_ohsu_2018_722","aml_ohsu_2018_12-00150",NA,NA,NA,NA,"Intermediate","Negative",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"931","aml_ohsu_2018_757","aml_ohsu_2018_13-00537",82.66,"1:DECEASED","Negative","Negative","Intermediate","Negative","HiDAC","Decitabine, Sirolimus","Donor Lymphocyte Infusion","3+7 (Cytarabine, Daunorubicin)","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","MEC (Cytarabine, Etoposide, Mitoxantrone)","FLAG (Fludarabine, High-dose Cytarabine, G-CSF)","Decitabine","Busulfan,",NA,NA,NA,NA
"932","aml_ohsu_2018_764","aml_ohsu_2018_12-00211",45.92,"0:LIVING",NA,NA,"Good","Positive","7+3 (Cytarabine, Idarubicin)","ATRA (Tretinoin)","HiDAC","Bu/Flu/TBI (Busulfan, Fludarabine, Total Body Irradiation)",NA,NA,NA,NA,NA,NA,NA,NA,NA
"933","aml_ohsu_2018_799","aml_ohsu_2018_12-00258",4.84,"1:DECEASED",NA,NA,"Poor","Negative","Azacitidine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"934","aml_ohsu_2018_819","aml_ohsu_2018_13-00147",8.45,"1:DECEASED",NA,NA,"Intermediate","Positive","7+3 (Cytarabine, Idarubicin)","HiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"935","aml_ohsu_2018_825","aml_ohsu_2018_12-00294",0.1,"1:DECEASED",NA,NA,"Poor","Negative",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"936","aml_ohsu_2018_829","aml_ohsu_2018_12-00301",42.34,"1:DECEASED",NA,NA,"Good","Negative","7+3 (Cytarabine, Idarubicin)","MiDAC",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"937","aml_ohsu_2018_923","aml_ohsu_2018_12-00423",NA,NA,NA,NA,"Intermediate","Negative","3+7 (Cytarabine, Daunorubicin)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"938","aml_ohsu_2018_924","aml_ohsu_2018_14-00180",20.46,"1:DECEASED","Negative","Negative","Good","Positive","3+7 (Cytarabine, Daunorubicin)","Azacitidine","Azacitidine, Lenalidomide","Decitabine",NA,NA,NA,NA,NA,NA,NA,NA,NA
"939","aml_ohsu_2018_928","aml_ohsu_2018_13-00226",47.01,"0:LIVING","Negative","Negative","Good","Negative","ATRA, Arsenic Trioxide","Idarubicin",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"940","aml_ohsu_2018_953","aml_ohsu_2018_13-00028",39.7,"0:LIVING",NA,"Negative","Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","HiDAC","Donor Lymphocyte Infusion","FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)","Busulfan, Cyclophosphamide",NA,NA,NA,NA,NA,NA,NA,NA
"941","aml_ohsu_2018_958","aml_ohsu_2018_13-00034",0.53,"1:DECEASED",NA,NA,"Intermediate","Negative",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"942","aml_ohsu_2018_967","aml_ohsu_2018_13-00160",38.32,"1:DECEASED",NA,NA,"Intermediate","Negative","7+3 (Cytarabine, Idarubicin)","Azacitidine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
